DeSCID main publications


Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.

Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, RRn
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017, 75, 59-67.

Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, ETG
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.

Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OSG
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.

Günther SC, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.

Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.

Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.

Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, WGfAUitI
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.

Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OSG
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.

Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.

Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, DeSG
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.

Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, Cti
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.

Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.

Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.

Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.

Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.

Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.

Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.

Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.

Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.

Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.

DeSCID exhaustive list of publications


(click to expand or collapse)

 2020                                                                            

Saied WI, Martin-Loeches I, Timsit JF
What is new in non-ventilated ICU-acquired pneumonia?.
Intensive Care Medicine 2020

Barbier F, Mer M, Szychowiak P, Miller RF, Mariotte É, Galicier L, Bouadma L, Tattevin P, Azoulay É
Management of HIV-infected patients in the intensive care unit.
Intensive Care Medicine 2020

TASG, Moulignier A, Viret-Vilayphon AC, Lescure FX, Plaisier E, Salomon L, Lamirel C, Pialoux G
Microalbuminuria: a sentinel of neurocognitive impairment in HIV-infected individuals?.
Journal of Neurology 2020

Sonneville R, Mazighi M, Bresson D, Crassard I, Crozier S, de Montmollin E, Degos V, Faugeras F, Gayat E, Josse L, Lamy C, Magalhaes E, Maldjian A, Ruckly S, Servan J, Vassel P, Vigué B, Timsit JF, Woimant F, Si
Outcomes of Acute Stroke Patients Requiring Mechanical Ventilation: Study Protocol for the SPICE Multicenter Prospective Observational Study.
Neurocritical Care 2020

TFSG, Bénézit F, Loubet P, Galtier F, Pronier C, Lenzi N, Lesieur Z, Jouneau S, Lagathu G, L’Honneur AS, Foulongne V, Vallejo C, Alain S, Duval X, Houhou N, Costa Y, Vanhems P, Amour S, Carrat F, Lina B, Launay O, Tattevin P
Non-influenza respiratory viruses in adult patients admitted with influenza-like illness: a 3-year prospective multicenter study.
Infection 2020

Pichon M, Joly V, Argy N, Houze S, Bretagne S, Alanio A, Wassef M, Verillaud B, Yazdanpanah Y
Aspergillus flavus malignant external otitis in a diabetic patient: case report and literature review.
Infection 2020

Delacôte C, Bauvin P, Louvet A, Dautrecque F, Ntandja Wandji LC, Lassailly G, Voican C, Perlemuter G, Naveau S, Mathurin P, Deuffic-Burban S
A Model to Identify Heavy Drinkers at High Risk for Liver Disease Progression.
Clinical Gastroenterology and Hepatology 2020

Tubiana S, Varon E, Biron C, Ploy MC, Mourvillier B, Taha MK, Revest M, Poyart C, Martin-Blondel G, Lecuit M, Cua E, Pasquet B, Preau M, Hoen B, Duval X, Xavier D, Bruno H, Bruno M, Marie-Cécile P, Sarah T, Emmanuelle V, François C, Pierre-Edouard B, Olivier G, Muhamed-Kheir T, Claire P, Stephane B, François V, Emmanuelle C, Marc L, Alain G, Bruno F, Thomas DB, Daniel LB, François R, AN, Laurent A, Sophie A, Laurence AL, Stephanie B, Regine B, Guilene B, Guillaume B, Louis B, Georges B, Dominique B, Emilie B, Typhaine BP, Charlotte B, Stephane B, Julien B, Patrice B, Sandra B, Aurore B, Sophie B, Alexis BG, Laurent B, Cedric B, François B, Elsa B, Michel B, Jennifer B, Christophe B, Jean C, Mathieu C, Emmanuelle C, Guillaume C, Christophe C, François C, Anne C, Bernard C, Eric C, Charles C, Amelie C, Thibaut CB, Vanessa CM, Chantal C, Caroline CW, Chirouze Catherine CH, Bernard C, Julien C, Jean-Marie C, Hugues C, Philippe C, Joël C, Pierrick C, Eric C, Anne DD, Sylvie D, Nicolas D, Sophie D, Deborah D, Eric D, Pierre-Francois D, Diane D, Elodie D, Jean-Luc D, Jean-Luc D, Jerome D, Aurelien D, Xavier D, Lelia E, Claude F, Frederic F, Clara F, Nathalie F, Emmanuel F, Nicolas F, Amandine, Garandeau GB, Magali G, Denis G, Stephane G, François G, Alain G, Valerie GF, Marine G, Camelia G, Isabelle G, Dominique G, Thomas G, Jerome G, Tahar H, Jean-Pierre H, Sandrine H, Benoit H, Anne-Cecile H, Bruno H, Gabriela I, Sylvain J, Irene J, Françoise J, Cedric J, Marie-Emmanuelle J, Samer K, Flore L, Isabelle L, Philippe L, Etienne L, Henri L, Cecile LB, Vincent LM, Paul LT, Herve L, Sylvie L, Celine L, Adrien L, Chantal L, Ludovic L, Olivier L, Marion L, Claire L, Silvija M, Edith M, Guillaume MB, Matthieu M, Raphael M, Olivier M, Aurore M, Frederic M, Guillaume M, Audrey M, Caroline MM, Adrien M, Joy MY, David M, Stephane M, Natacha M, Sophie N, Yohan N, Maja O, Eric O, Bernard P, Solene PD, Isabelle P, Andre P, Sandrine P, Lionel PP, Claire P, Patrice P, Marie-Cecile P, Laurent P, Patrice P, Marie P, Claire P, Thierry P, Luc Q, François R, Adriatsiferana R, Christophe R, Laurent R, Josette R, Matthieu R, Agnes R, Stephanie RV, Frederic R, Jp R, Florence R, Anne-Laure R, Cecile R, Matthieu S, Dominique S, Carlo S, Luc SJ, Manuela S, Christine S, Valerie ST, Nathalie S, Kerneis S, Olivia S, Simon S, Florence S, Didier T, Jacques T, Nadia V, Nicolas VG, François V, Emmanuelle V, Renaud V, Michel V, Veronique VG, Magali V, Virginie V, Daniel V, Fanny V, Isabelle G, Cédric L, Estelle M, France M, Blandine P, Carine R, Sarah T, S, C, S, S, R, S, A, S, O(P, G(L
Community-acquired bacterial meningitis in adults: in-hospital prognosis, long term disability and determinants of outcome in a multicentre prospective cohort.
Clinical Microbiology and Infection 2020

Visseaux B, Hué S, Le Hingrat Q, Salmona M, Lebourgeois S, Delaugerre C, Descamps D, Chaix ML, Ghosn J
Phylogenetic investigation of HCV-4d epidemic in Paris MSM HIV population reveals a still active outbreak and a strong link to the Netherlands.
Clinical Microbiology and Infection 2020, S1198743X20300616.

Peiffer-Smadja N, Dellière S, Rodriguez C, Birgand G, Lescure FX, Fourati S, Ruppé E
Machine learning in the clinical microbiology laboratory: has the time come for routine practice?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2020

Bouzid D, Zanella MC, Kerneis S, Visseaux B, May L, Schrenzel J, Cattoir V
Rapid diagnostic tests for infectious diseases in the emergency department.
Clinical Microbiology and Infection 2020, S1198743X20301075.

Mizrahi A, Delerue T, Morel H, Le Monnier A, Carbonnelle E, Pilmis B, Zahar JR, obtSJSG
Infections caused by naturally AmpC-producing Enterobacteriaceae: Can we use third-generation cephalosporins? A narrative review.
International Journal of Antimicrobial Agents 2020, 55, 105834.

Benchetrit L, Mathy V, Armand-Lefevre L, Bouadma L, Timsit JF
Successful treatment of septic shock due to NDM-1-producing Klebsiella pneumoniae using ceftazidime/avibactam combined with aztreonam in solid organ transplant recipients: report of two cases.
International Journal of Antimicrobial Agents 2020, 55, 105842.

Tsopra R, Courtine M, Sedki K, Eap D, Cabal M, Cohen S, Bouchaud O, Mechaï F, Lamy JB
AntibioGame®: A serious game for teaching medical students about antibiotic use.
International Journal of Medical Informatics 2020, 136, 104074.

Bailly S, Galerneau LM, Ruckly S, Seiller A, Terzi N, Schwebel C, Dupuis C, Tamisier R, Mourvillier B, Pepin JL, Timsit JF
Impact of obstructive sleep apnea on the obesity paradox in critically ill patients.
Journal of Critical Care 2020, 56, 120-124.

Denis N, Timsit JF, Giaj Levra M, Sakhri L, Duruisseaux M, Schwebel C, Merle P, Pinsolle J, Ferrer L, Moro-Sibilot D, Toffart AC
Impact of systematic advanced care planning in lung cancer patients: A prospective study.
Respiratory Medicine and Research 2020, 77, 11-17.

Tzou PL, Descamps D, Rhee SY, Raugi DN, Charpentier C, Taveira N, Smith RA, Soriano V, de Mendoza C, Holmes SP, Gottlieb GS, Shafer RW
Expanded Spectrum of Antiretroviral-Selected Mutations in Human Immunodeficiency Virus Type 2.
The Journal of Infectious Diseases 2020

Brice J, Sylla M, Desire N, Sayon S, Telly F, Bocar-Fofana D, Murphy R, Peytavin G, Diallo S, Nastouli E, Calvez V, Marcelin AG, Issiaka Maiga A, Lambert-Niclot S
Characterization of drug resistance and the defective HIV reservoir in virally suppressed vertically infected children in Mali.
Journal of Antimicrobial Chemotherapy 2020, dkaa002.

Jary A, Marcelin AG, Charpentier C, Wirden M, Lê MP, Peytavin G, Descamps D, Calvez V
M184V/I does not impact the efficacy of abacavir/lamivudine/dolutegravir use as switch therapy in virologically suppressed patients.
Journal of Antimicrobial Chemotherapy 2020, dkaa019.

Soulie C, Santoro MM, Storto A, Abdi B, Charpentier C, Armenia D, Jary A, Forbici F, Bertoli A, Gennari W, Andreoni M, Mussini C, Antinori A, Perno CF, Calvez V, Ceccherini-Silberstein F, Descamps D, Marcelin AG
Prevalence of doravirine-associated resistance mutations in HIV-1-infected antiretroviral-experienced patients from two large databases in France and Italy.
Journal of Antimicrobial Chemotherapy 2020

Barbier F, Timsit JF
Risk stratification for multidrug-resistant bacteria in patients with skin and soft tissue infection:.
Current Opinion in Infectious Diseases 2020

Timsit J, Leverger G, Milpied N, Gachot B
Treatment of invasive fungal infections in intensive care units with micafungin: the MYRIADE study.
Mycoses 2020, myc.13060.

Le Hingrat Q, Visseaux B, Bertine M, Chauveau L, Schwartz O, Collin F, Damond F, Matheron S, Descamps D, Charpentier C
Genetic variability of Long Terminal Repeat region between HIV-2 groups impacts transcriptional activity.
Journal of Virology 2020

Bouchaud O, Matheron S, Loarec A, Dupouy Camet J, Bourée P, Godineau N, Poilane I, Cailhol J, Caumes E
Imported loiasis in France: a retrospective analysis of 167 cases with comparison between sub-Saharan and non sub-Saharan African patients.
BMC Infectious Diseases 2020, 20,

tPRSG, Birgand G, Mutters NT, Ahmad R, Tacconelli E, Lucet JC, Holmes A
Risk perception of antimicrobial resistance by infection control specialists in Europe: a case-vignette study.
Antimicrobial Resistance & Infection Control 2020, 9, 33.

Fauroux B, Hascoët JM, Jarreau PH, Magny JF, Rozé JC, Saliba E, Schwarzinger M, Katz M
Risk factors for bronchiolitis hospitalization in infants: A French nationwide retrospective cohort study over four consecutive seasons (2009-2013).
PLOS ONE 2020, 15, e0229766.

Bernard Stoecklin S, Rolland P, Silue Y, Mailles A, Campese C, Simondon A, Mechain M, Meurice L, Nguyen M, Bassi C, Yamani E, Behillil S, Ismael S, Nguyen D, Malvy D, Lescure FX, Georges S, Lazarus C, Tabaï A, Stempfelet M, Enouf V, Coignard B, Levy-Bruhl D, It
First cases of coronavirus disease 2019 (COVID-19) in France: surveillance, investigations and control measures, January 2020.
Eurosurveillance 2020, 25,

Lévy Y, Lelièvre JD, Assoumou L, Aznar E, Pulido F, Tambussi G, Crespo M, Meybeck A, Molina JM, Delaugerre C, Izopet J, Peytavin G, Cardon F, Diallo A, Lancar R, Béniguel L, Costagliola D
Addition of Maraviroc Versus Placebo to Standard Antiretroviral Therapy for Initial Treatment of Advanced HIV Infection: A Randomized Trial.
Annals of Internal Medicine 2020

 2019                                                                            

Garrouste-Orgeas M, Bailly S, Timsit JF
Use of an ICU Diary and Patient Posttraumatic Stress Disorder Symptoms—Reply.
JAMA 2019, 322, 2025.

Garrouste-Orgeas M, Flahault C, Vinatier I, Rigaud JP, Thieulot-Rolin N, Mercier E, Rouget A, Grand H, Lesieur O, Tamion F, Hamidfar R, Renault A, Parmentier-Decrucq E, Monseau Y, Argaud L, Bretonnière C, Lautrette A, Badié J, Boulet E, Floccard B, Forceville X, Kipnis E, Soufir L, Valade S, Bige N, Gaffinel A, Hamzaoui O, Simon G, Thirion M, Bouadma L, Large A, Mira JP, Amdjar-Badidi N, Jourdain M, Jost PH, Maxime V, Santoli F, Ruckly S, Vioulac C, Leborgne MA, Bellalou L, Fasse L, Misset B, Bailly S, Timsit JF
Effect of an ICU Diary on Posttraumatic Stress Disorder Symptoms Among Patients Receiving Mechanical Ventilation: A Randomized Clinical Trial.
JAMA 2019, 322, 229-239.

Brunet-Possenti F, Charpentier C, Bouhnik Y, Deschamps L, Descamps D, Moins-Teisserenc H, Descamps V
Occurrence of Extensive Cutaneous Human Papillomavirus Infection After Initiation of Tofacitinib Therapy.
JAMA Dermatology 2019, 155, 629.

Luyt CE, Forel JM, Hajage D, Jaber S, Cayot-Constantin S, Rimmelé T, Coupez E, Lu Q, Diallo MH, Penot-Ragon C, Clavel M, Schwebel C, Timsit JF, Bedos JP, Hauw-Berlemont C, Bourenne J, Mayaux J, Lefrant JY, Mira JP, Combes A, Wolff M, Chastre J, Papazian L, ftPTfHSGREdreVAN
Acyclovir for Mechanically Ventilated Patients With Herpes Simplex Virus Oropharyngeal Reactivation: A Randomized Clinical Trial.
JAMA Internal Medicine 2019

Heyard R, Timsit J, Essaied WI, Held L, obotCc
Dynamic clinical prediction models for discrete time‐to‐event data with competing risks—A case study on the OUTCOMEREA database.
Biometrical Journal 2019, 61, 514-534.

von Cube M, Schumacher M, Putter H, Timsit JF, van de Velde C, Wolkewitz M
The population-attributable fraction for time-dependent exposures using dynamic prediction and landmarking.
Biometrical Journal. Biometrische Zeitschrift 2019

Heyard R, Timsit JF, Held L, CMc
Validation of discrete time-to-event prediction models in the presence of competing risks.
Biometrical Journal. Biometrische Zeitschrift 2019

Avettand-Fenoel V, Bayan T, Gardiennet E, Boufassa F, Lopez P, Lecuroux C, Noel N, Trémeaux P, Monceaux V, Autran B, Meyer L, Saez-Cirion A, Lambotte O, Rouzioux C, CACSG
Dynamics in HIV-DNA levels over time in HIV controllers.
Journal of the International AIDS Society 2019, 22, e25221.

Lê MP, Valantin MA, Assoumou L, Soulie C, Le Mestre S, Weiss L, Yazdanpanah Y, Molina JM, Bouchaud O, Raffi F, Reynes J, Calvez V, Marcelin AG, Costagliola D, Katlama C, Peytavin G, A1Esg
Lack of a Clinically Significant Pharmacokinetic Interaction between Etravirine and Raltegravir Using an Original Approach Based on Drug Metabolism, Protein Binding, and Penetration in Seminal Fluid: A Pharmacokinetic Substudy of the ANRS-163 ETRAL Study.
Pharmacotherapy 2019, 39, 514-520.

von Cube M, Schumacher M, Bailly S, Timsit JF, Lepape A, Savey A, Machut A, Wolkewitz M
The population-attributable fraction for time-dependent exposures and competing risks-A discussion on estimands.
Statistics in Medicine 2019

Lucet JC, Heard I, Roueli A, Lafourcade A, Mandelbrot L, Estellat C, Dommergues M, PSG
Transvaginal ultrasound probes are human papillomavirus-free following low-level disinfection: cross-sectional multicenter survey.
Ultrasound in Obstetrics & Gynecology: The Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology 2019, 54, 688-695.

tIASG, Kalfon P, Alessandrini M, Boucekine M, Renoult S, Geantot MA, Deparis-Dusautois S, Berric A, Collange O, Floccard B, Mimoz O, Julien A, Robert R, Audibert J, Renault A, Follin A, Thevenin D, Revel N, Venot M, Patrigeon RG, Signouret T, Fromentin M, Sharshar T, Vigne C, Pottecher J, Levrat Q, Sossou A, Garrouste-Orgeas M, Quenot JP, Boulle C, Azoulay E, Baumstarck K, Auquier P
Tailored multicomponent program for discomfort reduction in critically ill patients may decrease post-traumatic stress disorder in general ICU survivors at 1 year.
Intensive Care Medicine 2019, 45, 223-235.

Timsit JF, Bassetti M, Cremer O, Daikos G, de Waele J, Kallil A, Kipnis E, Kollef M, Laupland K, Paiva JA, Rodríguez-Baño J, Ruppé É, Salluh J, Taccone FS, Weiss E, Barbier F
Rationalizing antimicrobial therapy in the ICU: a narrative review.
Intensive Care Medicine 2019, 45, 172-189.

Papin G, Sonneville R, Nataf P, Bouadma L
Emergency craniotomy in semi-lateral position for posterior fossa hemorrhage evacuation under venoarterial extracorporeal membrane oxygenation.
Intensive Care Medicine 2019

Schnell D, Montlahuc C, Bruneel F, Resche-Rigon M, Kouatchet A, Zahar JR, Darmon M, Pene F, Lemiale V, Rabbat A, Vincent F, Azoulay E, Mokart D
De-escalation of antimicrobial therapy in critically ill hematology patients: a prospective cohort study.
Intensive Care Medicine 2019, 45, 743-745.

Timsit JF, Citerio G, Lavilloniere M, Perner A, Ruckly S, Bakker J, Bassetti M, Benoit D, Curtis JR, Doig GS, Herridge M, Jaber S, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Determinants of downloads and citations for articles published in Intensive Care Medicine.
Intensive Care Medicine 2019, 45, 1058-1060.

Pons S, Timsit JF, Ruckly S, Schwebel C, Papazian L, Azoulay E, Reignier J, Zafrani L
Impact of macrolide therapy in critically ill patients with acute respiratory failure: a desirability of outcome ranking analysis to investigate the OUTCOMEREA database.
Intensive Care Medicine 2019

Timsit JF, Sonneville R, Kalil AC, Bassetti M, Ferrer R, Jaber S, Lanternier F, Luyt CE, Machado F, Mikulska M, Papazian L, Pène F, Poulakou G, Viscoli C, Wolff M, Zafrani L, Van Delden C
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients.
Intensive Care Medicine 2019

Martin-Loeches I, Antonelli M, Cuenca-Estrella M, Dimopoulos G, Einav S, De Waele JJ, Garnacho-Montero J, Kanj SS, Machado FR, Montravers P, Sakr Y, Sanguinetti M, Timsit JF, Bassetti M
ESICM/ESCMID task force on practical management of invasive candidiasis in critically ill patients.
Intensive Care Medicine 2019

Timsit JF, Schwebel C, Styfalova L, Cornet M, Poirier P, Forrestier C, Ruckly S, Jacob MC, Souweine B
Impact of bronchial colonization with Candida spp. on the risk of bacterial ventilator-associated pneumonia in the ICU: the FUNGIBACT prospective cohort study.
Intensive Care Medicine 2019

Blot S, Poulakou G, Timsit JF
Catheter-associated bloodstream infection rates: how low can you go?.
Intensive Care Medicine 2019, 45, 896-897.

Jaquet P, de Montmollin E, Dupuis C, Sazio C, Conrad M, Susset V, Demeret S, Tadie JM, Argaud L, Barbier F, Sarton B, Chabane R, Daubin D, Brulé N, Lerolle N, Alves M, Da Silva D, Kalioubi AE, Silva S, Bailly P, Wolff M, Bouadma L, Timsit JF, Sonneville R, Esg
Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study.
Intensive Care Medicine 2019, 45, 1103-1111.

May F, Peytavin G, Fourati S, Pressiat C, Carteaux G, Razazi K, Mekontso Dessap A, de Prost N
Paracetamol absorption test to detect poor enteric absorption of oseltamivir in intensive care unit patients with severe influenza: a pilot study.
Intensive Care Medicine 2019, 45, 1484-1486.

Laurent A, Reignier J, Le Gouge A, Cottereau A, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Robert R, Kentish-Barnes N
"You helped me keep my head above water"-experience of bereavement research after loss of a loved one in the ICU: insights from the ARREVE study.
Intensive Care Medicine 2019, 45, 1252-1261.

Lucet JC, Harris AD, Guidet B
Less contact isolation is more in the ICU: not sure.
Intensive Care Medicine 2019

Buetti N, Ruckly S, Lucet JC, Mimoz O, Souweine B, Timsit JF
Short-term dialysis catheter versus central venous catheter infections in ICU patients: a post hoc analysis of individual data of 4 multi-centric randomized trials.
Intensive Care Medicine 2019

Blot S, Antonelli M, Arvaniti K, Blot K, Creagh-Brown B, de Lange D, De Waele J, Deschepper M, Dikmen Y, Dimopoulos G, Eckmann C, Francois G, Girardis M, Koulenti D, Labeau S, Lipman J, Lipovestky F, Maseda E, Montravers P, Mikstacki A, Paiva JA, Pereyra C, Rello J, Timsit JF, Vogelaers D, ASS(gobotTGotESoICM
Epidemiology of intra-abdominal infection and sepsis in critically ill patients: "AbSeS", a multinational observational cohort study and ESICM Trials Group Project.
Intensive Care Medicine 2019, 45, 1703-1717.

Denny KJ, Kumar A, Timsit JF, Laupland KB
Extra-cardiac endovascular infections in the critically ill.
Intensive Care Medicine 2019

Tabah A, Bassetti M, Kollef MH, Zahar JR, Paiva JA, Timsit JF, Roberts JA, Schouten J, Giamarellou H, Rello J, De Waele J, Shorr AF, Leone M, Poulakou G, Depuydt P, Garnacho-Montero J
Antimicrobial de-escalation in critically ill patients: a position statement from a task force of the European Society of Intensive Care Medicine (ESICM) and European Society of Clinical Microbiology and Infectious Diseases (ESCMID) Critically Ill Patients Study Group (ESGCIP).
Intensive Care Medicine 2019

Delerue T, Cordel H, Delerue T, Figoni J, Dziri S, Billard-Pomares T, Bouchaud O, Carbonnelle E, Zahar JR
Prediction of methicillin-resistant Staphylococcus aureus bloodstream infection: do we need rapid diagnostic tests?.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019, 38, 1319-1326.

ftESG, Rello J, Ramírez-Estrada S, Romero A, Arvaniti K, Koulenti D, Nseir S, Oztoprak N, Bouadma L, Vidaur L, Lagunes L, Peña-López Y
Factors associated with ventilator-associated events: an international multicenter prospective cohort study.
European Journal of Clinical Microbiology & Infectious Diseases 2019, 38, 1693-1699.

Senard O, Lafaurie M, Lesprit P, Nguyen Y, Lescure X, Therby A, Fihman V, Oubaya N, Lepeule R
Efficacy of cefoxitin versus carbapenem in febrile male urinary tract infections caused by extended spectrum beta-lactamase-producing Escherichia coli: a multicenter retrospective cohort study with propensity score analysis.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2019

Mageau A, Timsit JF, Perrozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Sacre K
The burden of chronic kidney disease in systemic lupus erythematosus: A nationwide epidemiologic study.
Autoimmunity Reviews 2019, 18, 733-737.

Tacconelli E, Mazzaferri F, de Smet AM, Bragantini D, Eggimann P, Huttner BD, Kuijper EJ, Lucet JC, Mutters NT, Sanguinetti M, Schwaber MJ, Souli M, Torre-Cisneros J, Price JR, Rodríguez-Baño J
ESCMID-EUCIC clinical guidelines on decolonization of multidrug-resistant Gram-negative bacteria carriers.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019, 25, 807-817.

Ferré VM, Ekouevi DK, Gbeasor-Komlanvi FA, Collin G, Le Hingrat Q, Tchounga B, Salou M, Descamps D, Charpentier C, Dagnra AC
Prevalence of human papillomavirus, human immunodeficiency virus and other sexually transmitted infections among female sex workers in Togo: a national cross-sectional survey.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019

Loubet P, Tubiana S, Claessens YE, Epelboin L, Ficko C, Le Bel J, Rammaert B, Garin N, Prendki V, Stirnemann J, Leport C, Yazdanpanah Y, Varon E, Duval X, Esg, ScSc, Ac, Ci, Madm, S
Community-acquired pneumonia in the emergency department: an algorithm to facilitate diagnosis and guide chest CT scan indication.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019

Schweitzer VA, van Werkhoven CH, Rodríguez Baño J, Bielicki J, Harbarth S, Hulscher M, Huttner B, Islam J, Little P, Pulcini C, Savoldi A, Tacconelli E, Timsit JF, van Smeden M, Wolkewitz M, Bonten MJM, Walker AS, Llewelyn MJ, JPIoAR(WGoDoASE
Optimizing design of research to evaluate antibiotic stewardship interventions: consensus recommendations of a multinational working group.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019

Peiffer-Smadja N, Rawson TM, Ahmad R, Buchard A, Pantelis G, Lescure FX, Birgand G, Holmes AH
Machine learning for clinical decision support in infectious diseases: a narrative review of current applications.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019

de Grooth HJ, Timsit JF, Mermel L, Mimoz O, Buetti N, du Cheyron D, Oudemans-van Straaten HM, Parienti JJ, 3CaDg
Validity of surrogate endpoints assessing central venous catheter-related infection: evidence from individual- and study-level analyses.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2019

Saliba R, Zahar JR, El Allaoui F, Carbonnelle E, Lescat M
Impact of freeze/thaw cycles and single freezing at −80 °C on the viability of aerobic bacteria from rectal swabs performed with the ESwabTM system.
Diagnostic Microbiology and Infectious Disease 2019, 114895.

Pilmis B, Lourtet-Hascoët J, Barraud O, Piau C, Isnard C, Hery-Arnaud G, Amara M, Merens A, Farfour E, Thomas E, Jacquier H, Zahar JR, Bonnet E, Monnier AL, Cattoir V, Corvec S, Boutoille D, de Ponfilly GP, Reissier S, GSG
Be careful about MICs to amoxicillin for patients with Streptococci-related infective endocarditis.
International Journal of Antimicrobial Agents 2019, 53, 850-854.

Martin-Loeches I, Timsit JF, Leone M, de Waele J, Sartelli M, Kerrigan S, Azevedo LCP, Einav S
Clinical controversies in abdominal sepsis. Insights for critical care settings.
Journal of Critical Care 2019, 53, 53-58.

Saliba R, Neulier C, Seytre D, Fiacre A, Faibis F, Leduc P, Amara M, Jauréguy F, Carbonnelle E, Zahar JR, Marty L
Can real-time polymerase chain reaction allow a faster recovery of hospital activity in cases of an incidental discovery of carbapenemase-producing Enterobacteriaceae and vancomycin-resistant Enterococci carriers?.
Journal of Hospital Infection 2019, 103, 115-120.

Saliba R, Aho Glélé LS, Sarkis DK, Zahar JR
Evaluation of PCR assays for direct screening of Carbapenemase-Producing Enterobacteriaceae (CPE) from rectal swabs: a diagnostic meta-analysis.
Journal of Hospital Infection 2019

Pilmis B, Billard-Pomares T, Martin M, Clarempuy C, Lemezo C, Saint-Marc C, Bourlon N, Seytre D, Carbonnelle E, Zahar JR
Can we explain environmental contamination by particular traits associated with patients?.
The Journal of Hospital Infection 2019

Mageau A, Sacré K, Perozziello A, Ruckly S, Dupuis C, Bouadma L, Papo T, Timsit JF
Septic shock among patients with systemic lupus erythematosus: short and long-term outcome. Analysis of a French nationwide database.
The Journal of Infection 2019

de Montmollin E, Ruckly S, Schwebel C, Philippart F, Adrie C, Mariotte E, Marcotte G, Cohen Y, Sztrymf B, da Silva D, Bruneel F, Gainnier M, Garrouste-Orgeas M, Sonneville R, Timsit JF, OSG
Pneumonia in acute ischemic stroke patients requiring invasive ventilation: Impact on short and long-term outcomes.
The Journal of Infection 2019, 79, 220-227.

Saied WI, Merceron S, Schwebel C, Monnier AL, Oziel J, Garrouste-Orgeas M, Marcotte G, Ruckly S, Souweine B, Darmon M, Bouadma L, de Montmollin E, Mourvillier B, Reignier J, Papazian L, Siami S, Azoulay E, Bédos JP, Timsit JF
Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: Risk factors and outcome.
The Journal of Infection 2019

Pugliese P, Joly V, Valantin M, Cotte L, Huleux T, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Cuzin L
Which antiretrovirals should be prescribed as first-line treatments? Changes over the past 10 years in France.
Médecine et Maladies Infectieuses 2019, 49, 264-269.

Delaigue S, Signolet I, Consigny PH, de Gentile L, D'Ortenzio E, Gautret P, Sorge F, Strady C, Bouchaud O
New guidelines for the prevention of imported malaria in France.
Medecine Et Maladies Infectieuses 2019

Epelboin L, Rapp C, Faucher JF, Méchaï F, Bottieau E, Matheron S, Malvy D, Caumes E
Management and treatment of uncomplicated imported malaria in adults. Update of the French malaria clinical guidelines.
Medecine Et Maladies Infectieuses 2019

Bru JP, Alfandari S, Bleibtreu A, Chavanet P, Gauzit R, Lescure X, Lesprit P, Tattevin P
Carbapenems versus beta-lactam/beta-lactamase inhibitors to treat ESBL-producing Enterobacteriaceae infections.
Medecine Et Maladies Infectieuses 2019

Bleibtreu A, Bertine M, Bertin C, Houhou-Fidouh N, Visseaux B
Focus on Middle East respiratory syndrome coronavirus (MERS-CoV).
Medecine Et Maladies Infectieuses 2019

San C, Lê MP, Matheron S, Mourvillier B, Caseris M, Timsit JF, Wolff M, Yazdanpanah Y, Descamps D, Peytavin G
Management of oral antiretroviral administration in patients with swallowing disorders or with an enteral feeding tube.
Medecine Et Maladies Infectieuses 2019

Peiffer-Smadja N, Harent S, Messeca C, Lechapt-Zalcman E, Yazdanpanah Y, Joly V
A case of thoracic actinomycosis presenting as sudden paraplegia.
Revue Neurologique 2019, 175, 89-92.

Méchaï F, Bouchaud O
Tuberculous meningitis: Challenges in diagnosis and management.
Revue Neurologique 2019, 175, 451-457.

Jolivet S, Lucet JC
Surgical field and skin preparation.
Orthopaedics & Traumatology: Surgery & Research 2019, 105, S1-S6.

Pistone T, Ouattara E, Gabillard D, Lele N, Duvignaud A, Cordel H, Malvy D, Bouchaud O, Abgrall S, AVSG
Travel-related health events and their risk factors in HIV-infected sub-Saharan migrants living in France and visiting their native country: The ANRS VIHVO cohort study.
Travel Medicine and Infectious Disease 2019

Leroy J, Houzé S, Dardé ML, Yéra H, Rossi B, Delhaes L, Gabriel F, Loubet P, Deleplancque AS, Senneville E, Ajana F, Sendid B, Malvy D
Severe toxoplasmosis imported from tropical Africa in immunocompetent patients: A case series.
Travel Medicine and Infectious Disease 2019, 101509.

Le Hingrat Q, Perrier M, Charpentier C, Jacquot A, Houhou-Fidouh N, Descamps D, Visseaux B
Was Zika introduced to Brazil by participants at the 2013 Beach Soccer World Cup held in Tahiti: A phylogeographical analysis.
Travel Medicine and Infectious Disease 2019, 101512.

Billard-Pomares T, Bleibtreu A, Walewski V, Dziri S, Barbat A, Zahar JR, Cruaud P, Carbonnelle E
Proposition of a safe Mycobacterium tuberculosis complex denaturation method that does not compromise the integrity of DNA for whole-genome sequencing.
Tuberculosis 2019, 117, 62-64.

Kollef MH, Nováček M, Kivistik Ü, Réa-Neto Á, Shime N, Martin-Loeches I, Timsit JF, Wunderink RG, Bruno CJ, Huntington JA, Lin G, Yu B, Butterton JR, Rhee EG
Ceftolozane-tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial.
The Lancet. Infectious Diseases 2019

Lucet JC, Zahar JR
Simplified control measures for ESBL-producing Enterobacteriacae?.
The Lancet. Infectious Diseases 2019, 19, 1036-1037.

Wohl DA, Yazdanpanah Y, Baumgarten A, Clarke A, Thompson MA, Brinson C, Hagins D, Ramgopal MN, Antinori A, Wei X, Acosta R, Collins SE, Brainard D, Martin H
Bictegravir combined with emtricitabine and tenofovir alafenamide versus dolutegravir, abacavir, and lamivudine for initial treatment of HIV-1 infection: week 96 results from a randomised, double-blind, multicentre, phase 3, non-inferiority trial.
The lancet. HIV 2019, 6, e355-e363.

Le Hingrat Q, Charpentier C, Ghosn J, Thiébaut R, Peytavin G, Descamps D, Matheron S
New insights are game-changers in HIV-2 disease management.
The lancet. HIV 2019, 6, e214.

Eholie SP, Moh R, Benalycherif A, Gabillard D, Ello F, Messou E, Zoungrana J, Diallo I, Diallo M, Bado G, Cisse M, Maiga AI, Anzian A, Toni Td, Congo-Ouedraogo M, Toure-Kane C, Seydi M, Minta DK, Sawadogo A, Sangaré L, Drabo J, Karcher S, Le Carrou J, de Monteynard LA, Peytavin G, Gabassi A, Girard PM, Chaix ML, Anglaret X, Landman R, TA1SG
Implementation of an intensive adherence intervention in patients with second-line antiretroviral therapy failure in four west African countries with little access to genotypic resistance testing: a prospective cohort study.
The lancet. HIV 2019, 6, e750-e759.

Birgand G, Azevedo C, Rukly S, Pissard-Gibollet R, Toupet G, Timsit JF, Lucet JC, ASG
Motion-capture system to assess intraoperative staff movements and door openings: Impact on surrogates of the infectious risk in surgery.
Infection Control and Hospital Epidemiology 2019, 1-8.

Vieillard V, Combadière B, Tubiana R, Launay O, Pialoux G, Cotte L, Girard PM, Simon A, Dudoit Y, Reynes J, Rockstroh J, Garcia F, Gatell J, Devidas A, Yazdanpanah Y, Weiss L, Fätkenheuer G, Autran B, Joyeux D, Gharakhanian S, Debré P, Katlama C
HIV therapeutic vaccine enhances non-exhausted CD4+ T cells in a randomised phase 2 trial.
NPJ vaccines 2019, 4, 25.

Assi A, Abu Zaki S, Ghosn J, Kinge N, Naous J, Ghanem A, Abou Abbas D, Bakouny Z, Azzi G, Tomb R
Prevalence of HIV and other sexually transmitted infections and their association with sexual practices and substance use among 2238 MSM in Lebanon.
Scientific Reports 2019, 9, 15142.

Buetti N, Timsit JF
Management and Prevention of Central Venous Catheter-Related Infections in the ICU.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 508-523.

Kernéis S, Lucet JC
Controlling the Diffusion of Multidrug-Resistant Organisms in Intensive Care Units.
Seminars in Respiratory and Critical Care Medicine 2019, 40, 558-568.

Triki D, Kermarrec M, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effects of sequence variations between HIV-1 and HIV-2 proteases on their three-dimensional structures.
Journal of Biomolecular Structure and Dynamics 2019, 1-20.

Couffignal C, Papot E, Etienne A, Legac S, Laouénan C, Beres D, Blum L, Khuong-Josses MA, Lepretre A, Papazian P, Yazdanpanah Y, Bouvet E
Treatment as prevention (TasP) and perceived sexual changes in behavior among HIV-positive persons: a French survey in infectious diseases departments in Paris.
AIDS care 2019, 1-7.

Leo S, Lazarevic V, Gaïa N, Estellat C, Girard M, Matheron S, Armand-Lefèvre L, Andremont A, Schrenzel J, Ruppé E
The intestinal microbiota predisposes to traveler’s diarrhea and to the carriage of multidrug-resistant Enterobacteriaceae after traveling to tropical regions.
Gut Microbes 2019, 10, 631-641.

Parisey M, Louni F, Bouvet E, Landman R, Charpentier C, Lariven S, Joly V, Villemant A, Mackoumbou-Nkouka C, Yazdanpanah Y, Burdet C
HIV Infection in North African Patients.
AIDS research and human retroviruses 2019, 35, 628-633.

Bonnet B, Blum L, Charpentier C, Martres P, Ritvo PG, Autran B, Guihot A
Short Communication: Extremely Severe CD4 Lymphopenia During HIV-1 Primary Infection.
AIDS research and human retroviruses 2019, 35, 930-933.

Cousien A, Abel S, Monthieux A, Andronico A, Calmont I, Cervantes M, Cesaire R, Gallian P, de lamballerie X, Laouenan C, Najioullah F, Pierre-Francois S, Pircher M, Salje H, ten Bosch QA, Cabie A, Cauchemez S
Assessing Zika Virus Transmission Within Households During an Outbreak in Martinique, 2015-2016.
American Journal of Epidemiology 2019, 188, 1389-1396.

Weiss E, Zahar JR, Alder J, Asehnoune K, Bassetti M, Bonten MJM, Chastre J, De Waele J, Dimopoulos G, Eggimann P, Engelhardt M, Ewig S, Kollef M, Lipman J, Luna C, Martin-Loeches I, Pagani L, Palmer LB, Papazian L, Poulakou G, Prokocimer P, Rello J, Rex JH, Shorr AF, Talbot GH, Thamlikitkul V, Torres A, Wunderink RG, Timsit JF
Elaboration of consensus clinical endpoints to evaluate antimicrobial treatment efficacy in future HABP/VABP clinical trials.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019

Hage-Sleiman M, Tremeaux P, Fillion M, Boufassa F, Melard A, Gardiennet E, Mariaggi AA, Plantier JC, Rouzioux C, Lambotte O, Avettand-Fenoel V, CACSG
False-negative Results of Human Immunodeficiency Virus (HIV) Rapid Testing in HIV Controllers.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2019

Joly V, Burdet C, Landman R, Vigan M, Charpentier C, Katlama C, Cabié A, Benalycherif A, Peytavin G, Yeni P, Mentre F, Argoud AL, Amri I, Descamps D, Yazdanpanah Y, LSG
Dolutegravir and lamivudine maintenance therapy in HIV-1 virologically suppressed patients: results of the ANRS 167 trial (LAMIDOL).
The Journal of Antimicrobial Chemotherapy 2019, 74, 739-745.

Assoumou L, Bocket L, Pallier C, Grude M, Ait-Namane R, Izopet J, Raymond S, Charpentier C, Visseaux B, Wirden M, Trabaud MA, Le Guillou-Guillemette H, Allaoui C, Henquell C, Krivine A, Dos Santos G, Delamare C, Bouvier-Alias M, Montes B, Ferre V, De Monte A, Signori-Schmuck A, Maillard A, Morand-Joubert L, Tumiotto C, Fafi-Kremer S, Amiel C, Barin F, Marque-Juillet S, Courdavault L, Vallet S, Beby-Defaux A, de Rougemont A, Fenaux H, Avettand-Fenoel V, Allardet-Servent A, Plantier JC, Peytavin G, Calvez V, Chaix ML, Descamps D, AA4RSG
Stable prevalence of transmitted drug resistance mutations and increased circulation of non-B subtypes in antiretroviral-naive chronically HIV-infected patients in 2015/2016 in France.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1417-1424.

Marcelin AG, Grude M, Charpentier C, Bellecave P, Le Guen L, Pallier C, Raymond S, Mirand A, Bocket L, Fofana DB, Delaugerre C, Nguyen T, Montès B, Jeulin H, Mourez T, Fafi-Kremer S, Amiel C, Roussel C, Dina J, Trabaud MA, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Maillard A, Ferre V, Descamps D, Calvez V, Flandre P, AARG
Resistance to integrase inhibitors: a national study in HIV-1-infected treatment-naive and -experienced patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1368-1375.

Perrier M, Castain L, Regad L, Todesco E, Landman R, Visseaux B, Yazdanpanah Y, Rodriguez C, Joly V, Calvez V, Marcelin AG, Descamps D, Charpentier C
HIV-1 protease, Gag and gp41 baseline substitutions associated with virological response to a PI-based regimen.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1679-1692.

Mboumba Bouassa RS, Mossoro-Kpinde CD, Gody JC, Veyer D, Péré H, Matta M, Robin L, Grésenguet G, Charpentier C, Bélec L
High predictive efficacy of integrase strand transfer inhibitors in perinatally HIV-1-infected African children in therapeutic failure of first- and second-line antiretroviral drug regimens recommended by the WHO.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2030-2038.

Néant N, Solas C, Bouazza N, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Gattacceca F
Concentration-response model of rilpivirine in a cohort of HIV-1-infected naive and pre-treated patients.
The Journal of Antimicrobial Chemotherapy 2019, 74, 1992-2002.

Castain L, Perrier M, Charpentier C, Palich R, Desire N, Wirden M, Descamps D, Sayon S, Landman R, Valantin MA, Joly V, Peytavin G, Yazdanpanah Y, Katlama C, Calvez V, Marcelin AG, Todesco E
New mechanisms of resistance in virological failure to protease inhibitors: selection of non-described protease, Gag and Gp41 mutations.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2019-2023.

Perozziello A, Lescure FX, Truel A, Routelous C, Vaillant L, Yazdanpanah Y, Lucet JC, Csg
Prescribers' experience and opinions on antimicrobial stewardship programmes in hospitals: a French nationwide survey.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2451-2458.

Katlama C, Assoumou L, Valantin MA, Soulié C, Martinez E, Béniguel L, Bouchaud O, Raffi F, Molina JM, Fellahi S, Peytavin G, Marcelin AG, Kolta S, Capeau J, Gibowski S, Cardon F, Reynes J, Costagliola D, motA1Es
Dual therapy combining raltegravir with etravirine maintains a high level of viral suppression over 96 weeks in long-term experienced HIV-infected individuals over 45 years on a PI-based regimen: results from the Phase II ANRS 163 ETRAL study.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2742-2751.

Valantin MA, Durand L, Wirden M, Assoumou L, Caby F, Soulié C, Nguyen TTT, Tubiana R, Kirstetter M, Junot H, Marcelin AG, Peytavin G, Tilleul P, Katlama C
Antiretroviral drug reduction in highly experienced HIV-infected patients receiving a multidrug regimen: the ECOVIR study.
The Journal of Antimicrobial Chemotherapy 2019, 74, 2716-2722.

Peiffer-Smadja N, Guillotel E, Luque-Paz D, Maataoui N, Lescure FX, Cattoir V
In vitro bactericidal activity of amoxicillin combined with different cephalosporins against endocarditis-associated Enterococcus faecalis clinical isolates.
The Journal of Antimicrobial Chemotherapy 2019, 74, 3511-3514.

Visseaux B, Assoumou L, Mahjoub N, Grude M, Trabaud MA, Raymond S, Wirden M, Morand-Joubert L, Roussel C, Montes B, Bocket L, Fafi-Kremer S, Amiel C, De Monte A, Stefic K, Pallier C, Tumiotto C, Maillard A, Vallet S, Ferre V, Bouvier-Alias M, Dina J, Signori-Schmuck A, Carles MJ, Plantier JC, Meyer L, Descamps D, Chaix ML, AARG
Surveillance of HIV-1 primary infections in France from 2014 to 2016: toward stable resistance, but higher diversity, clustering and virulence?.
The Journal of Antimicrobial Chemotherapy 2019

Tzou PL, Rhee SY, Descamps D, Clutter DS, Hare B, Mor O, Grude M, Parkin N, Jordan MR, Bertagnolio S, Schapiro JM, Harrigan PR, Geretti AM, Marcelin AG, Shafer RW
Integrase strand transfer inhibitor (INSTI)-resistance mutations for the surveillance of transmitted HIV-1 drug resistance.
The Journal of Antimicrobial Chemotherapy 2019

Rockstroh JK, Yazdanpanah Y
HepCare Europe: a new user-friendly hepatitis C care service model. What have we learned? What are the remaining challenges?.
Journal of Antimicrobial Chemotherapy 2019, 74, v2-v4.

Tebano G, Soulié C, Schneider L, Blanc C, Agher R, Seang S, Valantin MA, Palich R, Tubiana R, Peytavin G, Marcelin AG, Assoumou L, Katlama C
Long-term follow-up of HIV-infected patients on dolutegravir monotherapy.
Journal of Antimicrobial Chemotherapy 2019

Tsopra R, Sedki K, Courtine M, Falcoff H, De Beco A, Madar R, Mechaï F, Lamy JB
Helping GPs to extrapolate guideline recommendations to patients for whom there are no explicit recommendations, through the visualization of drug properties. The example of AntibioHelp® in bacterial diseases.
Journal of the American Medical Informatics Association: JAMIA 2019, 26, 1010-1019.

Argy N, Lariven S, Rideau A, Lemoine A, Bourgeois Moine A, Allal L, Choudat L, Ravel C, Michard F, Buffet P, Faye A, Houze S, Yazdanpanah Y
Congenital Leishmaniasis in a Newborn Infant Whose Mother was Coinfected With Leishmaniasis and HIV.
Journal of the Pediatric Infectious Diseases Society 2019

Lescure FX, Fellahi S, Pialoux G, Bastard JP, Eme AL, Esteve E, Lebrette MG, Guiard-Schmid JB, Capeau J, Ronco P, Costagliola D, Plaisier E
Prevalence of tubulopathy and association with renal function loss in HIV-infected patients.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2019

McIlroy PA, King RS, Garrouste-Orgeas M, Tabah A, Ramanan M
The Effect of ICU Diaries on Psychological Outcomes and Quality of Life of Survivors of Critical Illness and Their Relatives: A Systematic Review and Meta-Analysis.
Critical Care Medicine 2019, 47, 273-279.

Bertrand PM, Pereira B, Adda M, Timsit JF, Wolff M, Hilbert G, Gruson D, Garrouste-Orgeas M, Argaud L, Constantin JM, Chabanne R, Quenot JP, Bohe J, Guerin C, Papazian L, Jonquet O, Klouche K, Delahaye A, Riu B, Zieleskiewicz L, Darmon M, Azoulay E, Souweine B, Lautrette A
Disagreement Between Clinicians and Score in Decision-Making Capacity of Critically Ill Patients*:.
Critical Care Medicine 2019, 47, 337-344.

Ibn Saied W, Mourvillier B, Cohen Y, Ruckly S, Reignier J, Marcotte G, Siami S, Bouadma L, Darmon M, de Montmollin E, Argaud L, Kallel H, Garrouste-Orgeas M, Soufir L, Schwebel C, Souweine B, Glodgran-Toledano D, Papazian L, Timsit JF
A Comparison of the Mortality Risk Associated With Ventilator-Acquired Bacterial Pneumonia and Nonventilator ICU-Acquired Bacterial Pneumonia*:.
Critical Care Medicine 2019, 47, 345-352.

Bourcier S, Coutrot M, Kimmoun A, Sonneville R, de Montmollin E, Persichini R, Schnell D, Charpentier J, Aubron C, Morawiec E, Bigé N, Nseir S, Terzi N, Razazi K, Azoulay E, Ferré A, Tandjaoui-Lambiotte Y, Ellrodt O, Hraiech S, Delmas C, Barbier F, Lautrette A, Aissaoui N, Repessé X, Pichereau C, Zerbib Y, Lascarrou JB, Carreira S, Reuter D, Frérou A, Peigne V, Fillatre P, Megarbane B, Voiriot G, Combes A, Schmidt M
Thyroid Storm in the ICU: A Retrospective Multicenter Study.
Critical Care Medicine 2019

Bertin C, Abbas R, Andrieu V, Michard F, Rioux C, Descamps V, Yazdanpanah Y, Bouscarat F
Illicit massive silicone injections always induce chronic and definitive silicone blood diffusion with dermatologic complications.
Medicine 2019, 98, e14143.

Palich R, Ghosn J, Chaillon A, Boilet V, Nere ML, Chaix ML, Delobel P, Molina JM, Lucht F, Bouchaud O, Rieux V, Thiebaut R, Levy Y, Delaugerre C, Lelievre JD
Viral rebound in semen after antiretroviral treatment interruption in an HIV therapeutic vaccine double-blind trial:.
AIDS 2019, 33, 279-284.

Lucar O, Sadjo Diallo M, Bayard C, Samri A, Tarantino N, Debré P, Thiébaut R, Brun-Vézinet F, Matheron S, Cheynier R, Vieillard V
B7-H6-mediated downregulation of NKp30 in natural killer cells contributes to HIV-2 immune escape:.
AIDS 2019, 33, 23-32.

Pommier JD, Laouénan C, Michard F, Papot E, Urios P, Boutten A, Peytavin G, Ghander C, Lariven S, Castanedo G, Moho D, Landman R, Phung B, Perez E, Julia Z, Descamps D, Roland-Nicaise P, Le Gac S, Yazdanpanah Y, Guibourdenche J, Yeni P
Metabolic syndrome and endocrine status in HIV-infected transwomen.
AIDS (London, England) 2019, 33, 855-865.

Januel E, Godin O, Moulignier A, Lescure FX, Savatovsky J, Lamirel C, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Dominique Costagliola n, Assoumou L, MBRAK(SG
Impact of ART classes on the increasing risk of cerebral small-vessel disease in middle-aged, well-controlled, cART-treated, HIV-infected individuals.
Journal of Acquired Immune Deficiency Syndromes (1999) 2019

Garnacho-Montero J, Timsit JF
Managing Acinetobacter baumannii infections:.
Current Opinion in Infectious Diseases 2019, 32, 69-76.

Patrier J, Timsit JF
Carbapenem use in critically ill patients:.
Current Opinion in Infectious Diseases 2019

Lê MP, Chaix M, Raffi F, Chevret S, Gallien S, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina J, Peytavin G, tADsg
Once‐daily darunavir/ritonavir 400/100 mg in triple therapy: efficacy and penetration in seminal compartment in ANRS ‐165 DARULIGHT study.
British Journal of Clinical Pharmacology 2019, 85, 277-280.

Hatzakis A, Lazarus JV, Cholongitas E, Baptista‐Leite R, Boucher C, Busoi C, Deuffic‐Burban S, Chhatwal J, Esmat G, Hutchinson S, Malliori M, Maticic M, Mozalevskis A, Negro F, Papandreou GA, Papatheodoridis GV, Peck‐Radosavljevic M, Razavi H, Reic T, Schatz E, Tozun N, Younossi Z, Manns MP
Securing sustainable funding for viral hepatitis elimination plans.
Liver International 2019

Bassetti M, Scudeller L, Giacobbe DR, Lamoth F, Righi E, Zuccaro V, Grecchi C, Rebuffi C, Akova M, Alastruey-Izquierdo A, Arikan-Akdagli S, Azoulay E, Blot SI, Cornely OA, Lass-Flörl C, Koehler P, Cuenca-Estrella M, de Lange DW, De Rosa FG, De Waele JJ, Dimopoulos G, Garnacho-Montero J, Hoenigl M, Kanj SS, Maertens J, Martin-Loeches I, Muñoz P, Kullberg BJ, Agvald-Ohman C, Poulakou G, Rello J, Sanguinetti M, Taccone FS, Timsit JF, Torres A, Vazquez JA, Calandra T, ftSGfIiCIP(atFISG(otESoCMaID(, ESoICM(, ECoMM(, MSGEaRC(
Developing definitions for invasive fungal diseases in critically ill adult patients in intensive care units. Protocol of the FUNgal infections Definitions in ICU patients (FUNDICU) project.
Mycoses 2019, 62, 310-319.

Stefic K, Guinard J, Peytavin G, Saboni L, Sommen C, Sauvage C, Lot F, Laperche S, Velter A, Barin F, Pwg
Screening for Human Immunodeficiency Virus infection using a fourth-generation antigen/antibody assay and dried blood spots: in depth analysis of sensitivity and performance assessment in a cross-sectional study.
Journal of Clinical Microbiology 2019

Baril L, Vallès X, Stenseth NC, Rajerison M, Ratsitorahina M, Pizarro-Cerdá J, Demeure C, Belmain S, Scholz H, Girod R, Hinnebusch J, Vigan-Womas I, Bertherat E, Fontanet A, Yazadanpanah Y, Carrara G, Deuve J, D'ortenzio E, Angulo JOC, Mead P, Horby PW
Can we make human plague history? A call to action.
BMJ Global Health 2019, 4, e001984.

Hentzien M, Dramé M, Delpierre C, Allavena C, Cabié A, Cuzin L, Rey D, Pugliese P, Hédelin G, Bani-Sadr F, DSG
HIV-related excess mortality and age-related comorbidities in patients with HIV aged ≥60: a relative survival analysis in the French Dat'AIDS cohort.
BMJ open 2019, 9, e024841.

Boisson M, Corbi P, Kerforne T, Camilleri L, Debauchez M, Demondion P, Eljezi V, Flecher E, Lepelletier D, Leprince P, Nesseler N, Nizou JY, Roussel JC, Rozec B, Ruckly S, Lucet JC, Timsit JF, Mimoz O
Multicentre, open-label, randomised, controlled clinical trial comparing 2% chlorhexidine-70% isopropanol and 5% povidone iodine-69% ethanol for skin antisepsis in reducing surgical-site infection after cardiac surgery: the CLEAN 2 study protocol.
BMJ open 2019, 9, e026929.

Gobat N, Amuasi J, Yazdanpanah Y, Sigfid L, Davies H, Byrne JP, Carson G, Butler C, Nichol A, Goossens H
Advancing preparedness for clinical research during infectious disease epidemics.
ERJ open research 2019

Lions C, Cabras O, Cotte L, Huleux T, Gagneux-Brugnon A, Makinson A, Cabié A, Bonnet B, Duvivier C, Hocqueloux L, Cua E, Cheret A, Hustache-Mathieu L, Obry-Roguet V, Jacomet C, Poizot-Martin I, DSG
Missed opportunities of HIV pre-exposure prophylaxis in France: a retrospective analysis in the French DAT'AIDS cohort.
BMC infectious diseases 2019, 19, 278.

Vaux S, Chevaliez S, Saboni L, Sauvage C, Sommen C, Barin F, Alexandre A, Jauffret-Roustide M, Lot F, Velter A, APg
Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015.
BMC infectious diseases 2019, 19, 315.

Jary A, Dienta S, Leducq V, Le Hingrat Q, Cisse M, Diarra AB, Fofana DB, Ba A, Baby M, Achenbach CJ, Murphy R, Calvez V, Marcelin AG, Maiga AI
Seroprevalence and risk factors for HIV, HCV, HBV and syphilis among blood donors in Mali.
BMC Infectious Diseases 2019, 19,

Garrouste-Orgeas M, Flahault C, Poulain E, Evin A, Guirimand F, Fossez-Diaz V, Perruchio S, Verlaine C, Vanbésien A, Kaczmarek W, Birkui de Francqueville L, De Larivière E, Bouquet G, Copel L, Verliac V, Marché V, Mathias C, Gracia D, Mhalla A, Michonneau-Gandon V, Poupardin C, Touzet L, Ranchou G, Guastella V, Richard B, Bienfait F, Sonrier M, Michel D, Ruckly S, Bailly S, Timsit JF
The Fami-life study: protocol of a prospective observational multicenter mixed study of psychological consequences of grieving relatives in French palliative care units on behalf of the family research in palliative care (F.R.I.P.C research network).
BMC Palliative Care 2019, 18,

Schwarzinger M, Luchini S, ESG
Estimating health state utility from activities of daily living in the French National Hospital Discharge Database: a feasibility study with head and neck cancer.
Health and Quality of Life Outcomes 2019, 17, 129.

Prevel R, Boyer A, M’Zali F, Lasheras A, Zahar JR, Rogues AM, Gruson D
Is systematic fecal carriage screening of extended-spectrum beta-lactamase-producing Enterobacteriaceae still useful in intensive care unit: a systematic review.
Critical Care 2019, 23,

Bassetti M, Giacobbe DR, Vena A, Trucchi C, Ansaldi F, Antonelli M, Adamkova V, Alicino C, Almyroudi MP, Atchade E, Azzini AM, Carannante N, Carnelutti A, Corcione S, Cortegiani A, Dimopoulos G, Dubler S, García-Garmendia JL, Girardis M, Cornely OA, Ianniruberto S, Kullberg BJ, Lagrou K, Le Bihan C, Luzzati R, Malbrain MLNG, Merelli M, Marques AJ, Martin-Loeches I, Mesini A, Paiva JA, Peghin M, Raineri SM, Rautemaa-Richardson R, Schouten J, Brugnaro P, Spapen H, Tasioudis P, Timsit JF, Tisa V, Tumbarello M, van den Berg CHSB, Veber B, Venditti M, Voiriot G, Wauters J, Montravers P
Incidence and outcome of invasive candidiasis in intensive care units (ICUs) in Europe: results of the EUCANDICU project.
Critical Care 2019, 23,

Morvan AC, Hengy B, Garrouste-Orgeas M, Ruckly S, Forel JM, Argaud L, Rimmelé T, Bedos JP, Azoulay E, Dupuis C, Mourvillier B, Schwebel C, Timsit JF, Osg
Impact of species and antibiotic therapy of enterococcal peritonitis on 30-day mortality in critical care-an analysis of the OUTCOMEREA database.
Critical Care (London, England) 2019, 23, 307.

Dumas G, Demoule A, Mokart D, Lemiale V, Nseir S, Argaud L, Pène F, Kontar L, Bruneel F, Klouche K, Barbier F, Reignier J, Stoclin A, Louis G, Constantin JM, Wallet F, Kouatchet A, Peigne V, Perez P, Girault C, Jaber S, Cohen Y, Nyunga M, Terzi N, Bouadma L, Lebert C, Lautrette A, Bigé N, Raphalen JH, Papazian L, Benoit D, Darmon M, Chevret S, Azoulay E
Center effect in intubation risk in critically ill immunocompromised patients with acute hypoxemic respiratory failure.
Critical Care (London, England) 2019, 23, 306.

obotOSG, Bouadma L, Mankikian S, Darmon M, Argaud L, Vinclair C, Siami S, Garrouste-Orgeas M, Papazian L, Cohen Y, Marcotte G, Styfalova L, Reignier J, Lautrette A, Schwebel C, Timsit JF
Influence of dyskalemia at admission and early dyskalemia correction on survival and cardiac events of critically ill patients.
Critical Care 2019, 23,

Birgand G, Haudebourg T, Grammatico-Guillon L, Ferrand L, Moret L, Gouin F, Mauduit N, Leux C, Le Manach Y, Lepelletier D, Tavernier E, Lucet JC, Giraudeau B
Improvement in staff behavior during surgical procedures to prevent post-operative complications (ARIBO2): study protocol for a cluster randomised trial.
Trials 2019, 20,

tPst, Lhomme E, Modet C, Augier A, Faye S, Dabakuyo-Yonli TS, Levy-Marchal C, D’Ortenzio E, Yazdanpanah Y, Chêne G, Beavogui AH, Richert L
Enrolling study personnel in Ebola vaccine trials: from guidelines to practice in a non-epidemic context.
Trials 2019, 20,

Pons S, Sonneville R, Bouadma L, Styfalova L, Ruckly S, Neuville M, Radjou A, Lebut J, Dilly MP, Mourvillier B, Dorent R, Nataf P, Wolff M, Timsit JF
Infectious complications following heart transplantation in the era of high-priority allocation and extracorporeal membrane oxygenation.
Annals of Intensive Care 2019, 9, 17.

Karpanen TJ, Casey AL, Whitehouse T, Timsit JF, Mimoz O, Palomar M, Elliott TSJ
A clinical evaluation of two central venous catheter stabilization systems.
Annals of Intensive Care 2019, 9, 49.

Balmier A, Dib F, Serret-Larmande A, De Montmollin E, Pouyet V, Sztrymf B, Megarbane B, Thiagarajah A, Dreyfuss D, Ricard JD, Roux D
Initial management of diabetic ketoacidosis and prognosis according to diabetes type: a French multicentre observational retrospective study.
Annals of Intensive Care 2019, 9, 91.

Smonig R, Magalhaes E, Bouadma L, Andremont O, de Montmollin E, Essardy F, Mourvillier B, Lebut J, Dupuis C, Neuville M, Lermuzeaux M, Timsit JF, Sonneville R
Impact of natural light exposure on delirium burden in adult patients receiving invasive mechanical ventilation in the ICU: a prospective study.
Annals of Intensive Care 2019, 9, 120.

Vaillant L, Birgand G, Esposito-Farese M, Astagneau P, Pulcini C, Robert J, Zahar JR, Sales-Wuillemin E, Tubach F, Lucet JC, PSg
Awareness among French healthcare workers of the transmission of multidrug resistant organisms: a large cross-sectional survey.
Antimicrobial Resistance and Infection Control 2019, 8, 173.

Kassi FK, Drakulovski P, Bellet V, Roger F, Chabrol A, Krasteva D, Doumbia A, Landman R, Kakou A, Reynes J, Delaporte E, Menan HEI, Bertout S, Govender NP
Cryptococcus genetic diversity and mixed infections in Ivorian HIV patients: A follow up study.
PLOS Neglected Tropical Diseases 2019, 13, e0007812.

Charani E, Smith I, Skodvin B, Perozziello A, Lucet JC, Lescure FX, Birgand G, Poda A, Ahmad R, Singh S, Holmes AH
Investigating the cultural and contextual determinants of antimicrobial stewardship programmes across low-, middle- and high-income countries-A qualitative study.
PloS One 2019, 14, e0209847.

Fournier AL, Yazdanpanah Y, Verdon R, Lariven S, Mackoumbou-Nkouka C, Phung BC, Papot E, Parienti JJ, Landman R, Champenois K, Yotebieng M
Incidence of and risk factors for medical care interruption in people living with HIV in recent years.
PLOS ONE 2019, 14, e0213526.

Gantner P, Cotte L, Allavena C, Bani-Sadr F, Huleux T, Duvivier C, Valantin MA, Jacomet C, Joly V, Chéret A, Pugliese P, Delobel P, Cabié A, Rey D, ftDSG, Huang JF
Higher rates of HBsAg clearance with tenofovir-containing therapy in HBV/HIV co-infection.
PLOS ONE 2019, 14, e0215464.

Cossais S, Schwarzinger M, Pol S, Fontaine H, Larrey D, Pageaux GP, Canva V, Mathurin P, Yazdanpanah Y, Deuffic-Burban S, Fischer F
Quality of life in patients with chronic hepatitis C infection: Severe comorbidities and disease perception matter more than liver-disease stage.
PLOS ONE 2019, 14, e0215596.

Gantner P, Sylla B, Morand-Joubert L, Frange P, Lacombe K, Khuong MA, Duvivier C, Launay O, Karmochkine M, Arvieux C, Ménard A, Piroth L, Canestri A, Trias D, Peytavin G, Landman R, Ghosn J, obotCISG, Güerri-Fernández R
“Real life” use of raltegravir during pregnancy in France: The Coferal-IMEA048 cohort study.
PLOS ONE 2019, 14, e0216010.

Raben D, Sullivan AK, Mocroft A, Kutsyna G, Hadžiosmanović V, Vassilenko A, Chkhartisvili N, Mitsura V, Pedersen C, Anderson J, Begovac J, Bak Dragsted U, Bertisch B, Grzeszczuk A, Minton J, Necsoi VC, Kitchen M, Ajana F, Sokhan A, Comi L, Farazmand P, Pesut D, De Wit S, Gatell JM, Gazzard B, d’Arminio Monforte A, Rockstroh JK, Yazdanpanah Y, Champenois K, Jakobsen ML, Lundgren JD, obotHSG, Sagar M
Improving the evidence for indicator condition guided HIV testing in Europe: Results from the HIDES II Study – 2012 – 2015.
PLOS ONE 2019, 14, e0220108.

Mandelbrot L, Ceccaldi PF, Duro D, Lê M, Pencolé L, Peytavin G
Placental transfer and tissue accumulation of dolutegravir in the ex vivo human cotyledon perfusion model.
PloS One 2019, 14, e0220323.

Samri A, Charpentier C, Diallo MS, Bertine M, Even S, Morin V, Oudin A, Parizot C, Collin G, Hosmalin A, Cheynier R, Thiébaut R, Matheron S, Collin F, Zoorob R, Brun-Vézinet F, Autran B, ACI2SG
Limited HIV-2 reservoirs in central-memory CD4 T-cells associated to CXCR6 co-receptor expression in attenuated HIV-2 infection.
PLoS pathogens 2019, 15, e1007758.

Visseaux B, Le Hingrat Q, Damond F, Charpentier C, Descamps D
Physiopathology of HIV-2 infection.
Virologie 2019, 23, 277-291.

Schernberg A, Sagaon-Teyssier L, Schwarzinger M
Clinical and economic burden of head and neck cancer: a nationwide retrospective cohort study from France.
ClinicoEconomics and outcomes research: CEOR 2019, 11, 441-451.

van de Laar MJ, Bosman A, Pharris A, Andersson E, Assoumou L, Ay E, Bannert N, Bartmeyer B, Brady M, Chaix ML, Descamps D, Dauwe K, Fonager J, Hauser A, Lunar M, Mezei M, Neary M, Poljak M, van Sighem A, Verhofstede C, Amato-Gauci AJ, Broberg EK
Piloting a surveillance system for HIV drug resistance in the European Union.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,

Wirden M, De Oliveira F, Bouvier-Alias M, Lambert-Niclot S, Chaix ML, Raymond S, Si-Mohammed A, Alloui C, André-Garnier E, Bellecave P, Malve B, Mirand A, Pallier C, Poveda JD, Rabenja T, Schneider V, Signori-Schmuck A, Stefic K, Calvez V, Descamps D, Plantier JC, Marcelin AG, Visseaux B, On Behalf Of The French National Agency For Research On Aids And Viral Hepatitis Anrs Ac Study Group n
New HIV-1 circulating recombinant form 94: from phylogenetic detection of a large transmission cluster to prevention in the age of geosocial-networking apps in France, 2013 to 2017.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2019, 24,

Liapis E, Bour M, Triponney P, Jové T, Zahar JR, Valot B, Jeannot K, Plésiat P
Identification of Diverse Integron and Plasmid Structures Carrying a Novel Carbapenemase Among Pseudomonas Species.
Frontiers in Microbiology 2019, 10, 404.

Garin N, Marti C, Carballo S, Darbellay Farhoumand P, Montet X, Roux X, Scheffler M, Serratrice C, Serratrice J, Claessens YE, Duval X, Loubet P, Stirnemann J, Prendki V
Rational Use of CT-Scan for the Diagnosis of Pneumonia: Comparative Accuracy of Different Strategies.
Journal of Clinical Medicine 2019

Azevedo-Coste C, Pissard-Gibollet R, Toupet G, Fleury É, Lucet JC, Birgand G
Tracking Clinical Staff Behaviors in an Operating Room.
Sensors (Basel, Switzerland) 2019, 19,

tACCsg, Abgrall S, Raho-Moussa M, Seng R, Ghislain M, Matheron S, Pialoux G, Goujard C, Meyer L
Elevated risk of viral rebound on ART in migrants living in France: role of socioeconomic factors.
Antiviral Therapy 2019

Perrineau S, Lachâtre M, Lê MP, Rioux C, Loubet P, Fréchet-Jachym M, Gonzales MC, Grall N, Bouvet E, Veziris N, Yazdanpanah Y, Peytavin G
Long-term plasma pharmacokinetics of bedaquiline for multidrug- and extensively drug-resistant tuberculosis.
The International Journal of Tuberculosis and Lung Disease 2019, 23, 99-104.

Popping S, Bade D, Boucher C, van der Valk M, El-Sayed M, Sigurour O, Sypsa V, Morgan T, Gamkrelidze A, Mukabatsinda C, Deuffic-Burban S, Ninburg M, Feld J, Hellard M, Ward J
The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals.
Journal of Virus Eradication 2019, 5, 60-66.

Wensing AM, Calvez V, Ceccherini-Silberstein F, Charpentier C, Günthard HF, Paredes R, Shafer RW, Richman DD
2019 update of the drug resistance mutations in HIV-1.
Topics in Antiviral Medicine 2019, 27, 111-121.

 2018                                                                            

Brunet-Possenti F, Deschamps L, Charpentier C
Use of Combination Systemic-Intratumoral HPV Vaccine to Treat Cutaneous Basaloid Squamous Cell Carcinomas.
JAMA dermatology 2018

Bluhmki T, Allignol A, Ruckly S, Timsit JF, Wolkewitz M, Beyersmann J
Estimation of adjusted expected excess length-of-stay associated with ventilation-acquired pneumonia in intensive care: A multistate approach accounting for time-dependent mechanical ventilation.
Biometrical Journal. Biometrische Zeitschrift 2018, 60, 1135-1150.

Costentin CE, Mourad A, Lahmek P, Causse X, Pariente A, Hagège H, Dobrin AS, Becker C, Marks B, Bader R, Condat B, Héluwaert F, Seitz JF, Lesgourgues B, Denis J, Deuffic-Burban S, Rosa I, Decaens T, CSG
Hepatocellular carcinoma is diagnosed at a later stage in alcoholic patients: Results of a prospective, nationwide study.
Cancer 2018, 124, 1964-1972.

Bailly S, Meyfroidt G, Timsit JF
What's new in ICU in 2050: big data and machine learning.
Intensive Care Medicine 2018, 44, 1524-1527.

De Waele JJ, Akova M, Antonelli M, Canton R, Carlet J, De Backer D, Dimopoulos G, Garnacho-Montero J, Kesecioglu J, Lipman J, Mer M, Paiva JA, Poljak M, Roberts JA, Rodriguez Bano J, Timsit JF, Zahar JR, Bassetti M
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance.
Intensive Care Medicine 2018, 44, 189-196.

La Combe B, Bleibtreu A, Messika J, Fernandes R, Clermont O, Branger C, Billard-Pomares T, Barnaud G, Magdoud F, Eveillard M, Kouatchet A, Lasocki S, Asfar P, Corvec S, Lakhal K, Armand-Lefevre L, Wolff M, Timsit JF, Bourdon S, Reignier J, Martin S, Fihman V, de Prost N, Bador J, Charles PE, Goret J, Boyer A, Wallet F, Jaillette E, Nseir S, Landraud L, Ruimy R, Danin PE, Dellamonica J, Cremniter J, Frat JP, Jauréguy F, Clec'h C, Decré D, Maury E, Dreyfuss D, Denamur E, Ricard JD
Decreased susceptibility to chlorhexidine affects a quarter of Escherichia coli isolates responsible for pneumonia in ICU patients.
Intensive Care Medicine 2018, 44, 531-533.

von Cube MK, Timsit JF, Sommer H, Darmon M, Schwebel C, Bailly S, Souweine B, Wolkewitz M
Relative risk and population-attributable fraction of ICU death caused by susceptible and resistant Pseudomonas aeruginosa ventilator-associated pneumonia: a competing risks approach to investigate the OUTCOMEREA database.
Intensive Care Medicine 2018, 44, 1177-1179.

Bouadma L, Karpanen T, Elliott T
Chlorhexidine use in adult patients on ICU.
Intensive Care Medicine 2018, 44, 2232-2234.

Barbier F, Bailly S, Schwebel C, Papazian L, Azoulay É, Kallel H, Siami S, Argaud L, Marcotte G, Misset B, Reignier J, Darmon M, Zahar JR, Goldgran-Toledano D, de Montmollin É, Souweine B, Mourvillier B, Timsit JF, OSG
Infection-related ventilator-associated complications in ICU patients colonised with extended-spectrum β-lactamase-producing Enterobacteriaceae.
Intensive Care Medicine 2018

Timsit JF, Bassetti M
Antipathy against SDD is justified: Yes.
Intensive Care Medicine 2018

Azoulay E, Lemiale V, Mourvillier B, Garrouste-Orgeas M, Schwebel C, Ruckly S, Argaud L, Cohen Y, Souweine B, Papazian L, Reignier J, Marcotte G, Siami S, Kallel H, Darmon M, Timsit JF, OSG
Management and outcomes of acute respiratory distress syndrome patients with and without comorbid conditions.
Intensive Care Medicine 2018

Timsit JF, Rupp M, Bouza E, Chopra V, Kärpänen T, Laupland K, Lisboa T, Mermel L, Mimoz O, Parienti JJ, Poulakou G, Souweine B, Zingg W
A state of the art review on optimal practices to prevent, recognize, and manage complications associated with intravascular devices in the critically ill.
Intensive Care Medicine 2018, 44, 742-759.

Kindermans M, Abid S, Alkhoder S, Bouadma L
Pulsatile bleeding after sternal bone marrow puncture.
Intensive Care Medicine 2018, 44, 1758-1759.

Bouadma L, Klompas M
Oral care with chlorhexidine: beware!.
Intensive Care Medicine 2018, 44, 1153-1155.

Puntillo KA, Max A, Timsit JF, Ruckly S, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu IM, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Pereira FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Pain distress: the negative emotion associated with procedures in ICU patients.
Intensive Care Medicine 2018, 44, 1493-1501.

Timsit JF, Ruppe E, Ferrer R
Focus on sepsis: new concepts and findings in sepsis care.
Intensive Care Medicine 2018, 44, 1997-1999.

Timsit JF, Aboab J, Parienti JJ
Is research from databases reliable? Yes.
Intensive Care Medicine 2018

Néant N, Gattacceca F, Lê MP, Yazdanpanah Y, Dhiver C, Bregigeon S, Mokhtari S, Peytavin G, Tamalet C, Descamps D, Lacarelle B, Solas C
Population pharmacokinetics of Rilpivirine in HIV-1-infected patients treated with the single-tablet regimen rilpivirine/tenofovir/emtricitabine.
European Journal of Clinical Pharmacology 2018, 74, 473-481.

Suzan-Monti M, Celse M, Vilotitch A, Demoulin B, Dray-Spira R, Yéni P, Lert F, Spire B, AVsg
Assessement of Awareness of, Concerns and Attitudes Towards HIV-Related Court-Case Sentences in France in a Representative Sample of People Living with HIV (ANRS VESPA2 Survey).
AIDS and behavior 2018, 22, 3264-3272.

Garrouste-Orgeas M, Azoulay E, Ruckly S, Schwebel C, de Montmollin E, Bedos JP, Souweine B, Marcotte G, Adrie C, Goldgran-Toledano D, Dumenil AS, Kallel H, Jamali S, Argaud L, Darmon M, Zahar JR, Timsit JF
Diabetes was the only comorbid condition associated with mortality of invasive pneumococcal infection in ICU patients: a multicenter observational study from the Outcomerea research group.
Infection 2018, 46, 669-677.

Leone M, Bouadma L, Bouhemad B, Brissaud O, Dauger S, Gibot S, Hraiech S, Jung B, Kipnis E, Launey Y, Luyt CE, Margetis D, Michel F, Mokart D, Montravers P, Monsel A, Nseir S, Pugin J, Roquilly A, Velly L, Zahar JR, Bruyère R, Chanques G
Hospital-acquired pneumonia in ICU.
Anaesthesia, Critical Care & Pain Medicine 2018, 37, 83-98.

Loubet P, Burdet C, Vindrios W, Grall N, Wolff M, Yazdanpanah Y, Andremont A, Duval X, Lescure FX
Cefazolin versus anti-staphylococcal penicillins for treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a narrative review.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 125-132.

Jolivet S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Ghodbane W, Nataf P, Lucet JC
Surgical site infection with extended-spectrum β-lactamase-producing Enterobacteriaceae after cardiac surgery: incidence and risk factors.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 283-288.

Lachâtre M, Méchain M, Etienne M, Gautret P, Matheron S, Nahon M, Coignard-Biehler H, Malvy D, Duval X, Tattevin P
No evidence for major adverse events related to suspicion of Ebola in France, 2014-2015.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 310-311.

Ruppé E, Burdet C, Grall N, de Lastours V, Lescure FX, Andremont A, Armand-Lefèvre L
Impact of antibiotics on the intestinal microbiota needs to be re-defined to optimize antibiotic usage.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 3-5.

Jolivet S, Vaillant L, Poncin T, Lolom I, Gaudonnet Y, Rondinaud E, Bendjelloul G, Lomont A, Lucet JC, Armand-Lefèvre L
Prevalence of carriage of extended-spectrum β-lactamase-producing enterobacteria and associated factors in a French hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1311-1314.

Peiffer-Smadja N, Abbara S, Rizk N, Pogliaghi M, Rondinaud E, Tesmoingt C, Massias L, Lucet JC, Alkhoder S, Armand-Lefèvre L, Lescure FX
High-dose daptomycin in patients with infective endocarditis or sternal wound infections.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 1106-1108.

Ruppé E, Martin-Loeches I, Rouzé A, Levast B, Ferry T, Timsit JF
What's new in restoring the gut microbiota in ICU patients? Potential role of faecal microbiota transplantation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2018, 24, 803-805.

Loubet P, Verger P, Abitbol V, Peyrin-Biroulet L, Launay O
Pneumococcal and influenza vaccine uptake in adults with inflammatory bowel disease in France: Results from a web-based study.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2018, 50, 563-567.

Cez A, Brocheriou I, Lescure FX, Adam C, Girard PM, Pialoux G, Moestrup SK, Fellahi S, Bastard JP, Ronco P, Plaisier E
Decreased expression of megalin and cubilin and altered mitochondrial activity in tenofovir nephrotoxicity.
Human Pathology 2018, 73, 89-101.

Zahar JR, Blot S
Dilemmas in infection control in the intensive care unit.
Intensive & Critical Care Nursing 2018, 46, 1-3.

Perozziello A, Routelous C, Charani E, Truel A, Birgand G, Yazdanpanah Y, Lescure FX, Lucet JC, CSG
Experiences and perspectives of implementing antimicrobial stewardship in five French hospitals: a qualitative study.
International Journal of Antimicrobial Agents 2018, 51, 829-835.

Macaux L, Ndoye O, Cordel H, Pomares TB, Seytre D, Bouchaud O, Cohen Y, Zahar JR, Carbonnelle E
Extensively-drug-resistant bacteria carriers among overseas travellers: one-third had not been hospitalized previously.
International Journal of Antimicrobial Agents 2018, 52, 385-389.

Nguyen T, Akhavan S, Caby F, Bonyhay L, Larrouy L, Gervais A, Lebray P, Poynard T, Calmus Y, Simon A, Valantin MA, Calvez V, Marcelin AG, Todesco E
Net emergence of substitutions at position 28 in NS5A of hepatitis C virus genotype 4 in patients failing direct-acting antivirals detected by next-generation sequencing.
International Journal of Antimicrobial Agents 2018

Soulie C, Morand-Joubert L, Cottalorda J, Charpentier C, Bellecave P, Le Guen L, Yerly S, Montes B, Fafi-Kremer S, Dina J, Avettand-Fenoel V, Amiel C, Roussel C, Pallier C, Zafilaza K, Sayon S, Signori-Schmuck A, Mirand A, Trabaud MA, Berger S, Calvez V, Marcelin AG, AArg
Performance of genotypic algorithms for predicting tropism for HIV-1 CRF01_AE recombinant.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2018, 99-100, 57-60.

Schwarzinger M, Rehm J, Mallet V
"Who killed JR": Chronic hepatitis C or alcohol use disorders?.
Journal of Hepatology 2018, 68, 1098-1099.

Deuffic-Burban S, Huneau A, Verleene A, Brouard C, Pillonel J, Le Strat Y, Cossais S, Roudot-Thoraval F, Canva V, Mathurin P, Dhumeaux D, Yazdanpanah Y
Assessing the cost-effectiveness of hepatitis C screening strategies in France.
Journal of Hepatology 2018, 69, 785-792.

Hilliquin D, Le Guern R, Thepot Seegers V, Neulier C, Lomont A, Marie V, Legeay C, Merrer J, Lepelletier D, Rogues AM, Grandbastien B, Lucet JC, Zahar JR
Risk factors for acquisition of OXA-48-producing Klebsiella pneumonia among contact patients: a multicentre study.
The Journal of Hospital Infection 2018, 98, 253-259.

Pilmis B, Cattoir V, Lecointe D, Limelette A, Grall I, Mizrahi A, Marcade G, Poilane I, Guillard T, Bourgeois Nicolaos N, Zahar JR, Le Monnier A
Carriage of ESBL-producing Enterobacteriaceae in French hospitals: the PORTABLSE study.
The Journal of Hospital Infection 2018, 98, 247-252.

Legeay C, Thépot-Seegers V, Pailhoriès H, Hilliquin D, Zahar JR
Is cohorting the only solution to control carbapenemase-producing Enterobacteriaceae outbreaks? A single-centre experience.
The Journal of Hospital Infection 2018, 99, 390-395.

Lemaignen A, Armand-Lefevre L, Birgand G, Mabileau G, Lolom I, Ghodbane W, Dilly MP, Nataf P, Lucet JC
Thirteen-year experience with universal Staphylococcus aureus nasal decolonization prior to cardiac surgery: a quasi-experimental study.
The Journal of Hospital Infection 2018, 100, 322-328.

Warszawski J, Thomas C, Dialla O, Garrait V, Dollfus C, Reliquet V, Clech L, Dert C, Mandelbrot L, Audrain M, Blanche S, AESG
T-Cell Receptor Excision Circles in HIV-Exposed, Uninfected Newborns Measured During a National Newborn Screening Program for Severe Combined Immunodeficiency.
The Journal of Pediatrics 2018, 202, 311-314.e2.

Le Hingrat Q, Perrier M, Collin G, Drumard S, Storto A, Bertine M, Larrouy L, Matheron S, Damond F, Charpentier C, Descamps D, Visseaux B
Efficiency of HIV-2 cultures from clinical isolates is enhanced after purification by anti-CD44 microbeads.
Journal of Virological Methods 2018, 257, 12-15.

D'Ortenzio E, Lemaître N, Brouat C, Loubet P, Sebbane F, Rajerison M, Baril L, Yazdanpanah Y
Plague: Bridging gaps towards better disease control.
Medecine Et Maladies Infectieuses 2018, 48, 307-317.

Bleibtreu A, Grall N, Laissy JP, Rioux C, Strukov A, Lariven S, Yeni P, Yazdanpanah Y, Joly V
Contribution of brain imaging to the diagnosis of intracranial tuberculoma and other brain lesions in patients presenting with miliary tuberculosis.
Medecine Et Maladies Infectieuses 2018, 48, 533-539.

N'Diaye DS, Launay O, Picone O, Tsatsaris V, Azria E, Rozenberg F, Schwarzinger M, Yazdanpanah Y
Cost-effectiveness of vaccination against cytomegalovirus (CMV) in adolescent girls to prevent infections in pregnant women living in France.
Vaccine 2018, 36, 1285-1296.

Reignier J, Boisramé-Helms J, Brisard L, Lascarrou JB, Ait Hssain A, Anguel N, Argaud L, Asehnoune K, Asfar P, Bellec F, Botoc V, Bretagnol A, Bui HN, Canet E, Da Silva D, Darmon M, Das V, Devaquet J, Djibre M, Ganster F, Garrouste-Orgeas M, Gaudry S, Gontier O, Guérin C, Guidet B, Guitton C, Herbrecht JE, Lacherade JC, Letocart P, Martino F, Maxime V, Mercier E, Mira JP, Nseir S, Piton G, Quenot JP, Richecoeur J, Rigaud JP, Robert R, Rolin N, Schwebel C, Sirodot M, Tinturier F, Thévenin D, Giraudeau B, Le Gouge A, N2TI, CRiICaS(g
Enteral versus parenteral early nutrition in ventilated adults with shock: a randomised, controlled, multicentre, open-label, parallel-group study (NUTRIREA-2).
Lancet (London, England) 2018, 391, 133-143.

Schwarzinger M, Pollock BG, Hasan OSM, Dufouil C, Rehm J, QSG
Contribution of alcohol use disorders to the burden of dementia in France 2008-13: a nationwide retrospective cohort study.
The Lancet. Public Health 2018, 3, e124-e132.

Triki D, Cano Contreras ME, Flatters D, Visseaux B, Descamps D, Camproux AC, Regad L
Analysis of the HIV-2 protease's adaptation to various ligands: characterization of backbone asymmetry using a structural alphabet.
Scientific Reports 2018, 8, 710.

Triki D, Billot T, Visseaux B, Descamps D, Flatters D, Camproux AC, Regad L
Exploration of the effect of sequence variations located inside the binding pocket of HIV-1 and HIV-2 proteases.
Scientific Reports 2018, 8, 5789.

Annane D, Renault A, Brun-Buisson C, Megarbane B, Quenot JP, Siami S, Cariou A, Forceville X, Schwebel C, Martin C, Timsit JF, Misset B, Ali Benali M, Colin G, Souweine B, Asehnoune K, Mercier E, Chimot L, Charpentier C, François B, Boulain T, Petitpas F, Constantin JM, Dhonneur G, Baudin F, Combes A, Bohé J, Loriferne JF, Amathieu R, Cook F, Slama M, Leroy O, Capellier G, Dargent A, Hissem T, Maxime V, Bellissant E, CTN
Hydrocortisone plus Fludrocortisone for Adults with Septic Shock.
The New England Journal of Medicine 2018, 378, 809-818.

Triki D, Fartek S, Visseaux B, Descamps D, Camproux AC, Regad L
Characterizing the structural variability of HIV-2 protease upon the binding of diverse ligands using a structural alphabet approach.
Journal of Biomolecular Structure & Dynamics 2018, 1-20.

Loubet P, Anselem O, Launay O
Immunization during pregnancy.
Expert Review of Vaccines 2018

Moulignier A, Savatovsky J, Assoumou L, Lescure FX, Lamirel C, Godin O, Valin N, Tubiana R, Canestri A, Roux P, Sadik JC, Salomon L, Abrivard M, Katlama C, Yazdanpanah Y, Pialoux G, Girard PM, Costagliola D, MBRaK(SG
Silent Cerebral Small-Vessel Disease Is Twice as Prevalent in Middle-Aged Individuals With Well-Controlled, Combination Antiretroviral Therapy-Treated Human Immunodeficiency Virus (HIV) Than in HIV-Uninfected Individuals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 1762-1769.

Birgand G, Zahar JR, Lucet JC
Insight Into the Complex Epidemiology of Multidrug-Resistant Enterobacteriaceae.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 66, 494-496.

Melliez H, Mary-Krause M, Bocket L, Guiguet M, Abgrall S, De Truchis P, Katlama C, Martin-Blondel G, Henn A, Revest M, Robineau O, Khuong-Josses MA, Canestri A, De Castro N, Joly V, Mokhtari S, Risso K, Gasnault J, Costagliola D, FHDoH(C
Risk of Progressive Multifocal Leukoencephalopathy in the Combination Antiretroviral Therapy Era in the French Hospital Database on Human Immunodeficiency Virus (ANRS-C4).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Ferré VM, Gbeasor-Komlanvi FA, Collin G, Dagnra AC, Le Hingrat Q, Jaquet A, Salou M, Descamps D, Charpentier C, Ekouevi DK
Prevalence of Human Papillomavirus, HIV and other sexually transmitted infections among men having sex with men in Togo: a national cross-sectional survey.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Peiffer-Smadja N, Hanslik T, Mordant P, Lescure FX
Cultural differences between surgical and medical teams: is it time for comanagement?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Argy N, Le Gal S, Coppée R, Song Z, Vindrios W, Massias L, Kao WC, Hunte C, Yazdanpanah Y, Lucet JC, Houzé S, Clain J, Nevez G
Pneumocystis Cytochrome b Mutants Associated With Atovaquone Prophylaxis Failure as the Cause of Pneumocystis Infection Outbreak Among Heart Transplant Recipients.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 913-919.

Luong Nguyen LB, Yazdanpanah Y, Maman D, Wanjala S, Vandenbulcke A, Price J, Parker RA, Hennequin W, Mendiharat P, Freedberg KA
Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 719-726.

Matheron S, Descamps D, Gallien S, Besseghir A, Sellier P, Blum L, Mortier E, Charpentier C, Tubiana R, Damond F, Peytavin G, Ponscarme D, Collin F, Brun-Vezinet F, Chene G, A1H2tSG
First line raltegravir/emtricitabine/tenofovir combination in HIV-2 infection: phase 2 non-comparative trial (ANRS 159 HIV-2).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

de Kraker MEA, Sommer H, de Velde F, Gravestock I, Weiss E, McAleenan A, Nikolakopoulos S, Amit O, Ashton T, Beyersmann J, Held L, Lovering AM, MacGowan AP, Mouton JW, Timsit JF, Wilson D, Wolkewitz M, Bettiol E, Dane A, Harbarth S, CNC
Optimizing the Design and Analysis of Clinical Trials for Antibacterials Against Multidrug-resistant Organisms: A White Paper From COMBACTE's STAT-Net.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018, 67, 1922-1931.

Zahar JR, Blot S, Nordmann P, Martischang R, Timsit JF, Harbarth S, Barbier F
Screening for intestinal carriage of ESBL-producing Enterobacteriaceae in critically ill patients: expected benefits and evidence-based controversies.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Le Hingrat Q, Collin G, Lê M, Peytavin G, Visseaux B, Bertine M, Tubiana R, Karmochkine M, Valin N, Collin F, Lemaignen A, Bernard L, Damond F, Matheron S, Descamps D, Charpentier C, ACH2C
A new mechanism of resistance of HIV-2 to integrase inhibitors: a 5 amino-acids insertion in the integrase C-terminal domain.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2018

Le Roux E, Mellerio H, Jacquin P, Bourmaud A, Guilmin-Crépon S, Faye A, Matheron S, Boulkedid R, Alberti C
Practical generic guidelines for paediatric-to-adult transition for adolescents with chronic disease.
European Journal of Public Health 2018

Mariaggi AA, Péré H, Perrier M, Visseaux B, Collin G, Veyer D, Hingrat QL, Ferré VM, Joly V, Couvelard A, Bucau M, Davitian C, Descamps D, Abramowitz L, Charpentier C
Presence of HPV APOBEC-related Minority Variants in HPV16 Genomes from Anal and Cervical Samples but not in HPV52 and HPV58.
The Journal of Infectious Diseases 2018

Perrier M, Visseaux B, Landman R, Joly V, Todesco E, Yazdanpanah Y, Calvez V, Marcelin AG, Descamps D, Charpentier C
No impact of HIV-1 protease minority resistant variants on the virological response to a first-line PI-based regimen containing darunavir or atazanavir.
The Journal of Antimicrobial Chemotherapy 2018, 73, 173-176.

Seang S, Schneider L, Nguyen T, Lê MP, Soulie C, Calin R, Caby F, Valantin MA, Tubiana R, Assoumou L, Marcelin AG, Peytavin G, Katlama C
Darunavir/ritonavir monotherapy at a low dose (600/100 mg/day) in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2018, 73, 490-493.

de Truchis P, Assoumou L, Landman R, Mathez D, Le Dû D, Bellet J, Amat K, Katlama C, Gras G, Bouchaud O, Duracinsky M, Abe E, Alvarez JC, Izopet J, Saillard J, Melchior JC, Leibowitch J, Costagliola D, Girard PM, Perronne C, A14SG
Four-days-a-week antiretroviral maintenance therapy in virologically controlled HIV-1-infected adults: the ANRS 162-4D trial.
The Journal of Antimicrobial Chemotherapy 2018, 73, 738-747.

Le Meur L, Tantet C, Lê MP, Desselas E, Bonnal C, Lillo-Le-Louet A, Sonneville R, Massias L, Giraud J, Descamps D, Yazdanpanah Y, Lariven S, Peytavin G
Serious neuropsychiatric adverse effects related to interaction between itraconazole and darunavir/ritonavir in an HIV-infected patient with cerebral histoplasmosis.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1108-1110.

Pressiat C, Hirt D, Treluyer JM, Zheng Y, Morlat P, Naqvi A, Tran L, Viard JP, Avettand-Fenoel V, Rouzioux C, Meyer L, Cheret A, OSG
Decreased darunavir concentrations during once-daily co-administration with maraviroc and raltegravir: OPTIPRIM-ANRS 147 trial.
The Journal of Antimicrobial Chemotherapy 2018

Charpentier C, Malet I, Andre-Garnier E, Storto A, Bocket L, Amiel C, Morand-Joubert L, Tumiotto C, Nguyen T, Maillard A, Rodallec A, Leoz M, Montes B, Schneider V, Plantier JC, Dina J, Pallier C, Mirand A, Roussel C, Signori-Schmuck A, Raymond S, Calvez V, Delaugerre C, Marcelin AG, Descamps D
Phenotypic analysis of HIV-1 E157Q integrase polymorphism and impact on virological outcome in patients initiating an integrase inhibitor-based regimen.
The Journal of Antimicrobial Chemotherapy 2018

Storto A, Visseaux B, Bertine M, Le Hingrat Q, Collin G, Damond F, Khuong MA, Blum L, Tubiana R, Karmochkine M, Cazanave C, Matheron S, Descamps D, Charpentier C, AH2CC
Minority resistant variants are also present in HIV-2-infected antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2018

Meynard JL, Moinot L, Landman R, Morand-Joubert L, Besseghir A, Kolta S, Spire B, Todesco E, Bouchaud O, Fagard C, Chene G, Girard PM, A1DSG
Week 96 efficacy of lopinavir/ritonavir monotherapy in virologically suppressed patients with HIV: a randomized non-inferiority trial (ANRS 140 DREAM).
The Journal of Antimicrobial Chemotherapy 2018

Charpentier C, Peytavin G, Lê MP, Joly V, Cabras O, Perrier M, Le Gac S, Phung B, Yazdanpanah Y, Descamps D, Landman R
High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort.
The Journal of Antimicrobial Chemotherapy 2018, 73, 1665-1671.

Lambert-Niclot S, Grude M, Chaix ML, Charpentier C, Reigadas S, Le Guillou-Guillemette H, Rodallec A, Amiel C, Maillard A, Dufayard J, Mourez T, Mirand A, Guinard J, Montes B, Vallet S, Marcelin AG, Descamps D, Flandre P, Delaugerre C, Morand-Joubert L, AA1RG
Emerging resistance mutations in PI-naive patients failing an atazanavir-based regimen (ANRS multicentre observational study).
The Journal of Antimicrobial Chemotherapy 2018

Molina JM, Gallien S, Chaix ML, El Abbassi EM, Madelaine I, Katlama C, Valin N, Delobel P, Desseaux K, Peytavin G, Saillard J, Raffi F, Chevret S, A1DSG
Low-dose ritonavir-boosted darunavir in virologically suppressed HIV-1-infected adults: an open-label trial (ANRS 165 Darulight).
The Journal of Antimicrobial Chemotherapy 2018

Lê MP, Chaix ML, Chevret S, Bertrand J, Raffi F, Gallien S, El Abbassi EMB, Katlama C, Delobel P, Yazdanpanah Y, Saillard J, Molina JM, Peytavin G, A1DSG
Pharmacokinetic modelling of darunavir/ritonavir dose reduction (800/100 to 400/100 mg once daily) in a darunavir/ritonavir-containing regimen in virologically suppressed HIV-infected patients: ANRS 165 DARULIGHT sub-study.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2120-2128.

Nguyen T, Fofana DB, Lê MP, Charpentier C, Peytavin G, Wirden M, Lambert-Niclot S, Desire N, Grude M, Morand-Joubert L, Flandre P, Katlama C, Descamps D, Calvez V, Todesco E, Marcelin AG
Prevalence and clinical impact of minority resistant variants in patients failing an integrase inhibitor-based regimen by ultra-deep sequencing.
The Journal of Antimicrobial Chemotherapy 2018, 73, 2485-2492.

Alessandri-Gradt E, Charpentier C, Leoz M, Mourez T, Descamps D, Plantier JC
Impact of natural polymorphisms of HIV-1 non-group M on genotypic susceptibility to the attachment inhibitor fostemsavir.
The Journal of Antimicrobial Chemotherapy 2018

Fofana DB, d'Almeida M, Lambert-Niclot S, Peytavin G, Girard PM, Lafia B, Zohoun-Guidigbi L, Keke RK, Soulie C, Marcelin AG, Morand-Joubert L
Resistance profile and treatment outcomes in HIV-infected children at virological failure in Benin, West Africa.
The Journal of Antimicrobial Chemotherapy 2018

Ngo-Giang-Huong N, Huynh THK, Dagnra AY, Toni Td, Maiga AI, Kania D, Eymard-Duvernay S, Peeters M, Soulie C, Peytavin G, Rekacewicz C, Chaix ML, Aghokeng AF, A1SG
Prevalence of pretreatment HIV drug resistance in West African and Southeast Asian countries.
The Journal of Antimicrobial Chemotherapy 2018

Soulie C, Santoro MM, Charpentier C, Storto A, Paraskevis D, Di Carlo D, Gennari W, Sterrantino G, Zazzi M, Perno CF, Calvez V, Descamps D, Ceccherini-Silberstein F, Marcelin AG
Rare occurrence of doravirine resistance-associated mutations in HIV-1-infected treatment-naive patients.
The Journal of Antimicrobial Chemotherapy 2018

Dimeglio C, Raymond S, Nicot F, Jeanne N, Carcenac R, Lefebvre C, Izopet J, FNAfRoAaVH(ARSG
Impact of the mutational load on the virological response to a first-line rilpivirine-based regimen.
The Journal of Antimicrobial Chemotherapy 2018

Cuzin L, Pugliese P, Katlama C, Bani-Sadr F, Ferry T, Rey D, Lourenco J, Bregigeon S, Allavena C, Reynes J, Cabié A, DSG
Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort.
The Journal of Antimicrobial Chemotherapy 2018

Mabileau G, Scutelniciuc O, Tsereteli M, Konorazov I, Yelizaryeva A, Popovici S, Saifuddin K, Losina E, Manova M, Saldanha V, Malkin JE, Yazdanpanah Y
Intervention Packages to Reduce the Impact of HIV and HCV Infections Among People Who Inject Drugs in Eastern Europe and Central Asia: A Modeling and Cost-effectiveness Study.
Open Forum Infectious Diseases 2018, 5, ofy040.

Cazals N, Le Hingrat Q, Abraham B, Da Silva P, Guindre L, Goffart S, Damond F, Visseaux B, Charpentier C, Ranger-Rogez S, Descamps D
HIV-2 Primary Infection in a French 69-Year-Old Bisexual Man.
Open Forum Infectious Diseases 2018, 5, ofy223.

Chaix ML, Charreau I, Pintado C, Delaugerre C, Mahjoub N, Cotte L, Capitant C, Raffi F, Cua E, Pialoux G, Tremblay C, Meyer L, Molina JM, AISG
Effect of On-Demand Oral Pre-exposure Prophylaxis With Tenofovir/Emtricitabine on Herpes Simplex Virus-1/2 Incidence Among Men Who Have Sex With Men: A Substudy of the ANRS IPERGAY Trial.
Open Forum Infectious Diseases 2018, 5, ofy295.

Dananché C, Vanhems P, Machut A, Aupée M, Bervas C, L'Hériteau F, Lepape A, Lucet JC, Stoeckel V, Timsit JF, Berger-Carbonne A, Savey A, Bénet T, HAI(SNoI(RR
Trends of Incidence and Risk Factors of Ventilator-Associated Pneumonia in Elderly Patients Admitted to French ICUs Between 2007 and 2014.
Critical Care Medicine 2018, 46, 869-877.

Sommer H, Timsit JF, von Cube M, Schumacher M, Darmon M, Schwebel C, Ruckly S, Wolkewitz M, CMC
The Impact of Early Adequate Treatment on Extubation and Discharge Alive of Patients With Pseudomonas aeruginosa-Related Ventilator-Associated Pneumonia.
Critical Care Medicine 2018, 46, 1643-1648.

Gros A, Dupuis C, Ruckly S, Lautrette A, Garrouste-Orgeas M, Gainnier M, Forel JM, Marcotte G, Azoulay E, Cohen Y, Schwebel C, Argaud L, de Montmollin E, Siami S, Goldgran-Toledano D, Darmon M, Timsit JF, OSG
Association Between Body Weight Variation and Survival and Other Adverse Events in Critically Ill Patients With Shock: A Multicenter Cohort Study of the OUTCOMEREA Network.
Critical Care Medicine 2018, 46, e981-e987.

de Léotoing L, Yazdanpanah Y, Finkielsztejn L, Chaize G, Vainchtock A, Nachbaur G, Aubin C, Bonnet F
Costs associated with hospitalization in HIV-positive patients in France.
AIDS (London, England) 2018, 32, 2059-2066.

Champenois K, Seng R, Persoz A, Essat A, Gaud C, Laureillard D, Robineau O, Duvivier C, Yazdanpanah Y, Goujard C, Meyer L, APcsg
Calendar trends in sexual behaviours in a cohort of HIV-infected MSM at the era of treatment as prevention of HIV infection.
AIDS (London, England) 2018, 32, 1871-1879.

Colin De Verdiere N, Durier C, Samri A, Meiffredy V, Launay O, Matheron S, Mercier-Delarue S, Even S, Aboulker JP, Molina JM, Autran B, Simon F, atAENG
Immunogenicity and safety of yellow fever vaccine in HIV-1-infected patients: ANRS EP46 NOVAA.
AIDS (London, England) 2018

Benhammou V, Tubiana R, Matheron S, Sellier P, Mandelbrot L, Chenadec JL, Marel E, Khoshnood B, Warszawski J, ACEFPCsg
HBV or HCV Coinfection in HIV-1-Infected Pregnant Women in France: Prevalence and Pregnancy Outcomes.
Journal of Acquired Immune Deficiency Syndromes (1999) 2018, 77, 439-450.

Costagliola D, Potard V, Lang S, Abgrall S, Duvivier C, Fischer H, Joly V, Lacombe JM, Valantin MA, Mary-Krause M, Rozenberg S, FAC
Impact of antiretroviral drugs on fracture risk in HIV-infected individuals: A case-control study nested within the French Hospital Database on HIV (FHDH-ANRS CO4).
Journal of Acquired Immune Deficiency Syndromes (1999) 2018

Provoost A, Dramé M, Cotte L, Cuzin L, Garraffo R, Rey D, Raffi F, Poizot-Martin I, Pugliese P, Bani-Sadr F, Dsg
Risk of diabetes in HIV-infected patients is associated with cirrhosis but not with chronic HCV coinfection in a French nationwide HIV cohort.
Alimentary Pharmacology & Therapeutics 2018

Brunet-Possenti F, Charpentier C, Collin G, Descamps D, Descamps V
Impact of anti-interleukin-17 treatment on cutaneous and genital human papillomavirus infection.
The British Journal of Dermatology 2018, 179, 1179-1180.

Pouga L, Mercedes Santoro M, Charpentier C, Di Carlo D, Romeo I, Artese A, Alcaro S, Antinori A, Wirden M, Perno CF, Ambrosio FA, Calvez V, Descamps D, Marcelin AG, Ceccherini-Silberstein F, Lambert-Niclot S
New Resistance Mutations to Nucleoside Reverse Transcriptase Inhibitors at Codon 184 of HIV-1 Reverse Transcriptase (M184L and M184T).
Chemical Biology & Drug Design 2018

MHWGftCoOHERiE(iE
Immunological and virological response to antiretroviral treatment in migrant and native men and women in Western Europe; is benefit equal for all?.
HIV medicine 2018, 19, 42-48.

Cuzin L, Yazdanpanah Y, Huleux T, Cotte L, Pugliese P, Allavena C, Reynes J, Poizot-Martin I, Bani-Sadr F, Delpierre C, DSG
No relationship between late HIV diagnosis and social deprivation in newly diagnosed patients in France.
HIV medicine 2018, 19, 238-242.

Rosenthal E, Fougerou-Leurent C, Renault A, Carrieri MP, Marcellin F, Garraffo R, Teicher E, Aumaitre H, Lacombe K, Bailly F, Billaud E, Chevaliez S, Dominguez S, Valantin MA, Reynes J, Naqvi A, Cotte L, Metivier S, Leroy V, Dupon M, Allegre T, De Truchis P, Jeantils V, Chas J, Salmon-Ceron D, Morlat P, Neau D, Perré P, Piroth L, Pol S, Bourlière M, Pageaux GP, Alric L, Zucman D, Girard PM, Poizot-Martin I, Yazdanpanah Y, Raffi F, Pabic EL, Tual C, Pailhé A, Amri I, Bellissant E, Molina JM, AHSSG
Efficacy, safety and patient-reported outcomes of ledipasvir/sofosbuvir in NS3/4A protease inhibitor-experienced individuals with hepatitis C virus genotype 1 and HIV coinfection with and without cirrhosis (ANRS HC31 SOFTRIH study).
HIV medicine 2018, 19, 227-237.

Hentzien M, Cabie A, Pugliese P, Billaud É, Poizot-Martin I, Duvivier C, Valantin MA, Kaladjian A, Dramé M, Bani-Sadr F, DSG
Factors associated with deaths from suicide in a French nationwide HIV-infected cohort.
HIV medicine 2018

Gallien S, Massetti M, Flandre P, Leleu H, Descamps D, Lazaro E
Comparison of 48-week efficacies of elvitegravir/cobicistat/emtricitabine/tenofovir alafenamide and nucleoside/nucleotide reverse transcriptase inhibitor-sparing regimens: a systematic review and network meta-analysis.
HIV medicine 2018

Nassereddine H, Charpentier C, Bucau M, Joly V, Bienvenu L, Davitian C, Abramowitz L, Benabderrahmane D, Kotelevets L, Chastre E, Lehy T, Walker F
Interest of cytology combined with Xpert® HPV and Anyplex® II HPV28 Detection human papillomavirus (HPV) typing: differential profiles of anal and cervical HPV lesions in HIV-infected patients on antiretroviral therapy.
HIV medicine 2018

Papatheodoridis GV, Hatzakis A, Cholongitas E, Baptista-Leite R, Baskozos I, Chhatwal J, Colombo M, Cortez-Pinto H, Craxi A, Goldberg D, Gore C, Kautz A, Lazarus JV, Mendão L, Peck-Radosavljevic M, Razavi H, Schatz E, Tözün N, van Damme P, Wedemeyer H, Yazdanpanah Y, Zuure F, Manns MP
Hepatitis C: The beginning of the end-key elements for successful European and national strategies to eliminate HCV in Europe.
Journal of Viral Hepatitis 2018, 25 Suppl 1, 6-17.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Mabileau G, Dhersin JS, Yazdanpanah Y
Effectiveness and cost-effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: The case of France.
Journal of Viral Hepatitis 2018, 25, 1197-1207.

Jary A, Leducq V, Palich R, Gothland A, Descamps D, Joly V, Lambert-Niclot S, Amiel C, Canestri A, Mirand A, Gault E, Vabret A, Valantin MA, Katlama C, Calvez V, Dupin N, Spano JP, Marcelin AG
Usefulness of Kaposi's Sarcoma-Associated Herpesvirus (KSHV) DNA Viral Load in Whole Blood for Diagnosis and Monitoring of KSHV-Associated Diseases.
Journal of Clinical Microbiology 2018, 56,

Burdet C, Loubet P, Le Moing V, Vindrios W, Esposito-Farèse M, Linard M, Ferry T, Massias L, Tattevin P, Wolff M, Vandenesch F, Grall N, Quintin C, Mentré F, Duval X, Lescure FX, Csg
Efficacy of cloxacillin versus cefazolin for methicillin-susceptible Staphylococcus aureus bacteraemia (CloCeBa): study protocol for a randomised, controlled, non-inferiority trial.
BMJ open 2018, 8, e023151.

Kirchgesner J, Beaugerie L, Carrat F, Andersen NN, Jess T, Schwarzinger M, Bsg
Increased risk of acute arterial events in young patients and severely active IBD: a nationwide French cohort study.
Gut 2018, 67, 1261-1268.

Januel E, Martin-Blondel G, Lamirel C, Picard H, Pialoux G, Katlama C, Cochereau I, Lescure FX, Moulignier A
Do CCR5 antagonists improve the overall survival of patients with AIDS-related progressive multifocal leucoencephalopathy?.
Journal of Neurology, Neurosurgery, and Psychiatry 2018, 89, 1125-1126.

Bleibtreu A, Jaureguiberry S, Houhou N, Boutolleau D, Guillot H, Vallois D, Lucet JC, Robert J, Mourvillier B, Delemazure J, Jaspard M, Lescure FX, Rioux C, Caumes E, Yazdanapanah Y
Clinical management of respiratory syndrome in patients hospitalized for suspected Middle East respiratory syndrome coronavirus infection in the Paris area from 2013 to 2016.
BMC infectious diseases 2018, 18, 331.

Désiré N, Cerutti L, Le Hingrat Q, Perrier M, Emler S, Calvez V, Descamps D, Marcelin AG, Hué S, Visseaux B
Characterization update of HIV-1 M subtypes diversity and proposal for subtypes A and D sub-subtypes reclassification.
Retrovirology 2018, 15, 80.

Cantier M, Morisot A, Guérot E, Megarbane B, Razazi K, Contou D, Mariotte E, Canet E, De Montmollin E, Dubée V, Boulet E, Gaudry S, Voiriot G, Mayaux J, Pène F, Neuville M, Mourvillier B, Ruckly S, Bouadma L, Wolff M, Timsit JF, Sonneville R, Esg
Functional outcomes in adults with tuberculous meningitis admitted to the ICU: a multicenter cohort study.
Critical Care (London, England) 2018, 22, 210.

Truche AS, Ragey SP, Souweine B, Bailly S, Zafrani L, Bouadma L, Clec'h C, Garrouste-Orgeas M, Lacave G, Schwebel C, Guebre-Egziabher F, Adrie C, Dumenil AS, Zaoui P, Argaud L, Jamali S, Goldran Toledano D, Marcotte G, Timsit JF, Darmon M
ICU survival and need of renal replacement therapy with respect to AKI duration in critically ill patients.
Annals of Intensive Care 2018, 8, 127.

Birgand G, Castro-Sánchez E, Hansen S, Gastmeier P, Lucet JC, Ferlie E, Holmes A, Ahmad R
Comparison of governance approaches for the control of antimicrobial resistance: Analysis of three European countries.
Antimicrobial Resistance and Infection Control 2018, 7, 28.

Bougnoux ME, Brun S, Zahar JR
Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention.
Antimicrobial Resistance and Infection Control 2018, 7, 45.

Perrier M, Désiré N, Storto A, Todesco E, Rodriguez C, Bertine M, Le Hingrat Q, Visseaux B, Calvez V, Descamps D, Marcelin AG, Charpentier C
Evaluation of different analysis pipelines for the detection of HIV-1 minority resistant variants.
PloS One 2018, 13, e0198334.

Allavena C, Hanf M, Rey D, Duvivier C, BaniSadr F, Poizot-Martin I, Jacomet C, Pugliese P, Delobel P, Katlama C, Joly V, Chidiac C, Dournon N, Merrien D, May T, Reynes J, Gagneux-Brunon A, Chirouze C, Huleux T, Cabié A, Raffi F, Dsg
Antiretroviral exposure and comorbidities in an aging HIV-infected population: The challenge of geriatric patients.
PloS One 2018, 13, e0203895.

de Monteynard LA, Matheron S, Grabar S, de Truchis P, Gilquin J, Pavie J, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Mahamat A, Dray-Spira R, Simon A, Costagliola D, Abgrall S, FAC
Influence of geographic origin on AIDS and serious non-AIDS morbidity/mortality during cART among heterosexual HIV-infected men and women in France.
PloS One 2018, 13, e0205385.

Arrive E, Viard JP, Salanave B, Dollfus C, Matheron S, Reliquet V, Arezes E, Nailler L, Vigouroux C, Warszawski J, ACCaEsg
Metabolic risk factors in young adults infected with HIV since childhood compared with the general population.
PloS One 2018, 13, e0206745.

Lorme F, Maataoui N, Rondinaud E, Esposito-Farèse M, Clermont O, Ruppe E, Arlet G, Genel N, VRsg, Matheron S, Andremont A, Armand-Lefevre L
Acquisition of plasmid-mediated cephalosporinase producing Enterobacteriaceae after a travel to the tropics.
PloS One 2018, 13, e0206909.

Pilmis B, Zahar JR
Ventilator-associated pneumonia related to ESBL-producing gram negative bacilli.
Annals of Translational Medicine 2018, 6, 424.

Gangneux JP, Cornet M, Bailly S, Fradin C, Féger C, Timsit JF, Leroy O, Sendid B, Bougnoux ME
Clinical Impact of Antifungal Susceptibility, Biofilm Formation and Mannoside Expression of Candida Yeasts on the Outcome of Invasive Candidiasis in ICU: An Ancillary Study on the Prospective AmarCAND2 Cohort.
Frontiers in Microbiology 2018, 9, 2907.

Ségéral O, Nerrienet E, Neth S, Spire B, Khol V, Ferradini L, Sarun S, Mom C, Ngin S, Charpentier C, Men P, Mora M, Mean Chhi V, Ly P, Saphonn V
Positive Virological Outcomes of HIV-Infected Patients on Protease Inhibitor-Based Second-Line Regimen in Cambodia: The ANRS 12276 2PICAM Study.
Frontiers in Public Health 2018, 6, 63.

Charpentier C, Descamps D
Resistance to HIV Integrase Inhibitors: About R263K and E157Q Mutations.
Viruses 2018, 10,

Todesco E, Mazzola A, Akhavan S, Abravanel F, Poynard T, Roque-Afonso AM, Peytavin G, Marcelin AG, Calmus Y, Lecuyer L, Guillemain R, Conti F
Chronic hepatitis E in a heart transplant patient: sofosbuvir and ribavirin regimen not fully effective.
Antiviral Therapy 2018

Salmon D, Trimoulet P, Gilbert C, Solas C, Lafourcade E, Chas J, Piroth L, Lacombe K, Katlama C, Peytavin G, Aumaitre H, Alric L, Boué F, Morlat P, Poizot-Martin I, Billaud E, Rosenthal E, Naqvi A, Miailhes P, Bani-Sadr F, Esterle L, Carrieri P, Dabis F, Sogni P, Wittkop L, ACHsG
Factors associated with DAA virological treatment failure and resistance-associated substitutions description in HIV/HCV coinfected patients.
World Journal of Hepatology 2018, 10, 856-866.

 2017                                                                            

Khoo S, Peytavin G, Burger D, Hill A, Brown K, Moecklinghoff C, La Porte C, Hadacek MB
Pharmacokinetics and Safety of Darunavir/Ritonavir in HIV-Infected Pregnant Women.
AIDS reviews 2017, 19, 16-23.

Gantner P, Mélard A, Damond F, Delaugerre C, Dina J, Gueudin M, Maillard A, Sauné K, Rodallec A, Tuaillon E, Plantier JC, Rouzioux C, Avettand-Fenoel V, AAQWG
Interlaboratory quality control of total HIV-1 DNA load measurement for multicenter reservoir studies.
Journal of Medical Virology 2017, 89, 2047-2050.

Sonneville R, Gimenez L, Labreuche J, Smonig R, Magalhaes E, Bouadma L, Timsit JF, Mazighi M
What is the prognosis of acute stroke patients requiring ICU admission?.
Intensive Care Medicine 2017, 43, 271-272.

Capuzzo M, Garrouste-Orgeas M, Martin-Loeches I
What were you able to do in your daily life? Performance status for the critically ill patient.
Intensive Care Medicine 2017, 43, 104-106.

Kentish-Barnes N, Chevret S, Champigneulle B, Thirion M, Souppart V, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Calvet L, Galon M, Cohen-Solal Z, Cariou A, Azoulay E, FSG
Effect of a condolence letter on grief symptoms among relatives of patients who died in the ICU: a randomized clinical trial.
Intensive Care Medicine 2017, 43, 473-484.

Bassetti M, Garnacho-Montero J, Calandra T, Kullberg B, Dimopoulos G, Azoulay E, Chakrabarti A, Kett D, Leon C, Ostrosky-Zeichner L, Sanguinetti M, Timsit JF, Richardson MD, Shorr A, Cornely OA
Intensive care medicine research agenda on invasive fungal infection in critically ill patients.
Intensive Care Medicine 2017, 43, 1225-1238.

Cambau E, Durand-Zaleski I, Bretagne S, Brun-Buisson C, Cordonnier C, Duval X, Herwegh S, Pottecher J, Courcol R, Bastuji-Garin S, Est
Performance and economic evaluation of the molecular detection of pathogens for patients with severe infections: the EVAMICA open-label, cluster-randomised, interventional crossover trial.
Intensive Care Medicine 2017, 43, 1613-1625.

Poulakou G, Matthaiou DK, Bassetti M, Erdem H, Dimopoulos G, Curcio DJ, Carlet J, Lipman J, Timsit JF, Giamarellou H, Arfaras-Melainis A, Rello J, EI
"Salvage treatment" for infections by extensively- and pan-drug-resistant pathogens is common and often sub-optimal.
Intensive Care Medicine 2017, 43, 1164-1166.

Timsit JF, de Kraker MEA, Sommer H, Weiss E, Bettiol E, Wolkewitz M, Nikolakopoulos S, Wilson D, Harbarth S, CNc
Appropriate endpoints for evaluation of new antibiotic therapies for severe infections: a perspective from COMBACTE's STAT-Net.
Intensive Care Medicine 2017, 43, 1002-1012.

Sonneville R, de Montmollin E, Poujade J, Garrouste-Orgeas M, Souweine B, Darmon M, Mariotte E, Argaud L, Barbier F, Goldgran-Toledano D, Marcotte G, Dumenil AS, Jamali S, Lacave G, Ruckly S, Mourvillier B, Timsit JF
Potentially modifiable factors contributing to sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1075-1084.

Perner A, Gordon AC, Angus DC, Lamontagne F, Machado F, Russell JA, Timsit JF, Marshall JC, Myburgh J, Shankar-Hari M, Singer M
The intensive care medicine research agenda on septic shock.
Intensive Care Medicine 2017, 43, 1294-1305.

Laupland KB, Paiva JA, Timsit JF
Focus on severe infections.
Intensive Care Medicine 2017, 43, 1033-1036.

Yamaga S, Shime N, Sonneville R, de Montmollin E, Timsit JF
Risk factors for sepsis-associated encephalopathy.
Intensive Care Medicine 2017, 43, 1548-1549.

Robert R, Le Gouge A, Kentish-Barnes N, Cottereau A, Giraudeau B, Adda M, Annane D, Audibert J, Barbier F, Bardou P, Bourcier S, Bourenne J, Boyer A, Brenas F, Das V, Desachy A, Devaquet J, Feissel M, Ganster F, Garrouste-Orgeas M, Grillet G, Guisset O, Hamidfar-Roy R, Hyacinthe AC, Jochmans S, Jourdain M, Lautrette A, Lerolle N, Lesieur O, Lion F, Mateu P, Megarbane B, Merceron S, Mercier E, Messika J, Morin-Longuet P, Philippon-Jouve B, Quenot JP, Renault A, Repesse X, Rigaud JP, Robin S, Roquilly A, Seguin A, Thevenin D, Tirot P, Vinatier I, Azoulay E, Reignier J
Terminal weaning or immediate extubation for withdrawing mechanical ventilation in critically ill patients (the ARREVE observational study).
Intensive Care Medicine 2017, 43, 1793-1807.

Lefebvre A, Lucet JC, Bertrand X, Chavanet P, Astruc K, Quantin C, Vanhems P, Aho-Glélé LS
Detection of temporal clusters of health care-associated infections or colonizations with Pseudomonas aeruginosa.
American Journal of Infection Control 2017, 45, 72-74.

Pilmis B, Thepot-Seegers V, Angebault C, Weiss E, Alaabouche I, Bougnoux ME, Zahar JR
Could we predict airborne Aspergillus contamination during construction work?.
American Journal of Infection Control 2017, 45, 39-41.

Montravers P, Perrigault PF, Timsit JF, Mira JP, Lortholary O, Leroy O, Gangneux JP, Guillemot D, Bensoussan C, Bailly S, Azoulay E, Constantin JM, Dupont H, ASG
Antifungal therapy for patients with proven or suspected Candida peritonitis: Amarcand2, a prospective cohort study in French intensive care units.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 117.e1-117.e8.

Argy N, Bertin GI, Milet J, Hubert V, Clain J, Cojean S, Houzé P, Tuikue-Ndam N, Kendjo E, Deloron P, Houzé S, CSG
Preferential expression of domain cassettes 4, 8 and 13 of Plasmodium falciparum erythrocyte membrane protein 1 in severe malaria imported in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 211.e1-211.e4.

Loubet P, Lenzi N, Valette M, Foulongne V, Krivine A, Houhou N, Lagathu G, Rogez S, Alain S, Duval X, Galtier F, Postil D, Tattevin P, Vanhems P, Carrat F, Lina B, Launay O, FSG
Clinical characteristics and outcome of respiratory syncytial virus infection among adults hospitalized with influenza-like illness in France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 253-259.

Bleibtreu A, Arias P, Vallois D, Debit A, Lermuzeaux M, Rioux C, Cabras O, Lucet JC, Choquet C, Timsit JF, Yazdanpanah Y, Lescure FX
Delayed management of Staphyloccocus aureus infective endocarditis in a Middle East respiratory syndrome coronavirus possible case hospitalized in 2015 in Paris, France.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2017, 23, 416-417.

Rhee SY, Varghese V, Holmes SP, Van Zyl GU, Steegen K, Boyd MA, Cooper DA, Nsanzimana S, Saravanan S, Charpentier C, de Oliveira T, Etiebet MAA, Garcia F, Goedhals D, Gomes P, Günthard HF, Hamers RL, Hoffmann CJ, Hunt G, Jiamsakul A, Kaleebu P, Kanki P, Kantor R, Kerschberger B, Marconi VC, D'amour Ndahimana J, Ndembi N, Ngo-Giang-Huong N, Rokx C, Santoro MM, Schapiro JM, Schmidt D, Seu L, Sigaloff KCE, Sirivichayakul S, Skhosana L, Sunpath H, Tang M, Yang C, Carmona S, Gupta RK, Shafer RW
Mutational correlates of virological failure in individuals receiving a WHO-recommended tenofovir-containing first-line regimen: An international collaboration.
EBioMedicine 2017

Guet-Revillet H, Tomini E, Emirian A, Join-Lambert O, Lécuyer H, Zahar JR, Jullien V
Piperacillin/tazobactam as an alternative antibiotic therapy to carbapenems in the treatment of urinary tract infections due to extended-spectrum β-lactamase-producing Enterobacteriaceae: an in silico pharmacokinetic study.
International Journal of Antimicrobial Agents 2017, 49, 62-66.

Zahar JR, Lesprit P, Ruckly S, Eden A, Hikombo H, Bernard L, Harbarth S, Timsit JF, Brun-Buisson C, BSG
Predominance of healthcare-associated cases among episodes of community-onset bacteraemia due to extended-spectrum β-lactamase-producing Enterobacteriaceae.
International Journal of Antimicrobial Agents 2017, 49, 67-73.

Bailly S, Leroy O, Dupont H, Timsit JF
Secondarily documented invasive candidiasis is unpredictable using traditional risk factors in non transplant - non-neutropenic adult ICU patients.
International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases 2017, 54, 31-33.

Loubet P, Voiriot G, Houhou-Fidouh N, Neuville M, Bouadma L, Lescure FX, Descamps D, Timsit JF, Yazdanpanah Y, Visseaux B
Impact of respiratory viruses in hospital-acquired pneumonia in the intensive care unit: A single-center retrospective study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 91, 52-57.

Wirden M, Larrouy L, Mahjoub N, Todesco E, Damond F, Delagreverie H, Akhavan S, Charpentier C, Chaix ML, Descamps D, Calvez V, Marcelin AG
Multicenter comparison of the new Cobas 6800 system with Cobas Ampliprep/Cobas TaqMan and Abbott RealTime for the quantification of HIV, HBV and HCV viral load.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 96, 49-53.

Antoniol S, Fidouh N, Ghazali A, Ichou H, Bouzid D, Kenway P, Choquet C, Visseaux B, Casalino E, EDsgorv
Diagnostic performances of the Xpert® Flu PCR test and the OSOM® immunochromatographic rapid test for influenza A and B virus among adult patients in the Emergency Department.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2017, 99-100, 5-9.

Deuffic-Burban S, Boursier J, Leroy V, Yazdanpanah Y, Castera L, Mathurin P
Are targeted treatment recommendations in chronic hepatitis C tailored to diagnostic methods of fibrosis?.
Journal of Hepatology 2017, 66, 304-312.

Mallet V, Hamed K, Schwarzinger M
Prognosis of patients with chronic hepatitis B in France (2008-2013): A nationwide, observational and hospital-based study.
Journal of Hepatology 2017, 66, 514-520.

Schwarzinger M, Baillot S, Yazdanpanah Y, Rehm J, Mallet V
Contribution of alcohol use disorders on the burden of chronic hepatitis C in France, 2008-2013: A nationwide retrospective cohort study.
Journal of Hepatology 2017, 67, 454-461.

Loison G, Troughton R, Raymond F, Lepelletier D, Lucet JC, Avril C, Birgand G, AWG
Compliance with clothing regulations and traffic flow in the operating room: a multi-centre study of staff discipline during surgical procedures.
The Journal of Hospital Infection 2017, 96, 281-285.

Adrie C, Garrouste-Orgeas M, Ibn Essaied W, Schwebel C, Darmon M, Mourvillier B, Ruckly S, Dumenil AS, Kallel H, Argaud L, Marcotte G, Barbier F, Laurent V, Goldgran-Toledano D, Clec'h C, Azoulay E, Souweine B, Timsit JF, OSG
Attributable mortality of ICU-acquired bloodstream infections: Impact of the source, causative micro-organism, resistance profile and antimicrobial therapy.
The Journal of Infection 2017, 74, 131-141.

Bailly S, Leroy O, Azoulay E, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Timsit JF, ASG
Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
The Journal of Infection 2017, 74, 408-417.

Baldesi O, Bailly S, Ruckly S, Lepape A, L'Heriteau F, Aupee M, Boussat S, Bervas C, Machut A, Berger-Carbonne A, Savey A, Timsit JF, RRn
ICU-acquired candidaemia in France: Epidemiology and temporal trends, 2004-2013 - A study from the REA-RAISIN network.
The Journal of Infection 2017, 75, 59-67.

Welfringer A, Vuong V, Argy N, Chochillon C, Deschamps L, Rollin G, Harent S, Joly V, Vindrios W, Descamps V
A rare fungal infection: Phaehyphomycosis due to Veronaea botryosa and review of literature.
Medical Mycology Case Reports 2017, 15, 21-24.

Lequilliec N, Raymond R, Vanjak D, Baghdadi N, Boulestreau H, Zahar JR, Gangneux JP
Practices of infectious control management during neutropenia: A survey from 149 French hospitals.
Journal De Mycologie Medicale 2017, 27, 227-231.

Hoogewoud F, Frumholtz L, Loubet P, Charlier C, Blanche P, Lebeaux D, Benhaddou N, Sedira N, Coutte L, Vanhaecke C, Launay O, Le Jeunne C, Héron E, Monnet D, Lortholary O, Sahel JA, Dupin N, Brézin A, Errera MH, Salah S, Groh M
Prognostic Factors in Syphilitic Uveitis.
Ophthalmology 2017, 124, 1808-1816.

Pourcher G, Peytavin G, Schneider L, Gallien S, Force G, Pourcher V
Bariatric surgery in HIV patients: experience of an Obesity Reference Center in France.
Surgery for Obesity and Related Diseases: Official Journal of the American Society for Bariatric Surgery 2017, 13, 1990-1996.

Peiffer-Smadja N, Ouedraogo R, D'Ortenzio E, Cissé PN, Zeggani Z, Beavogui AH, Faye SL, Le Marcis F, Yazdanpanah Y, Nguyen VK
Vaccination and blood sampling acceptability during Ramadan fasting month: A cross-sectional study in Conakry, Guinea.
Vaccine 2017, 35, 2569-2574.

Charlier C, Perrodeau É, Leclercq A, Cazenave B, Pilmis B, Henry B, Lopes A, Maury MM, Moura A, Goffinet F, Dieye HB, Thouvenot P, Ungeheuer MN, Tourdjman M, Goulet V, de Valk H, Lortholary O, Ravaud P, Lecuit M, Msg
Clinical features and prognostic factors of listeriosis: the MONALISA national prospective cohort study.
The Lancet. Infectious Diseases 2017

Badje A, Moh R, Gabillard D, Guéhi C, Kabran M, Ntakpé JB, Carrou JL, Kouame GM, Ouattara E, Messou E, Anzian A, Minga A, Gnokoro J, Gouesse P, Emieme A, Toni Td, Rabe C, Sidibé B, Nzunetu G, Dohoun L, Yao A, Kamagate S, Amon S, Kouame AB, Koua A, Kouamé E, Daligou M, Hawerlander D, Ackoundzé S, Koule S, Séri J, Ani A, Dembélé F, Koné F, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatunde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Karcher S, Rouzioux C, Kouame A, Assi R, Bakayoko A, Domoua SK, Deschamps N, Aka K, N'Dri-Yoman T, Salamon R, Journot V, Ahibo H, Ouassa T, Menan H, Inwoley A, Danel C, Eholié SP, Anglaret X, TA1SG
Effect of isoniazid preventive therapy on risk of death in west African, HIV-infected adults with high CD4 cell counts: long-term follow-up of the Temprano ANRS 12136 trial.
The Lancet. Global Health 2017, 5, e1080-e1089.

Molina JM, Charreau I, Spire B, Cotte L, Chas J, Capitant C, Tremblay C, Rojas-Castro D, Cua E, Pasquet A, Bernaud C, Pintado C, Delaugerre C, Sagaon-Teyssier L, Mestre SL, Chidiac C, Pialoux G, Ponscarme D, Fonsart J, Thompson D, Wainberg MA, Doré V, Meyer L, AISG
Efficacy, safety, and effect on sexual behaviour of on-demand pre-exposure prophylaxis for HIV in men who have sex with men: an observational cohort study.
The lancet. HIV 2017, 4, e402-e410.

Mamede JI, Damond F, Bernardo Ad, Matheron S, Descamps D, Battini JL, Sitbon M, Courgnaud V
Cyclophilins and nucleoporins are required for infection mediated by capsids from circulating HIV-2 primary isolates.
Scientific Reports 2017, 7, 45214.

Timsit JF, Pilmis B, Zahar JR
How Should We Treat Hospital-Acquired and Ventilator-Associated Pneumonia Caused by Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae?.
Seminars in Respiratory and Critical Care Medicine 2017, 38, 287-300.

Post FA, Yazdanpanah Y, Schembri G, Lazzarin A, Reynes J, Maggiolo F, Yan M, Abram ME, Tran-Muchowski C, Cheng A, Rhee MS
Efficacy and safety of emtricitabine/tenofovir alafenamide (FTC/TAF) vs. emtricitabine/tenofovir disoproxil fumarate (FTC/TDF) as a backbone for treatment of HIV-1 infection in virologically suppressed adults: subgroup analysis by third agent of a randomized, double-blind, active-controlled phase 3 trial.
HIV clinical trials 2017, 18, 135-140.

Pichon M, Mikail N, Ben Ali K, Rouzet F, Burdet C, Yazdanpanah Y, Joly V, Lepage L, Sarda-Mantel L
18FDG-PET/CT: a useful tool for the management of patients in infectious diseases.
Infectious Diseases (London, England) 2017, 49, 155-157.

Senard O, Burdet C, Visseaux B, Charpentier C, Le Gac S, Julia Z, Lariven S, Descamps D, Yazdanpanah Y, Yeni P, Joly V
Epidemiological Profile of Newly Diagnosed HIV-Infected Patients in Northern Paris: A Retrospective Study.
AIDS research and human retroviruses 2017, 33, 11-16.

Pourcher V, Desnoyer A, Assoumou L, Lebbe C, Curjol A, Marcelin AG, Cardon F, Gibowski S, Salmon D, Chennebault JM, Poizot-Martin I, Peytavin G, Boué F, Costagliola D
Phase II Trial of Lenalidomide in HIV-Infected Patients with Previously Treated Kaposi's Sarcoma: Results of the ANRS 154 Lenakap Trial.
AIDS research and human retroviruses 2017, 33, 1–10.

Raymond S, Nicot F, Pallier C, Bellecave P, Maillard A, Trabaud MA, Morand-Joubert L, Rodallec A, Amiel C, Mourez T, Bocket L, Beby-Defaux A, Bouvier-Alias M, Lambert-Niclot S, Charpentier C, Malve B, Mirand A, Dina J, Le Guillou-Guillemette H, Marque-Juillet S, Signori-Schmuck A, Barin F, Si-Mohamed A, Avettand Fenoel V, Roussel C, Calvez V, Saune K, Marcelin AG, Rodriguez C, Descamps D, Izopet J, AARSG
Impact of HIV-1 minority variants on the virus response to a rilpivirine-based first line regimen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017

Unal G, Alessandri-Gradt E, Leoz M, Pavie J, Lefevre C, Panjo H, Charpentier C, Descamps D, Barin F, Simon F, Meyer L, Plantier JC
HIV-1 group O infection in France: clinical features and immunovirological response to antiretrovirals.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017

Duval X, Millot S, Chirouze C, Selton-Suty C, Moby V, Tattevin P, Strady C, Euvrard E, Agrinier N, Thomas D, Hoen B, Alla F, EdAplelPdlI(SG
Oral Streptococcal Endocarditis, Oral Hygiene Habits, and Recent Dental Procedures: A Case-Control Study.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 64, 1678-1685.

Tschudin-Sutter S, Lucet JC, Mutters NT, Tacconelli E, Zahar JR, Harbarth S
Contact precautions for preventing nosocomial transmission of ESBL-producing Escherichia coli - a point/counterpoint review.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 342-347.

Vindrios W, Argy N, Le Gal S, Lescure FX, Massias L, Le MP, Wolff M, Yazdanpanah Y, Nevez G, Houze S, Dorent R, Lucet JC
Outbreak of Pneumocystis jirovecii Infection Among Heart Transplant Recipients: Molecular Investigation and Management of an Interhuman Transmission.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2017, 65, 1120-1126.

Jullien V, Azoulay E, Schwebel C, Le Saux T, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Cour M, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Wolff M, Timsit JF, ETSG
Population pharmacokinetics of micafungin in ICU patients with sepsis and mechanical ventilation.
The Journal of Antimicrobial Chemotherapy 2017, 72, 181-189.

Calvez V, Hocqueloux L, Meynard JL, Muret P, Castan B, Tardy JC, Peytavin G, Landman R
Less-drug regimen including atazanavir in maintenance treatment of HIV infection: how, who, when, why?.
The Journal of Antimicrobial Chemotherapy 2017, 72, 19-28.

Raffi F, Le Moing V, Assuied A, Habak S, Spire B, Cazanave C, Billaud E, Dellamonica P, Ferry T, Fagard C, Leport C, ACCSG
Failure to achieve immunological recovery in HIV-infected patients with clinical and virological success after 10 years of combined ART: role of treatment course.
The Journal of Antimicrobial Chemotherapy 2017, 72, 240-245.

Fonsart J, Saragosti S, Taouk M, Peytavin G, Bushman L, Charreau I, Hance A, Goldwirt L, Morel S, Mammano F, Loze B, Capitant C, Clavel F, Mahjoub N, Meyer L, Anderson PL, Delaugerre C, Molina JM
Single-dose pharmacokinetics and pharmacodynamics of oral tenofovir and emtricitabine in blood, saliva and rectal tissue: a sub-study of the ANRS IPERGAY trial.
The Journal of Antimicrobial Chemotherapy 2017, 72, 478–485.

Briand C, Dollfus C, Faye A, Kantor E, Avettand-Fenoel V, Caseris M, Descamps D, Schneider V, Tabone MD, Vaudre G, Veber F, Blanche S, Frange P
Efficacy and tolerance of dolutegravir-based combined ART in perinatally HIV-1-infected adolescents: a French multicentre retrospective study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 837–843.

Wirden M, Charpentier C, Tubiana R, Le MP, Desire N, Dionou S, Pichon F, Valantin MA, Yasdanpanah Y, Descamps D, Peytavin G, Katlama C, Calvez V, Marcelin AG
HIV-1 diagnosis with unquantifiable viraemia: don't be naive, look for antiretroviral drugs.
The Journal of Antimicrobial Chemotherapy 2017, 72, 630-632.

Madelain V, Le MP, Champenois K, Charpentier C, Landman R, Joly V, Yeni P, Descamps D, Yazdanpanah Y, Peytavin G
Impact of obesity on antiretroviral pharmacokinetics and immuno-virological response in HIV-infected patients: a case-control study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1137-1146.

Perrier M, Charpentier C, Peytavin G, Lê M, Blondel L, Visseaux B, Joly V, Pinto A, Matheron S, Yazdanpanah Y, Descamps D, Landman R
Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1745-1751.

Assoumou L, Charpentier C, Recordon-Pinson P, Grudé M, Pallier C, Morand-Joubert L, Fafi-Kremer S, Krivine A, Montes B, Ferré V, Bouvier-Alias M, Plantier JC, Izopet J, Trabaud MA, Yerly S, Dufayard J, Alloui C, Courdavault L, Le Guillou-Guillemette H, Maillard A, Amiel C, Vabret A, Roussel C, Vallet S, Guinard J, Mirand A, Beby-Defaux A, Barin F, Allardet-Servent A, Ait-Namane R, Wirden M, Delaugerre C, Calvez V, Chaix ML, Descamps D, Reigadas S, AA1RSG
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL: a 2014 French nationwide study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 1769-1773.

Soulie C, Grudé M, Descamps D, Amiel C, Morand-Joubert L, Raymond S, Pallier C, Bellecave P, Reigadas S, Trabaud MA, Delaugerre C, Montes B, Barin F, Ferré V, Jeulin H, Alloui C, Yerly S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, AARSG
Antiretroviral-treated HIV-1 patients can harbour resistant viruses in CSF despite an undetectable viral load in plasma.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2351-2354.

Alessandri-Gradt E, Collin G, Tourneroche A, Bertine M, Leoz M, Charpentier C, Unal G, Descamps D, Plantier JC
HIV-1 non-group M phenotypic susceptibility to integrase strand transfer inhibitors.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2431-2437.

Perrier M, Bertine M, Le Hingrat Q, Joly V, Visseaux B, Collin G, Landman R, Yazdanpanah Y, Descamps D, Charpentier C
Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2954-2955.

Wittkop L, Arsandaux J, Trevino A, Schim van der Loeff M, Anderson J, van Sighem A, Böni J, Brun-Vezinet F, Soriano V, Boufassa F, Brockmeyer N, Calmy A, Dabis F, Jarrin I, Dorrucci M, Duque V, Fätkenheuer G, Zangerle R, Ferrer E, Porter K, Judd A, Sipsas NV, Lambotte O, Shepherd L, Leport C, Morrison C, Mussini C, Obel N, Ruelle J, Schwarze-Zander C, Sonnerborg A, Teira R, Torti C, Valadas E, Colin C, Friis-Møller N, Costagliola D, Thiebaut R, Chene G, Matheron S, CiEaASG
CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: a multinational, multicohort European study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2869-2878.

Charpentier C, Montes B, Perrier M, Meftah N, Reynes J
HIV-1 DNA ultra-deep sequencing analysis at initiation of the dual therapy dolutegravir + lamivudine in the maintenance DOLULAM pilot study.
The Journal of Antimicrobial Chemotherapy 2017, 72, 2831-2836.

Lê MP, Belarbi L, Chaix ML, Dulioust E, Mahjoub N, Salmon D, Viard JP, Duvivier C, Peytavin G, Launay O, Ghosn J
Penetration and antiviral efficacy of total and unbound maraviroc, raltegravir and rilpivirine in both female and male genital fluids from HIV-positive patients receiving regimens containing these antiretrovirals.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3167-3171.

Supervie V, Assoumou L, Breban R, Lert F, Costagliola D, Pialoux G, Landman R, Girard PM, Slama L, I0DSG
Risk of HIV transmission during combined ART initiation for HIV-infected persons with severe immunosuppression.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3172-3176.

Raffi F, Hanf M, Ferry T, Khatchatourian L, Joly V, Pugliese P, Katlama C, Robineau O, Chirouze C, Jacomet C, Delobel P, Poizot-Martin I, Ravaux I, Duvivier C, Gagneux-Brunon A, Rey D, Reynes J, May T, Bani-Sadr F, Hoen B, Morrier M, Cabie A, Allavena C, DSG
Impact of baseline plasma HIV-1 RNA and time to virological suppression on virological rebound according to first-line antiretroviral regimen.
The Journal of Antimicrobial Chemotherapy 2017, 72, 3425-3434.

Squires K, Bekker LG, Katlama C, Yazdanpanah Y, Zhou Y, Rodgers AJ, DiNubile MJ, Sklar PA, Leavitt RY, Teppler H
Influence of Sex/Gender and Race on Responses to Raltegravir Combined With Tenofovir-Emtricitabine in Treatment-Naive Human Immunodeficiency Virus-1 Infected Patients: Pooled Analyses of the STARTMRK and QDMRK Studies.
Open Forum Infectious Diseases 2017, 4, ofw047.

Ragonnet R, Deuffic-Burban S, Boesecke C, Guiguet M, Lacombe K, Guedj J, Rockstroh JK, Yazdanpanah Y
Estimating the Time to Diagnosis and the Chance of Spontaneous Clearance During Acute Hepatitis C in Human Immunodeficiency Virus-Infected Individuals.
Open Forum Infectious Diseases 2017, 4, ofw235.

Kentish-Barnes N, Cohen-Solal Z, Souppart V, Galon M, Champigneulle B, Thirion M, Gilbert M, Lesieur O, Renault A, Garrouste-Orgeas M, Argaud L, Venot M, Demoule A, Guisset O, Vinatier I, Troché G, Massot J, Jaber S, Bornstain C, Gaday V, Robert R, Rigaud JP, Cinotti R, Adda M, Thomas F, Azoulay E
"It Was the Only Thing I Could Hold Onto, But…": Receiving a Letter of Condolence After Loss of a Loved One in the ICU: A Qualitative Study of Bereaved Relatives' Experience.
Critical Care Medicine 2017, 45, 1965-1971.

Dupuis C, Garrouste-Orgeas M, Bailly S, Adrie C, Goldgran-Toledano D, Azoulay E, Ruckly S, Marcotte G, Souweine B, Darmon M, Cohen Y, Schwebel C, Lacave G, Bouadma L, Timsit JF, OSG
Effect of Transfusion on Mortality and Other Adverse Events Among Critically Ill Septic Patients: An Observational Study Using a Marginal Structural Cox Model.
Critical Care Medicine 2017, 45, 1972-1980.

Crowell CS, Maiga AI, Sylla M, Taiwo B, Kone N, Oron AP, Murphy RL, Marcelin AG, Traore B, Fofana DB, Peytavin G, Chadwick EG
High Rates of Baseline Drug Resistance and Virologic Failure Among ART-naive HIV-infected Children in Mali.
The Pediatric Infectious Disease Journal 2017, 36, e258-e263.

Papot E, Landman R, Louni F, Charpentier C, Peytavin G, Certain A, Fradet C, Castro DR, Preau M, Goujard C, Yeni P, Yazdanpanah Y, AGSG
Budget impact of antiretroviral therapy in a French clinic cohort.
AIDS (London, England) 2017, 31, 1271-1279.

Todesco E, Demeret S, Calin R, Roque-Afonso AM, Thibault V, Mallet V, Akhavan S, Jaspard M, Peytavin G, Poynard T, Katlama C, Pourcher V
Chronic hepatitis E in HIV/HBV coinfected patient: lack of power of sofosbuvir-ribavirin.
AIDS (London, England) 2017, 31, 1346-1348.

Seng R, Ghislain M, Girard PM, Cotte L, Meybeck A, Raffi F, Abgrall S, Yazdanpanah Y, Goujard C, Dray-Spira R, Meyer L
Sub-Saharan African migrants have slower initial CD4+ cell recovery after combined antiretroviral treatment initiation than French natives.
AIDS (London, England) 2017, 31, 1323-1332.

Lebrun D, Hentzien M, Cuzin L, Rey D, Joly V, Cotte L, Allavena C, Dellamonica P, Servettaz A, Bani-Sadr F, atDsg
Epidemiology of autoimmune and inflammatory diseases in a French nationwide HIV cohort.
AIDS (London, England) 2017, 31, 2159-2166.

Bardon VF, Mandelbrot L, Duro D, Dussaux C, Le M, Peytavin G
Placental transfer of elvitegravir and cobicistat in an Ex Vivo human cotyledon double perfusion model.
AIDS (London, England) 2017

Dutertre M, Cuzin L, Demonchy E, Puglièse P, Joly V, Valantin MA, Cotte L, Huleux T, Delobel P, Martin-Blondel G, DSG
Initiation of Antiretroviral Therapy Containing Integrase Inhibitors Increases the Risk of IRIS Requiring Hospitalization.
Journal of Acquired Immune Deficiency Syndromes (1999) 2017, 76, e23-e26.

Desvignes C, Becquart C, Launay D, Terriou L, Patenotre P, Deheul S, Peytavin G, Dupin N, Delaporte E, Staumont-Sallé D
Extensive levamisole-induced vasculitis.
Clinical and Experimental Dermatology 2017

Bouteloup V, Sabin C, Mocroft A, Gras L, Pantazis N, Le Moing V, d'Arminio Monforte A, Mary-Krause M, Roca B, Miro JM, Battegay M, Brockmeyer N, Berenguer J, Morlat P, Obel N, De Wit S, Fätkenheuer G, Zangerle R, Ghosn J, Pérez-Hoyos S, Campbell M, Prins M, Chêne G, Meyer L, Dorrucci M, Torti C, Thiébaut R, SRDoCRtHPTftCoOHERE(iE
Reference curves for CD4 T-cell count response to combination antiretroviral therapy in HIV-1-infected treatment-naïve patients.
HIV medicine 2017, 18, 33–44.

Judd A, Lodwick R, Noguera-Julian A, Gibb DM, Butler K, Costagliola D, Sabin C, van Sighem A, Ledergerber B, Torti C, Mocroft A, Podzamczer D, Dorrucci M, De Wit S, Obel N, Dabis F, Cozzi-Lepri A, García F, Brockmeyer NH, Warszawski J, Gonzalez-Tome MI, Mussini C, Touloumi G, Zangerle R, Ghosn J, Castagna A, Fätkenheuer G, Stephan C, Meyer L, Campbell MA, Chene G, Phillips A, PLTOI(IPTftCoOHERE(iE
Higher rates of triple-class virological failure in perinatally HIV-infected teenagers compared with heterosexually infected young adults in Europe.
HIV medicine 2017, 18, 171–180.

Tron L, Lert F, Spire B, Dray-Spira R, ANdRslSelHV(SG
Levels and determinants of breast and cervical cancer screening uptake in HIV-infected women compared with the general population in France.
HIV medicine 2017, 18, 181-195.

Feuillet P, Lert F, Tron L, Aubriere C, Spire B, Dray-Spira R, ANdRslSelHV(VEslpa(SG
Prevalence of and factors associated with depression among people living with HIV in France.
HIV medicine 2017, 18, 383-394.

Cuzin L, Katlama C, Cotte L, Pugliese P, Cheret A, Bernaud C, Rey D, Poizot-Martin I, Chirouze C, Bani-Sadr F, Cabié A, DSG
Ageing with HIV: do comorbidities and polymedication drive treatment optimization?.
HIV medicine 2017, 18, 395-401.

Gantner P, Cuzin L, Allavena C, Cabie A, Pugliese P, Valantin MA, Bani-Sadr F, Joly V, Ferry T, Poizot-Martin I, Garraffo R, Peytavin G, Fafi-Kremer S, Rey D, Dsg
Efficacy and safety of dolutegravir and rilpivirine dual therapy as a simplification strategy: a cohort study.
HIV medicine 2017, 18, 704-708.

Todesco E, Charpentier C, Bertine M, Wirden M, Storto A, Desire N, Grude M, Nguyen T, Sayon S, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG
Disparities in HIV-1 transmitted drug resistance detected by ultradeep sequencing between men who have sex with men and heterosexual populations.
HIV medicine 2017, 18, 696-700.

Bertine M, Gueudin M, Mélard A, Damond F, Descamps D, Matheron S, Collin F, Rouzioux C, Plantier JC, Avettand-Fenoel V
New Highly Sensitive Real-Time PCR Assay for HIV-2 Group A and Group B DNA Quantification.
Journal of Clinical Microbiology 2017, 55, 2850-2857.

Malet I, Subra F, Charpentier C, Collin G, Descamps D, Calvez V, Marcelin AG, Delelis O
Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors.
mBio 2017

Kardaś-Słoma L, Lucet JC, Perozziello A, Pelat C, Birgand G, Ruppé E, Boëlle PY, Andremont A, Yazdanpanah Y
Universal or targeted approach to prevent the transmission of extended-spectrum beta-lactamase-producing Enterobacteriaceae in intensive care units: a cost-effectiveness analysis.
BMJ open 2017, 7, e017402.

Sugarman J, Revill P, Zoulim F, Yazdanpanah Y, Janssen HLA, Lim SG, Lewin SR
Ethics and hepatitis B cure research.
Gut 2017, 66, 389-392.

de Montmollin E, Demeret S, Brulé N, Conrad M, Dailler F, Lerolle N, Navellou JC, Schwebel C, Alves M, Cour M, Engrand N, Tonnelier JM, Maury E, Ruckly S, Picard G, Rogemond V, Magalhaes É, Sharshar T, Timsit JF, Honnorat J, Sonneville R, ESG‡
Anti-N-Methyl-d-Aspartate Receptor Encephalitis in Adult Patients Requiring Intensive Care.
American Journal of Respiratory and Critical Care Medicine 2017, 195, 491-499.

Torres A, Niederman MS, Chastre J, Ewig S, Fernandez-Vandellos P, Hanberger H, Kollef M, Li Bassi G, Luna CM, Martin-Loeches I, Paiva JA, Read RC, Rigau D, Timsit JF, Welte T, Wunderink R
International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT).
The European Respiratory Journal 2017, 50,

Veziris N, Bernard C, Guglielmetti L, Le Du D, Marigot-Outtandy D, Jaspard M, Caumes E, Lerat I, Rioux C, Yazdanpanah Y, Tiotiu A, Lemaitre N, Brossier F, Jarlier V, Robert J, Sougakoff W, Aubry A, CMatTCotCM, CMaTCotCM
Rapid emergence of Mycobacterium tuberculosis bedaquiline resistance: lessons to avoid repeating past errors.
The European Respiratory Journal 2017, 49,

Guglielmetti L, Jaspard M, Le Dû D, Lachâtre M, Marigot-Outtandy D, Bernard C, Veziris N, Robert J, Yazdanpanah Y, Caumes E, Fréchet-Jachym M, FMTMG
Long-term outcome and safety of prolonged bedaquiline treatment for multidrug-resistant tuberculosis.
The European Respiratory Journal 2017, 49,

Cousien A, Leclerc P, Morissette C, Bruneau J, Roy É, Tran VC, Yazdanpanah Y, Cox J
The need for treatment scale-up to impact HCV transmission in people who inject drugs in Montréal, Canada: a modelling study.
BMC infectious diseases 2017, 17, 162.

Douine M, Mosnier E, Le Hingrat Q, Charpentier C, Corlin F, Hureau L, Adenis A, Lazrek Y, Niemetsky F, Aucouturier AL, Demar M, Musset L, Nacher M
Illegal gold miners in French Guiana: a neglected population with poor health.
BMC public health 2017, 18, 23.

Viglino D, Vesin A, Ruckly S, Morelli X, Slama R, Debaty G, Danel V, Maignan M, Timsit JF
Daily volume of cases in emergency call centers: construction and validation of a predictive model.
Scandinavian Journal of Trauma, Resuscitation and Emergency Medicine 2017, 25, 86.

Mirouse A, Vignon P, Piron P, Robert R, Papazian L, Géri G, Blanc P, Guitton C, Guérin C, Bigé N, Rabbat A, Lefebvre A, Razazi K, Fartoukh M, Mariotte E, Bouadma L, Ricard JD, Seguin A, Souweine B, Moreau AS, Faguer S, Mari A, Mayaux J, Schneider F, Stoclin A, Perez P, Maizel J, Lafon C, Ganster F, Argaud L, Girault C, Barbier F, Lecuyer L, Lambert J, Canet E
Severe varicella-zoster virus pneumonia: a multicenter cohort study.
Critical Care (London, England) 2017, 21, 137.

Weiss E, Essaied W, Adrie C, Zahar JR, Timsit JF
Treatment of severe hospital-acquired and ventilator-associated pneumonia: a systematic review of inclusion and judgment criteria used in randomized controlled trials.
Critical Care (London, England) 2017, 21, 162.

Terzi N, Darmon M, Reignier J, Ruckly S, Garrouste-Orgeas M, Lautrette A, Azoulay E, Mourvillier B, Argaud L, Papazian L, Gainnier M, Goldgran-Toledano D, Jamali S, Dumenil AS, Schwebel C, Timsit JF, Osg
Initial nutritional management during noninvasive ventilation and outcomes: a retrospective cohort study.
Critical Care (London, England) 2017, 21, 293.

Garrouste-Orgeas M, Flahault C, Fasse L, Ruckly S, Amdjar-Badidi N, Argaud L, Badie J, Bazire A, Bige N, Boulet E, Bouadma L, Bretonnière C, Floccard B, Gaffinel A, de Forceville X, Grand H, Halidfar R, Hamzaoui O, Jourdain M, Jost PH, Kipnis E, Large A, Lautrette A, Lesieur O, Maxime V, Mercier E, Mira JP, Monseau Y, Parmentier-Decrucq E, Rigaud JP, Rouget A, Santoli F, Simon G, Tamion F, Thieulot-Rolin N, Thirion M, Valade S, Vinatier I, Vioulac C, Bailly S, Timsit JF
The ICU-Diary study: prospective, multicenter comparative study of the impact of an ICU diary on the wellbeing of patients and families in French ICUs.
Trials 2017, 18, 542.

Dupuis C, Sonneville R, Adrie C, Gros A, Darmon M, Bouadma L, Timsit JF
Impact of transfusion on patients with sepsis admitted in intensive care unit: a systematic review and meta-analysis.
Annals of Intensive Care 2017, 7, 5.

Adrie C, Lugosi M, Sonneville R, Souweine B, Ruckly S, Cartier JC, Garrouste-Orgeas M, Schwebel C, Timsit JF, Osg
Persistent lymphopenia is a risk factor for ICU-acquired infections and for death in ICU patients with sustained hypotension at admission.
Annals of Intensive Care 2017, 7, 30.

Neuville M, El-Helali N, Magalhaes E, Radjou A, Smonig R, Soubirou JF, Voiriot G, Le Monnier A, Ruckly S, Bouadma L, Sonneville R, Timsit JF, Mourvillier B
Systematic overdosing of oxa- and cloxacillin in severe infections treated in ICU: risk factors and side effects.
Annals of Intensive Care 2017, 7, 34.

Delerue T, de Pontual L, Carbonnelle E, Zahar JR
The potential role of microbiota for controlling the spread of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE) in neonatal population.
F1000Research 2017, 6, 1217.

Timsit JF, Esaied W, Neuville M, Bouadma L, Mourvllier B
Update on ventilator-associated pneumonia.
F1000Research 2017, 6, 2061.

Visseaux B, Collin G, Ichou H, Charpentier C, Bendhafer S, Dumitrescu M, Allal L, Cojocaru B, Desfrère L, Descamps D, Mandelbrot L, Houhou-Fidouh N
Usefulness of multiplex PCR methods and respiratory viruses' distribution in children below 15 years old according to age, seasons and clinical units in France: A 3 years retrospective study.
PloS One 2017, 12, e0172809.

Azoulay E, Timsit JF, Lautrette A, Legriel S, Max A, Ruckly S, Misset B, Cohen Y, Wolff M
Weekly high-dose liposomal amphotericin B (L-AmB) in critically ill septic patients with multiple Candida colonization: The AmBiDex study.
PloS One 2017, 12, e0177093.

Visseaux B, Burdet C, Voiriot G, Lescure FX, Chougar T, Brugière O, Crestani B, Casalino E, Charpentier C, Descamps D, Timsit JF, Yazdanpanah Y, Houhou-Fidouh N
Prevalence of respiratory viruses among adults, by season, age, respiratory tract region and type of medical unit in Paris, France, from 2011 to 2016.
PloS One 2017, 12, e0180888.

Casalino E, Antoniol S, Fidouh N, Choquet C, Lucet JC, Duval X, Visseaux B, Pereira L
Influenza virus infections among patients attending emergency department according to main reason to presenting to ED: A 3-year prospective observational study during seasonal epidemic periods.
PloS One 2017, 12, e0182191.

Ibn Saied W, Souweine B, Garrouste-Orgeas M, Ruckly S, Darmon M, Bailly S, Cohen Y, Azoulay E, Schwebel C, Radjou A, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Papazian L, Goldgran-Toledano D, Bouadma L, Timsit JF, Osg
Respective impact of implementation of prevention strategies, colonization with multiresistant bacteria and antimicrobial use on the risk of early- and late-onset VAP: An analysis of the OUTCOMEREA network.
PloS One 2017, 12, e0187791.

Neuville M, Mourvillier B, Bouadma L, Timsit JF
Bundle of care decreased ventilator-associated events-implications for ventilator-associated pneumonia prevention.
Journal of Thoracic Disease 2017, 9, 430-433.

Ara-Somohano C, Bonadona A, Carpentier F, Pavese P, Vesin A, Hamidfar-Roy R, Minet C, Vanzetto G, Schwebel C, Timsit JF
Evaluation of eight biomarkers to predict short-term mortality in patients with acute severe dyspnea.
Minerva Anestesiologica 2017, 83, 824-835.

Sanna A, Le Strat Y, Roudot-Thoraval F, Deuffic Burban S, Carrieri P, Delarocque-Astagneau E, Larsen C
Severe liver disease related to chronic hepatitis C virus infection in treatment-naive patients: epidemiological characteristics and associated factors at first expert centre visit, France, 2000 to 2007 and 2010 to 2014.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,

Sullivan AK, Sperle I, Raben D, Amato-Gauci AJ, Lundgren JD, Yazdanpanah Y, Jakobsen SF, Tavoschi L
HIV testing in Europe: Evaluating the impact, added value, relevance and usability of the European Centre for Disease Prevention and Control (ECDC)'s 2010 HIV testing guidance.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2017, 22,

Guerrier G, Lefèvre P, Chouvin C, D'Ortenzio E
Jarisch-Herxheimer Reaction Among Patients with Leptospirosis: Incidence and Risk Factors.
The American Journal of Tropical Medicine and Hygiene 2017, 96, 791-794.

Haddad E, Lescure FX, Ghodhbane W, Lepage L, D'humieres C, Vindrios W, Yazdanpanah Y, Nataf P, Kirsch M
Left ventricular assist pump pocket infection: conservative treatment strategy for destination therapy candidates.
The International Journal of Artificial Organs 2017, 40, 90-95.

Delory T, Ferrand H, Grall N, Casalino E, Lafarge M, Melot B, Hajage D, Charpentier C, Aubier M, Tubach F, Bouvet E, Gault N, Yazdanpanah Y
Score for pulmonary tuberculosis in patients with clinical presumption of tuberculosis in a low-prevalence area.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2017, 21, 1272-1279.

Sommer H, Timsit JF, Wolkewitz M
Bezlotoxumab and Recurrent Clostridium difficile Infection.
The New England Journal of Medicine 2017, 376, 1594.

 2016                                                                            

Timsit JF, Azoulay E, Schwebel C, Charles PE, Cornet M, Souweine B, Klouche K, Jaber S, Trouillet JL, Bruneel F, Argaud L, Cousson J, Meziani F, Gruson D, Paris A, Darmon M, Garrouste-Orgeas M, Navellou JC, Foucrier A, Allaouchiche B, Das V, Gangneux JP, Ruckly S, Maubon D, Jullien V, Wolff M, ETG
Empirical Micafungin Treatment and Survival Without Invasive Fungal Infection in Adults With ICU-Acquired Sepsis, Candida Colonization, and Multiple Organ Failure: The EMPIRICUS Randomized Clinical Trial.
JAMA 2016, 316, 1555-1564.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Hepatitis C treatment as prevention of viral transmission and liver-related morbidity in persons who inject drugs.
Hepatology (Baltimore, Md.) 2016, 63, 1090-1101.

Delory T, Papot E, Rioux C, Charpentier C, Auge-Courtoi C, Michard F, Peytavin G, Descamps D, Matheron S, Yazdanpanah Y
Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience.
Journal of Medical Virology 2016, 88, 1204-1210.

Bailly S, Pirracchio R, Timsit JF
What's new in the quantification of causal effects from longitudinal cohort studies: a brief introduction to marginal structural models for intensivists.
Intensive Care Medicine 2016, 42, 576-579.

Garrouste-Orgeas M, Flaatten H, Moreno R
Understanding medical errors and adverse events in ICU patients.
Intensive Care Medicine 2016, 42, 107-109.

Mekontso Dessap A, Ware LB, Bouadma L
What's new with biomarker-driven clinical strategy in sepsis and circulatory failure?.
Intensive Care Medicine 2016, 42, 418-421.

Poulakou G, Bassetti M, Timsit JF
Critically ill migrants with infection: diagnostic considerations for intensive care physicians in Europe.
Intensive Care Medicine 2016, 42, 245-248.

Sakr Y, Ferrer R, Reinhart K, Beale R, Rhodes A, Moreno R, Timsit JF, Brochard L, Thompson BT, Rezende E, Chiche JD, IGI, ETG
The Intensive Care Global Study on Severe Acute Respiratory Infection (IC-GLOSSARI): a multicenter, multinational, 14-day inception cohort study.
Intensive Care Medicine 2016, 42, 817-828.

Mimoz O, Chopra V, Timsit JF
What's new in catheter-related infection: skin cleansing and skin antisepsis.
Intensive Care Medicine 2016, 42, 1784-1786.

Gélisse E, Neuville M, de Montmollin E, Bouadma L, Mourvillier B, Timsit JF, Sonneville R
Extracorporeal membrane oxygenation (ECMO) does not impact on amikacin pharmacokinetics: a case-control study.
Intensive Care Medicine 2016, 42, 946-948.

Bassetti M, Poulakou G, Timsit JF
Focus on antimicrobial use in the era of increasing antimicrobial resistance in ICU.
Intensive Care Medicine 2016, 42, 955-958.

Bruneel F, Tubach F, Mira JP, Houze S, Gibot S, Huisse MG, Megarbane B, Choquet C, Corne P, Peytel E, Villers D, Camus C, Bouchaud O, Caumes E, Girard PM, Simon F, Kalloumeh A, Roy C, Durand R, Le Bras J, Matheron S, Wolff M, PSG
Imported falciparum malaria in adults: host- and parasite-related factors associated with severity. The French prospective multicenter PALUREA cohort study.
Intensive Care Medicine 2016

Truche AS, Darmon M, Bailly S, Clec'h C, Dupuis C, Misset B, Azoulay E, Schwebel C, Bouadma L, Kallel H, Adrie C, Dumenil AS, Argaud L, Marcotte G, Jamali S, Zaoui P, Laurent V, Goldgran-Toledano D, Sonneville R, Souweine B, Timsit JF, OSG
Continuous renal replacement therapy versus intermittent hemodialysis in intensive care patients: impact on mortality and renal recovery.
Intensive Care Medicine 2016, 42, 1408-1417.

Weiss E, Zahar JR, Garrouste-Orgeas M, Ruckly S, Essaied W, Schwebel C, Timsit JF, OSG
De-escalation of pivotal beta-lactam in ventilator-associated pneumonia does not impact outcome and marginally affects MDR acquisition.
Intensive Care Medicine 2016, 42, 2098-2100.

Citerio G, Perner A, Timsit JF
The ten wishes and hopes of the deputy editors of Intensive Care Medicine.
Intensive Care Medicine 2016, 42, 1316-1318.

Timsit JF, Paiva JA, Bassetti M
Focus on optimization of early antimicrobial therapy in ICU-acquired infections.
Intensive Care Medicine 2016, 42, 1658-1660.

Jensen JU, Bouadma L
Why biomarkers failed in sepsis.
Intensive Care Medicine 2016, 42, 2049-2051.

Truche AS, Darmon M, Timsit JF, OSG
Renal replacement therapy modalities in the ICU: the continuity is intermittent-response to comments by Schefold.
Intensive Care Medicine 2016, 42, 1840-1841.

Benoit DD, Doig G, Timsit JF
Focus on adequate antimicrobial treatment and de-escalation in the ICU.
Intensive Care Medicine 2016, 42, 1856-1858.

Günther SC, Schwebel C, Hamidfar-Roy R, Bonadona A, Lugosi M, Ara-Somohano C, Minet C, Potton L, Cartier JC, Vésin A, Chautemps M, Styfalova L, Ruckly S, Timsit JF
Complications of intravascular catheters in ICU: definitions, incidence and severity. A randomized controlled trial comparing usual transparent dressings versus new-generation dressings (the ADVANCED study).
Intensive Care Medicine 2016, 42, 1753-1765.

Timsit JF, Perner A
Sepsis: find me, manage me, and stop me!.
Intensive Care Medicine 2016, 42, 1851-1853.

Castañeda-Sanabria J, Hajage D, Le Jouan M, Perozziello A, Tubach F
Off-label use of the expensive orphan drug eculizumab in France 2009-2013 and the impact of literature: focus on the transplantation field.
European Journal of Clinical Pharmacology 2016, 72, 737-746.

Mahé I, Puget H, Buzzi JC, Lamuraglia M, Chidiac J, Strukov A, Helfer H, Perozziello A
Adherence to treatment guidelines for cancer-associated thrombosis: a French hospital-based cohort study.
Supportive Care in Cancer: Official Journal of the Multinational Association of Supportive Care in Cancer 2016, 24, 3369-3377.

Bailly S, Garnaud C, Cornet M, Pavese P, Hamidfar-Roy R, Foroni L, Boisset S, Timsit JF, Maubon D
Impact of systemic antifungal therapy on the detection of Candida species in blood cultures in clinical cases of candidemia.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2016, 35, 1023-1032.

Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
Frequency of malignancy is high in patients admitted for a first venous thromboembolism episode: an observational study.
Journal of Thrombosis and Thrombolysis 2016, 42, 329-335.

Birgand G, Moore LSP, Bourigault C, Vella V, Lepelletier D, Holmes AH, Lucet JC
Measures to eradicate multidrug-resistant organism outbreaks: how much do they cost?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2016, 22, 162.e1-9.

Moustarhfir M, Bresson B, Koch P, Perozziello A, Barreau G, Schouman-Claeys E, Henry-Feugeas MC, Ou P, Dallaudière B
MR imaging of Schmorl's nodes: Imaging characteristics and epidemio-clinical relationships.
Diagnostic and Interventional Imaging 2016, 97, 411-417.

Roupie AL, Dossier A, Goulenok T, Perozziello A, Papo T, Sacre K
First venous thromboembolism in admitted patients younger than 50years old.
European Journal of Internal Medicine 2016, 34, e18-e20.

Stora C, Epelboin S, Devouche E, Matheron S, Epelboin L, Yazbeck C, Damond F, Longuet P, Dzineku F, Rajguru M, Delaroche L, Mandelbrot L, Luton D, Patrat C
Women infected with human immunodeficiency virus type 1 have poorer assisted reproduction outcomes: a case-control study.
Fertility and Sterility 2016, 105, 1193-1201.

Loubet P, Samih-Lenzi N, Galtier F, Vanhems P, Loulergue P, Duval X, Jouneau S, Postil D, Rogez S, Valette M, Merle C, Régis C, Costa Y, Lesieur Z, Tattevin P, Lina B, Carrat F, Launay O, FSG
Factors associated with poor outcomes among adults hospitalized for influenza in France: A three-year prospective multicenter study.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2016, 79, 68-73.

Picone O, Vauloup-Fellous C, D'Ortenzio E, Huissoud C, Carles G, Benachi A, Faye A, Luton D, Paty MC, Ayoubi JM, Yazdanpanah Y, Mandelbrot L, Matheron S
[Zika virus infection during pregnancy].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2016, 45, 415-423.

Desnoyer A, Pospai D, Lê MP, Gervais A, Heurgué-Berlot A, Laradi A, Harent S, Pinto A, Salmon D, Hillaire S, Fontaine H, Zucman D, Simonpoli AM, Muret P, Larrouy L, Bernard Chabert B, Descamps D, Yazdanpanah Y, Peytavin G
Pharmacokinetics, safety and efficacy of a full dose sofosbuvir-based regimen given daily in hemodialysis patients with chronic hepatitis C.
Journal of Hepatology 2016, 65, 40-47.

Lefebvre A, Bertrand X, Quantin C, Vanhems P, Lucet JC, Nuemi G, Astruc K, Chavanet P, Aho-Glélé LS
Association between Pseudomonas aeruginosa positive water samples and healthcare-associated cases: nine-year study at one university hospital.
The Journal of Hospital Infection 2016, 96, 238-243.

Bailly S, Maubon D, Fournier P, Pelloux H, Schwebel C, Chapuis C, Foroni L, Cornet M, Timsit JF
Impact of antifungal prescription on relative distribution and susceptibility of Candida spp. - Trends over 10 years.
The Journal of Infection 2016, 72, 103-111.

Perrier M, Désiré N, Deback C, Agut H, Boutolleau D, Burrel S
Complementary assays for monitoring susceptibility of varicella-zoster virus resistance to antivirals.
Journal of Virological Methods 2016, 233, 10–14.

Yazdanpanah Y, Schwarzinger M
Generic antiretroviral drugs and HIV care: An economic review.
Medecine Et Maladies Infectieuses 2016, 46, 67-71.

Lemaire X, Bonnet E, Castan B, Forestier E, Lescure FX, Roblot F, Pulcini C
Management of non-necrotizing cellulitis in France.
Medecine Et Maladies Infectieuses 2016, 46, 355-359.

Visseaux B, Damond F, Matheron S, Descamps D, Charpentier C
Hiv-2 molecular epidemiology.
Infection, Genetics and Evolution: Journal of Molecular Epidemiology and Evolutionary Genetics in Infectious Diseases 2016, 46, 233-240.

Collarino R, Vergeylen U, Emeraud C, Latournèrie G, Grall N, Mammeri H, Messika-Zeitoun D, Vallois D, Yazdanpanah Y, Lescure FX, Bleibtreu A
Mitral endocarditis due to Rothia aeria with cerebral haemorrhage and femoral mycotic aneurysms, first French description.
New Microbes and New Infections 2016, 13, 40-42.

Larbi A, Pesquer L, Reboul G, Omoumi P, Perozziello A, Abadie P, Loriaut P, Copin P, Ducouret E, Dallaudière B
MRI in patients with chronic pubalgia: Is precise useful information provided to the surgeon? A case-control study.
Orthopaedics & traumatology, surgery & research: OTSR 2016, 102, 747-754.

Rouzaud D, Alexandra JF, Chauchard M, Delon M, Dossier A, Chauveheid MP, Perozziello A, Papo T, Sacre K
Incidental venous thromboembolism diagnosed in patients admitted with a first venous thromboembolism: Frequency and clinical significance (an observational study).
Thrombosis Research 2016, 144, 116-118.

Delfraissy JF, Yazdanpanah Y, Levy Y
REACTing: the French response to infectious disease crises.
Lancet (London, England) 2016, 387, 2183-2185.

Benmoussa N, Charpentier C, Mariaggi AA, Collin G, Descamps D, Hourseau M, Barry B, Albert S, Picard A, Conan P, Charlier P
HPV 16 in squamous cell carcinoma of 19th century tonsils.
The Lancet. Oncology 2016, 17, e477–e478.

TSG
Global epidemiology of drug resistance after failure of WHO recommended first-line regimens for adult HIV-1 infection: a multicentre retrospective cohort study.
The Lancet. Infectious Diseases 2016, 16, 565-575.

Lachâtre M, Rioux C, Dû DL, Fréchet-Jachym M, Veziris N, Bouvet E, Yazdanpanah Y
Bedaquiline plus delamanid for XDR tuberculosis.
The Lancet. Infectious Diseases 2016, 16, 294.

Visseaux B, Mortier E, Houhou-Fidouh N, Brichler S, Collin G, Larrouy L, Charpentier C, Descamps D
Zika virus in the female genital tract.
The Lancet. Infectious Diseases 2016, 16, 1220.

Pépin JL, Timsit JF, Tamisier R, Borel JC, Lévy P, Jaber S
Prevention and care of respiratory failure in obese patients.
The Lancet. Respiratory Medicine 2016, 4, 407-418.

Frange P, Faye A, Avettand-Fenoël V, Bellaton E, Descamps D, Angin M, David A, Caillat-Zucman S, Peytavin G, Dollfus C, Le Chenadec J, Warszawski J, Rouzioux C, Sáez-Cirión A, AECPCatAEVsg
HIV-1 virological remission lasting more than 12 years after interruption of early antiretroviral therapy in a perinatally infected teenager enrolled in the French ANRS EPF-CO10 paediatric cohort: a case report.
The lancet. HIV 2016, 3, e49–54.

Pelat C, Kardaś-Słoma L, Birgand G, Ruppé E, Schwarzinger M, Andremont A, Lucet JC, Yazdanpanah Y
Hand Hygiene, Cohorting, or Antibiotic Restriction to Control Outbreaks of Multidrug-Resistant Enterobacteriaceae.
Infection Control and Hospital Epidemiology 2016, 37, 272-280.

Cuzin L, Dellamonica P, Yazdanpanah Y, Bouchez S, Rey D, Hoen B, Cabié A, DSG
Characteristics and consequences of medical care interruptions in HIV-infected patients in France.
Epidemiology and Infection 2016, 144, 2363-2370.

D'Ortenzio E, Matheron S, Yazdanpanah Y, de Lamballerie X, Hubert B, Piorkowski G, Maquart M, Descamps D, Damond F, Leparc-Goffart I
Evidence of Sexual Transmission of Zika Virus.
The New England Journal of Medicine 2016, 374, 2195-2198.

Sagaon-Teyssier L, Suzan-Monti M, Demoulin B, Capitant C, Lorente N, Préau M, Mora M, Rojas Castro D, Chidiac C, Chas J, Meyer L, Molina JM, Spire B, AISG
Uptake of PrEP and condom and sexual risk behavior among MSM during the ANRS IPERGAY trial.
AIDS care 2016, 28 Suppl 1, 48–55.

Préau M, Lorente N, Sagaon-Teyssier L, Champenois K, Gall JML, Mabire X, Spire B, Mora M, Yazdanpanah Y, Suzan M, ADgaACG
Factors associated with satisfaction with community-based non-medicalized counseling and testing using HIV rapid tests among MSM in France.
AIDS care 2016, 28, 1240-1248.

Tabah A, Cotta MO, Garnacho-Montero J, Schouten J, Roberts JA, Lipman J, Tacey M, Timsit JF, Leone M, Zahar JR, De Waele JJ, WGfAUitI
A Systematic Review of the Definitions, Determinants, and Clinical Outcomes of Antimicrobial De-escalation in the Intensive Care Unit.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 1009-1017.

Hofstra LM, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, Van de Vijver DAMC, Åsjö B, Beshkov D, Coughlan S, Descamps D, Griskevicius A, Hamouda O, Horban A, Van Kasteren M, Kolupajeva T, Kostrikis LG, Liitsola K, Linka M, Mor O, Nielsen C, Otelea D, Paraskevis D, Paredes R, Poljak M, Puchhammer-Stöckl E, Sönnerborg A, Staneková D, Stanojevic M, Van Laethem K, Zazzi M, Zidovec Lepej S, Boucher CAB, Schmit JC, Wensing AMJ, SP
Transmission of HIV Drug Resistance and the Predicted Effect on Current First-line Regimens in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 62, 655–663.

Matheron S, d'Ortenzio E, Leparc-Goffart I, Hubert B, de Lamballerie X, Yazdanpanah Y
Long-Lasting Persistence of Zika Virus in Semen.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1264.

PADCPWGfISATaCiE
Kaposi Sarcoma Risk in HIV-Infected Children and Adolescents on Combination Antiretroviral Therapy From Sub-Saharan Africa, Europe, and Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2016, 63, 1245–1253.

Piroth L, Moinot L, Yeni P, Avettand-Fénoel V, Reynes J, Girard PM, Marchou B, Georget A, Rouzioux C, Autran B, Duvillard L, Chêne G, Fagard C, A1TTSG
Immunity, inflammation and reservoir in patients at an early stage of HIV infection on intermittent ART (ANRS 141 TIPI Trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 490–496.

Lortholary O, Roussillon C, Boucherie C, Padoin C, Chaix ML, Breton G, Rami A, Veziris N, Patey O, Caumes E, May T, Molina JM, Robert J, Tod M, Fagard C, Chêne G, A1BTG
Tenofovir DF/emtricitabine and efavirenz combination therapy for HIV infection in patients treated for tuberculosis: the ANRS 129 BKVIR trial.
The Journal of Antimicrobial Chemotherapy 2016, 71, 783–793.

Barbier F, Pommier C, Essaied W, Garrouste-Orgeas M, Schwebel C, Ruckly S, Dumenil AS, Lemiale V, Mourvillier B, Clec'h C, Darmon M, Laurent V, Marcotte G, Lucet JC, Souweine B, Zahar JR, Timsit JF, OSG
Colonization and infection with extended-spectrum β-lactamase-producing Enterobacteriaceae in ICU patients: what impact on outcomes and carbapenem exposure?.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1088-1097.

Lambert-Niclot S, George EC, Pozniak A, White E, Schwimmer C, Jessen H, Johnson M, Dunn D, Perno CF, Clotet B, Plettenberg A, Blaxhult A, Palmisano L, Wittkop L, Calvez V, Marcelin AG, Raffi F, N01SG
Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1056–1062.

De Luca A, Flandre P, Dunn D, Zazzi M, Wensing A, Santoro MM, Günthard HF, Wittkop L, Kordossis T, Garcia F, Castagna A, Cozzi-Lepri A, Churchill D, De Wit S, Brockmeyer NH, Imaz A, Mussini C, Obel N, Perno CF, Roca B, Reiss P, Schülter E, Torti C, van Sighem A, Zangerle R, Descamps D, CaCiE
Improved darunavir genotypic mutation score predicting treatment response for patients infected with HIV-1 subtype B and non-subtype B receiving a salvage regimen.
The Journal of Antimicrobial Chemotherapy 2016, 71, 1352–1360.

Slama L, Landman R, Assoumou L, Benalycherif A, Samri A, Joly V, Pialoux G, Valin N, Cabié A, Duvivier C, Lambert-Niclot S, Marcelin AG, Peytavin G, Costagliola D, Girard PM, I0DSG
Efficacy and safety of once-daily ritonavir-boosted atazanavir or darunavir in combination with a dual nucleos(t)ide analogue backbone in HIV-1-infected combined ART (cART)-naive patients with severe immunosuppression: a 48 week, non-comparative, randomized, multicentre trial (IMEA 040 DATA trial).
The Journal of Antimicrobial Chemotherapy 2016, 71, 2252–2261.

Bocket L, Peytavin G, Alidjinou EK, Ajana F, Choisy P, Lê M, Charpentier C, Descamps D, Yazdanpanah Y, Katlama C, Simon A, Calvez V, Marcelin AG, Soulie C
Factors associated with virological response to a switch regimen containing maraviroc for antiretroviral-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2651-2653.

Katlama C, Soulié C, Caby F, Denis A, Blanc C, Schneider L, Valantin MA, Tubiana R, Kirstetter M, Valdenassi E, Nguyen T, Peytavin G, Calvez V, Marcelin AG
Dolutegravir as monotherapy in HIV-1-infected individuals with suppressed HIV viraemia.
The Journal of Antimicrobial Chemotherapy 2016, 71, 2646–2650.

Gantner P, Assoumou L, Leruez-Ville M, David L, Suzan-Monti M, Costagliola D, Rouzioux C, Ghosn J, EAE4SG
HIV-1-RNA in seminal plasma correlates with detection of HIV-1-DNA in semen cells, but not with CMV shedding, among MSM on successful antiretroviral regimens.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3202–3205.

de Truchis P, Lê MP, Daou M, Madougou B, Nouhou Y, Moussa Saley S, Sani A, Adehossi E, Rouveix E, Saidou M, Peytavin G, Delaugerre C
High efficacy of first-line ART in a West African cohort, assessed by dried blood spot virological and pharmacological measurements.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3222-3227.

Diallo YL, Ollivier V, Joly V, Faille D, Catalano G, Jandrot-Perrus M, Rauch A, Yeni P, Ajzenberg N
Abacavir has no prothrombotic effect on platelets in vitro.
The Journal of Antimicrobial Chemotherapy 2016, 71, 3506–3509.

Bassetti M, Peghin M, Timsit JF
The current treatment landscape: candidiasis.
The Journal of Antimicrobial Chemotherapy 2016, 71, ii13-ii22.

Sokal A, D'Ortenzio E, Houhou-Fidouh N, Brichler S, Dorchies J, Cabras O, Leparc-Goffart I, Yazdanpanah Y, Matheron S
Zika virus infection: report of the first imported cases in a Paris travel centre.
Journal of Travel Medicine 2016, 24,

Garrouste-Orgeas M, Max A, Lerin T, Grégoire C, Ruckly S, Kloeckner M, Brochon S, Pichot E, Simons C, El-Mhadri M, Bruel C, Philippart F, Fournier J, Tiercelet K, Timsit JF, Misset B
Impact of Proactive Nurse Participation in ICU Family Conferences: A Mixed-Method Study.
Critical Care Medicine 2016, 44, 1116-1128.

Toubiana J, Timsit S, Ferroni A, Grasseau M, Nassif X, Lortholary O, Zahar JR, Chalumeau M
Community-Onset Extended-Spectrum β-Lactamase-Producing Enterobacteriaceae Invasive Infections in Children in a University Hospital in France.
Medicine 2016, 95, e3163.

Sonneville R, Mariotte E, Neuville M, Minaud S, Magalhaes E, Ruckly S, Cantier M, Voiriot G, Radjou A, Smonig R, Soubirou JF, Mourvillier B, Bouadma L, Wolff M, Timsit JF
Early-onset status epilepticus in patients with acute encephalitis.
Medicine 2016, 95, e4092.

Sellier PO, Schnepf N, Amarsy R, Maylin S, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Simoneau G, Evans J, Souak S, Matheron S, Benifla JL, Simon F, Bergmann JF
Short article: Hepatitis B virus status in children born to HIV/HBV coinfected women in a French hospital: a cross-sectional study.
European Journal of Gastroenterology & Hepatology 2016, 28, 328–332.

Desgrees-du-Lou A, Pannetier J, Ravalihasy A, Le Guen M, Gosselin A, Panjo H, Bajos N, Lydie N, Lert F, Dray-Spira R, PSG
Is hardship during migration a determinant of HIV infection? Results from the ANRS PARCOURS study of sub-Saharan African migrants in France.
AIDS 2016, 30, 645–656.

Ananworanich J, Melvin D, Amador JTR, Childs T, Medin G, Boscolo V, Compagnucci A, Kanjanavanit S, Montero S, Gibb DM, P1SG
Neurocognition and quality of life after reinitiating antiretroviral therapy in children randomized to planned treatment interruption.
AIDS (London, England) 2016, 30, 1075–1081.

Jean K, Puren A, Cutler E, Singh B, Bouscaillou J, Rain-Taljaard R, Taljaard D, Gouws E, Lissouba P, Lewis DA, Peytavin G, Auvert B
Level of viral suppression and the cascade of HIV care in a South African semi-urban setting in 2012.
AIDS (London, England) 2016, 30, 2107-2116.

de Monteynard LA, Matheron S, Gilquin J, Pavie J, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Rey D, Simon A, Mahamat A, Dray-Spira R, Costagliola D, Abgrall S, FAC
Influence of geographic origin, sex, and HIV transmission group on the outcome of first-line combined antiretroviral therapy in France.
AIDS (London, England) 2016, 30, 2235–2246.

Bertine M, Visseaux B, Storto A, Collin G, Matheron S, Descamps D, Charpentier C, ACH2C
HIV-2 Vif Diversity Among Defective and Nondefective Sequences.
Journal of Acquired Immune Deficiency Syndromes (1999) 2016, 72, e9–e11.

De Sousa Mendes M, Hirt D, Vinot C, Valade E, Lui G, Pressiat C, Bouazza N, Foissac F, Blanche S, Lê MP, Peytavin G, Treluyer JM, Urien S, Benaboud S
Prediction of human fetal pharmacokinetics using ex vivo human placenta perfusion studies and physiologically based models.
British Journal of Clinical Pharmacology 2016, 81, 646–657.

Desnoyer A, Dupin N, Assoumou L, Carlotti A, Gaudin F, Deback C, Peytavin G, Marcelin AG, Boué F, Balabanian K, Pourcher-Martinez V, A1Ltg
Expression pattern of the CXCL12/CXCR4-CXCR7 trio in Kaposi's sarcoma skin lesions.
The British Journal of Dermatology 2016

Abramowitz L, Benabderrahmane D, Walker F, Yazdapanah Y, Yéni P, Rioux C, Bouscarat F, Lafferre E, Mentré F, Duval X
Determinants of macroscopic anal cancer and precancerous lesions in 1206 HIV-infected screened patients.
Colorectal Disease: The Official Journal of the Association of Coloproctology of Great Britain and Ireland 2016, 18, 997-1004.

Flandre P, Pugliese P, Allavena C, Katlama C, Cotte L, Cheret A, Cabié A, Rey D, Chirouze C, Bani-Sadr F, Cuzin L, DSg
Comparative risk of failure of ABC/3TC or TDF/FTC based first-line regimens in patients with a high viral load.
HIV medicine 2016, 17, 380–384.

Deuffic-Burban S, Obach D, Canva V, Pol S, Roudot-Thoraval F, Dhumeaux D, Mathurin P, Yazdanpanah Y
Cost-effectiveness and budget impact of interferon-free direct-acting antiviral-based regimens for hepatitis C treatment: the French case.
Journal of Viral Hepatitis 2016, 23, 767-779.

Bottero J, Brouard C, Roudot-Thoraval F, Deuffic-Burban S, Hofliger P, Abergel A, Volant J, Dhumeaux D, Yazdanpanah Y, VHTEg
2014 French guidelines for hepatitis B and C screening: a combined targeted and mass testing strategy of chronic viruses namely HBV, HCV and HIV.
Liver International: Official Journal of the International Association for the Study of the Liver 2016, 36, 1442-1449.

Vinot C, Tréluyer JM, Giraud C, Gavard L, Peytavin G, Mandelbrot L
Bidirectional Transfer of Raltegravir in an Ex Vivo Human Cotyledon Perfusion Model.
Antimicrobial Agents and Chemotherapy 2016, 60, 3112-3114.

Birgand G, Leroy C, Nerome S, Luong Nguyen LB, Lolom I, Armand-Lefevre L, Ciotti C, Lecorre B, Marcade G, Fihman V, Nicolas-Chanoine MH, Pelat C, Perozziello A, Fantin B, Yazdanpanah Y, Ricard JD, Lucet JC
Costs associated with implementation of a strict policy for controlling spread of highly resistant microorganisms in France.
BMJ open 2016, 6, e009029.

Mourvillier B, Radjou A, Timsit JF
Subclavian site should be preferred for central venous access.
Evidence-Based Nursing 2016, 19, 126.

Pépin JL, Tamisier R, Baguet JP, Lepaulle B, Arbib F, Arnol N, Timsit JF, Lévy P
Fixed-pressure CPAP versus auto-adjusting CPAP: comparison of efficacy on blood pressure in obstructive sleep apnoea, a randomised clinical trial.
Thorax 2016, 71, 726-733.

Carrara J, N'Diaye DS, Azria E, Launay O, Rozenberg F, Yazpandanah Y, Tsatsaris V, Ayoubi JM, Picone O
Management of Cytomegalovirus Seroconversion during Pregnancy in France.
Fetal Diagnosis and Therapy 2016, 39, 4-12.

Guglielmetti L, Le Dû D, Veziris N, Caumes E, Marigot-Outtandy D, Yazdanpanah Y, Robert J, Fréchet-Jachym M, MTMGotFNRCfMatPotFMTC
Is bedaquiline as effective as fluoroquinolones in the treatment of multidrug-resistant tuberculosis?.
The European Respiratory Journal 2016, 48, 582-585.

Sartelli M, Weber DG, Ruppé E, Bassetti M, Wright BJ, Ansaloni L, Catena F, Coccolini F, Abu-Zidan FM, Coimbra R, Moore EE, Moore FA, Maier RV, De Waele JJ, Kirkpatrick AW, Griffiths EA, Eckmann C, Brink AJ, Mazuski JE, May AK, Sawyer RG, Mertz D, Montravers P, Kumar A, Roberts JA, Vincent JL, Watkins RR, Lowman W, Spellberg B, Abbott IJ, Adesunkanmi AK, Al-Dahir S, Al-Hasan MN, Agresta F, Althani AA, Ansari S, Ansumana R, Augustin G, Bala M, Balogh ZJ, Baraket O, Bhangu A, Beltrán MA, Bernhard M, Biffl WL, Boermeester MA, Brecher SM, Cherry-Bukowiec JR, Buyne OR, Cainzos MA, Cairns KA, Camacho-Ortiz A, Chandy SJ, Che Jusoh A, Chichom-Mefire A, Colijn C, Corcione F, Cui Y, Curcio D, Delibegovic S, Demetrashvili Z, De Simone B, Dhingra S, Diaz JJ, Di Carlo I, Dillip A, Di Saverio S, Doyle MP, Dorj G, Dogjani A, Dupont H, Eachempati SR, Enani MA, Egiev VN, Elmangory MM, Ferrada P, Fitchett JR, Fraga GP, Guessennd N, Giamarellou H, Ghnnam W, Gkiokas G, Goldberg SR, Gomes CA, Gomi H, Guzmán-Blanco M, Haque M, Hansen S, Hecker A, Heizmann WR, Herzog T, Hodonou AM, Hong SK, Kafka-Ritsch R, Kaplan LJ, Kapoor G, Karamarkovic A, Kees MG, Kenig J, Kiguba R, Kim PK, Kluger Y, Khokha V, Koike K, Kok KYY, Kong V, Knox MC, Inaba K, Isik A, Iskandar K, Ivatury RR, Labbate M, Labricciosa FM, Laterre PF, Latifi R, Lee JG, Lee YR, Leone M, Leppaniemi A, Li Y, Liang SY, Loho T, Maegele M, Malama S, Marei HE, Martin-Loeches I, Marwah S, Massele A, McFarlane M, Melo RB, Negoi I, Nicolau DP, Nord CE, Ofori-Asenso R, Omari AH, Ordonez CA, Ouadii M, Pereira Júnior GA, Piazza D, Pupelis G, Rawson TM, Rems M, Rizoli S, Rocha C, Sakakhushev B, Sanchez-Garcia M, Sato N, Segovia Lohse HA, Sganga G, Siribumrungwong B, Shelat VG, Soreide K, Soto R, Talving P, Tilsed JV, Timsit JF, Trueba G, Trung NT, Ulrych J, van Goor H, Vereczkei A, Vohra RS, Wani I, Uhl W, Xiao Y, Yuan KC, Zachariah SK, Zahar JR, Zakrison TL, Corcione A, Melotti RM, Viscoli C, Viale P
Antimicrobials: a global alliance for optimizing their rational use in intra-abdominal infections (AGORA).
World journal of emergency surgery: WJES 2016, 11,

Paiva JA, Pereira JM, Tabah A, Mikstacki A, de Carvalho FB, Koulenti D, Ruckly S, Çakar N, Misset B, Dimopoulos G, Antonelli M, Rello J, Ma X, Tamowicz B, Timsit JF
Characteristics and risk factors for 28-day mortality of hospital acquired fungemias in ICUs: data from the EUROBACT study.
Critical Care (London, England) 2016, 20,

May F, El-Helali N, Timsit JF, Misset B
Absence of obvious link between supra-therapeutic serum levels of β lactams and clinical toxicity in ICU patients with acute renal failure treated with intermittent hemodialysis.
Critical Care (London, England) 2016, 20, 220.

Coupez E, Timsit JF, Ruckly S, Schwebel C, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Darmon M, Boyer A, Azoulay E, Bouadma L, Lautrette A, Souweine B
Guidewire exchange vs new site placement for temporary dialysis catheter insertion in ICU patients: is there a greater risk of colonization or dysfunction?.
Critical Care (London, England) 2016, 20, 230.

Voiriot G, Visseaux B, Cohen J, Nguyen LBL, Neuville M, Morbieu C, Burdet C, Radjou A, Lescure FX, Smonig R, Armand-Lefèvre L, Mourvillier B, Yazdanpanah Y, Soubirou JF, Ruckly S, Houhou-Fidouh N, Timsit JF
Viral-bacterial coinfection affects the presentation and alters the prognosis of severe community-acquired pneumonia.
Critical Care (London, England) 2016, 20, 375.

Kalfon P, Mimoz O, Loundou A, Geantot MA, Revel N, Villard I, Amour J, Azoulay E, Garrouste-Orgeas M, Martin C, Sharshar T, Baumstarck K, Auquier P
Reduction of self-perceived discomforts in critically ill patients in French intensive care units: study protocol for a cluster-randomized controlled trial.
Trials 2016, 17,

Leroy O, Bailly S, Gangneux JP, Mira JP, Devos P, Dupont H, Montravers P, Perrigault PF, Constantin JM, Guillemot D, Azoulay E, Lortholary O, Bensoussan C, Timsit JF, Asg
Systemic antifungal therapy for proven or suspected invasive candidiasis: the AmarCAND 2 study.
Annals of Intensive Care 2016, 6, 2.

Garrouste-Orgeas M, Ruckly S, Grégoire C, Dumesnil AS, Pommier C, Jamali S, Golgran-Toledano D, Schwebel C, Clec'h C, Soufir L, Fartoukh M, Marcotte G, Argaud L, Verdière B, Darmon M, Azoulay E, Timsit JF
Treatment intensity and outcome of nonagenarians selected for admission in ICUs: a multicenter study of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 31.

Boumendil A, Woimant M, Quenot JP, Rooryck FX, Makhlouf F, Yordanov Y, Delerme S, Takun K, Ray P, Kouka MC, Poly C, Garrouste-Orgeas M, Thomas C, Simon T, Azerad S, Leblanc G, Pateron D, Guidet B, IC2sn
Designing and conducting a cluster-randomized trial of ICU admission for the elderly patients: the ICE-CUB 2 study.
Annals of Intensive Care 2016, 6, 74.

Garrouste-Orgeas M, Vinatier I, Tabah A, Misset B, Timsit JF
Reappraisal of visiting policies and procedures of patient's family information in 188 French ICUs: a report of the Outcomerea Research Group.
Annals of Intensive Care 2016, 6, 82.

Schnell D, Azoulay E, Benoit D, Clouzeau B, Demaret P, Ducassou S, Frange P, Lafaurie M, Legrand M, Meert AP, Mokart D, Naudin J, Pene F, Rabbat A, Raffoux E, Ribaud P, Richard JC, Vincent F, Zahar JR, Darmon M
Management of neutropenic patients in the intensive care unit (NEWBORNS EXCLUDED) recommendations from an expert panel from the French Intensive Care Society (SRLF) with the French Group for Pediatric Intensive Care Emergencies (GFRUP), the French Society of Anesthesia and Intensive Care (SFAR), the French Society of Hematology (SFH), the French Society for Hospital Hygiene (SF2H), and the French Infectious Diseases Society (SPILF).
Annals of Intensive Care 2016, 6, 90.

Sissoko D, Laouenan C, Folkesson E, M'Lebing AB, Beavogui AH, Baize S, Camara AM, Maes P, Shepherd S, Danel C, Carazo S, Conde MN, Gala JL, Colin G, Savini H, Bore JA, Le Marcis F, Koundouno FR, Petitjean F, Lamah MC, Diederich S, Tounkara A, Poelart G, Berbain E, Dindart JM, Duraffour S, Lefevre A, Leno T, Peyrouset O, Irenge L, Bangoura N, Palich R, Hinzmann J, Kraus A, Barry TS, Berette S, Bongono A, Camara MS, Chanfreau Munoz V, Doumbouya L, Souley Harouna n, Kighoma PM, Koundouno FR, Réné Lolamou n, Loua CM, Massala V, Moumouni K, Provost C, Samake N, Sekou C, Soumah A, Arnould I, Komano MS, Gustin L, Berutto C, Camara D, Camara FS, Colpaert J, Delamou L, Jansson L, Kourouma E, Loua M, Malme K, Manfrin E, Maomou A, Milinouno A, Ombelet S, Sidiboun AY, Verreckt I, Yombouno P, Bocquin A, Carbonnelle C, Carmoi T, Frange P, Mely S, Nguyen VK, Pannetier D, Taburet AM, Treluyer JM, Kolie J, Moh R, Gonzalez MC, Kuisma E, Liedigk B, Ngabo D, Rudolf M, Thom R, Kerber R, Gabriel M, Di Caro A, Wölfel R, Badir J, Bentahir M, Deccache Y, Dumont C, Durant JF, El Bakkouri K, Gasasira Uwamahoro M, Smits B, Toufik N, Van Cauwenberghe S, Ezzedine K, D'Ortenzio E, Dortenzio E, Pizarro L, Etienne A, Guedj J, Fizet A, Barte de Sainte Fare E, Murgue B, Tran-Minh T, Rapp C, Piguet P, Poncin M, Draguez B, Allaford Duverger T, Barbe S, Baret G, Defourny I, Carroll M, Raoul H, Augier A, Eholie SP, Yazdanpanah Y, Levy-Marchal C, Antierrens A, Van Herp M, Günther S, de Lamballerie X, Keïta S, Mentre F, Anglaret X, Malvy D, JSG
Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea.
PLoS medicine 2016, 13, e1001967.

Elanga Ndille E, Doucoure S, Poinsignon A, Mouchet F, Cornelie S, D'Ortenzio E, DeHecq JS, Remoue F
Human IgG Antibody Response to Aedes Nterm-34kDa Salivary Peptide, an Epidemiological Tool to Assess Vector Control in Chikungunya and Dengue Transmission Area.
PLoS neglected tropical diseases 2016, 10, e0005109.

Kirchgesner J, Beaugerie L, Carrat F, Sokol H, Cosnes J, Schwarzinger M, BSG
Impact on Life Expectancy of Withdrawing Thiopurines in Patients with Crohn's Disease in Sustained Clinical Remission: A Lifetime Risk-Benefit Analysis.
PloS One 2016, 11, e0157191.

Bailly S, Destors M, Grillet Y, Richard P, Stach B, Vivodtzev I, Timsit JF, Lévy P, Tamisier R, Pépin JL, scaiotFnsar(
Obstructive Sleep Apnea: A Cluster Analysis at Time of Diagnosis.
PloS One 2016, 11, e0157318.

Angin M, Wong G, Papagno L, Versmisse P, David A, Bayard C, Charmeteau-De Muylder B, Besseghir A, Thiébaut R, Boufassa F, Pancino G, Sauce D, Lambotte O, Brun-Vézinet F, Matheron S, Rowland-Jones SL, Cheynier R, Sáez-Cirión A, Appay V, ACI2SG
Preservation of Lymphopoietic Potential and Virus Suppressive Capacity by CD8+ T Cells in HIV-2-Infected Controllers.
Journal of Immunology (Baltimore, Md.: 1950) 2016, 197, 2787–2795.

Loubet P, Palich R, Kojan R, Peyrouset O, Danel C, Nicholas S, Conde M, Porten K, Augier A, Yazdanpanah Y
Development of a Prediction Model for Ebola Virus Disease: A Retrospective Study in Nzérékoré Ebola Treatment Center, Guinea.
The American Journal of Tropical Medicine and Hygiene 2016, 95, 1362-1367.

Suzan-Monti M, Lorente N, Demoulin B, Marcellin F, Préau M, Dray-Spira R, Lert F, Spire B, AVSG
Sexual risk behaviour among people living with HIV according to the biomedical risk of transmission: results from the ANRS-VESPA2 survey.
J Int AIDS Soc 2016, 19, 20095.

 2015                                                                            

Lemiale V, Mokart D, Resche-Rigon M, Pène F, Mayaux J, Faucher E, Nyunga M, Girault C, Perez P, Guitton C, Ekpe K, Kouatchet A, Théodose I, Benoit D, Canet E, Barbier F, Rabbat A, Bruneel F, Vincent F, Klouche K, Loay K, Mariotte E, Bouadma L, Moreau AS, Seguin A, Meert AP, Reignier J, Papazian L, Mehzari I, Cohen Y, Schenck M, Hamidfar R, Darmon M, Demoule A, Chevret S, Azoulay E, GdReRRdpdH(O
Effect of Noninvasive Ventilation vs Oxygen Therapy on Mortality Among Immunocompromised Patients With Acute Respiratory Failure: A Randomized Clinical Trial.
JAMA 2015, 314, 1711-1719.

Obach D, Yazdanpanah Y, Esmat G, Avihingsanon A, Dewedar S, Durier N, Attia A, Anwar WA, Cousien A, Tangkijvanich P, Eholié SP, Doss W, Mostafa A, Fontanet A, Mohamed MK, Deuffic-Burban S
How to optimize hepatitis C virus treatment impact on life years saved in resource-constrained countries.
Hepatology (Baltimore, Md.) 2015, 62, 31-39.

Gautheret-Dejean A, Bocobza J, Brunet S, Damond F, Plantier JC, Barin F
Performance of rapid tests for discrimination between HIV-1 and/or HIV-2 infections.
Journal of Medical Virology 2015, 87, 2061–2066.

Laouénan C, Guedj J, Peytavin G, Nguyen TT, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Marcellin P, Mentré F
A Model-Based Illustrative Exploratory Approach to Optimize the Dosing of Peg-IFN/RBV in Cirrhotic Hepatitis C Patients Treated With Triple Therapy.
CPT: pharmacometrics & systems pharmacology 2015, 4, e00008.

Clémençon S, Cousien A, Felipe MD, Tran VC
On computer-intensive simulation and estimation methods for rare-event analysis in epidemic models.
Statistics in Medicine 2015, 34, 3696-3713.

Bakker J, Perner A, Timsit JF
Evaluation of 7.5 years of Surviving Sepsis Campaign Guidelines.
Intensive Care Medicine 2015, 41, 151-153.

Yazdanpanah Y, Arribas JR, Malvy D
Treatment of Ebola virus disease.
Intensive Care Medicine 2015, 41, 115-117.

Toffart AC, Dhalluin X, Girard N, Chouaid C, Audigier-Valette C, Duruisseaux M, Mennecier B, Parrot A, Fournel P, Moro-Sibilot D, Timsit JF
Patients with advanced lung cancer harboring oncogenic mutations should be admitted to intensive care units.
Intensive Care Medicine [Letter] 2015, 41, 164-165.

Garrouste-Orgeas M, Perrin M, Soufir L, Vesin A, Blot F, Maxime V, Beuret P, Troché G, Klouche K, Argaud L, Azoulay E, Timsit JF
The Iatroref study: medical errors are associated with symptoms of depression in ICU staff but not burnout or safety culture.
Intensive Care Medicine 2015, 41, 273-284.

Reignier J, Darmon M, Sonneville R, Borel AL, Garrouste-Orgeas M, Ruckly S, Souweine B, Dumenil AS, Haouache H, Adrie C, Argaud L, Soufir L, Marcotte G, Laurent V, Goldgran-Toledano D, Clec'h C, Schwebel C, Azoulay E, Timsit JF
Impact of early nutrition and feeding route on outcomes of mechanically ventilated patients with shock: a post hoc marginal structural model study.
Intensive Care Medicine 2015, 41, 875-886.

Timsit JF, Perner A, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Doig GS, Herridge M, Jaber S, Joannidis M, Papazian L, Peters MJ, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Citerio G, Azoulay E
Year in review in Intensive Care Medicine 2014: III. Severe infections, septic shock, healthcare-associated infections, highly resistant bacteria, invasive fungal infections, severe viral infections, Ebola virus disease and paediatrics.
Intensive Care Medicine [YEAR IN REVIEW 2014] 2015, 41, 575-588.

Bretonnière C, Leone M, Milési C, Allaouchiche B, Armand-Lefevre L, Baldesi O, Bouadma L, Decré D, Figueiredo S, Gauzit R, Guery B, Joram N, Jung B, Lasocki S, Lepape A, Lesage F, Pajot O, Philippart F, Souweine B, Tattevin P, Timsit JF, Vialet R, Zahar JR, Misset B, Bedos JP
Strategies to reduce curative antibiotic therapy in intensive care units (adult and paediatric).
Intensive Care Medicine 2015, 41, 1181-1196.

Bassetti M, Leon C, Timsit JF
Are prophylactic antifungals in highly colonized patients safe and effective?.
Intensive Care Medicine 2015, 41, 1336-1339.

Lautrette A, Garrouste-Orgeas M, Bertrand PM, Goldgran-Toledano D, Jamali S, Laurent V, Argaud L, Schwebel C, Mourvillier B, Darmon M, Ruckly S, Dumenil AS, Lemiale V, Souweine B, Timsit JF, OSG
Respective impact of no escalation of treatment, withholding and withdrawal of life-sustaining treatment on ICU patients' prognosis: a multicenter study of the Outcomerea Research Group.
Intensive Care Medicine 2015, 41, 1763-1772.

Schortgen F, Charles-Nelson A, Bouadma L, Bizouard G, Brochard L, Katsahian S
Respective impact of lowering body temperature and heart rate on mortality in septic shock: mediation analysis of a randomized trial.
Intensive Care Medicine 2015, 41, 1800-1808.

Bailly S, Leroy O, Montravers P, Constantin JM, Dupont H, Guillemot D, Lortholary O, Mira JP, Perrigault PF, Gangneux JP, Azoulay E, Timsit JF
Antifungal de-escalation was not associated with adverse outcome in critically ill patients treated for invasive candidiasis: post hoc analyses of the AmarCAND2 study data.
Intensive Care Medicine 2015, 41, 1931-1940.

Garnacho-Montero J, Dimopoulos G, Poulakou G, Akova M, Cisneros JM, De Waele J, Petrosillo N, Seifert H, Timsit JF, Vila J, Zahar JR, Bassetti M, ESoICM
Task force on management and prevention of Acinetobacter baumannii infections in the ICU.
Intensive Care Medicine 2015, 41, 2057-2075.

Lepelletier D, Lucet JC, Astagneau P, Coignard B, Vaux S, Rabaud C, Grandbastien B, Berthelot P
Control of emerging extensively drug-resistant organisms (eXDRO) in France: a survey among infection preventionists from 286 healthcare facilities.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2015, 34, 1615-1620.

Pichon M, Savatovsky J, Lamirel C, Joly V, Moulignier A
Isolated blepharoptosis may point to HIV-associated Burkitt's lymphoma.
Acta Neurologica Belgica 2015, 115, 833–835.

Brunetta J, Moreno Guillén S, Antinori A, Yeni P, Wade B, Johnson M, Shalit P, Ebrahimi R, Johnson B, Walker I, De-Oertel S
Patient-Reported Outcomes After a Switch to a Single-Tablet Regimen of Rilpivirine, Emtricitabine, and Tenofovir DF in HIV-1-Positive, Virologically Suppressed Individuals: Additional Findings From a Randomized, Open-Label, 48-Week Trial.
The Patient 2015

Birgand G, Toupet G, Rukly S, Antoniotti G, Deschamps MN, Lepelletier D, Pornet C, Stern JB, Vandamme YM, van der Mee-Marquet N, Timsit JF, Lucet JC
Air contamination for predicting wound contamination in clean surgery: A large multicenter study.
American Journal of Infection Control 2015, 43, 516-521.

Parienti JJ, Lucet JC, Lefort A, Armand-Lefèvre L, Wolff M, Caron F, Cattoir V, Yazdanpanah Y
Empirical therapies among adults hospitalized for community-acquired upper urinary tract infections: A decision-tree analysis of mortality, costs, and resistance.
American Journal of Infection Control 2015, 43, e53-e59.

Canlorbe G, Matheron S, Mandelbrot L, Oudet B, Luton D, Azria E
Vasculoplacental complications in pregnant women with HIV infection: a case-control study.
American Journal of Obstetrics and Gynecology 2015, 213, 241.e1-9.

Mabileau G, Schwarzinger M, Flores J, Patrat C, Luton D, Epelboin S, Mandelbrot L, Matheron S, Yazdanpanah Y
HIV-serodiscordant couples desiring a child: 'treatment as prevention,' preexposure prophylaxis, or medically assisted procreation?.
American Journal of Obstetrics and Gynecology 2015, 213, 341.e1-12.

Mallet V, Schwarzinger M, Vallet-Pichard A, Fontaine H, Corouge M, Sogni P, Pol S
Effect of nucleoside and nucleotide analogues on renal function in patients with chronic hepatitis B virus monoinfection.
Clinical Gastroenterology and Hepatology: The Official Clinical Practice Journal of the American Gastroenterological Association 2015, 13, 1181-1188.e1.

Lesprit P, de Pontfarcy A, Esposito-Farese M, Ferrand H, Mainardi JL, Lafaurie M, Parize P, Rioux C, Tubach F, Lucet JC
Postprescription review improves in-hospital antibiotic use: a multicenter randomized controlled trial.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 180.e1-7.

Le Dorze M, Gault N, Foucrier A, Ruppé E, Mourvillier B, Woerther PL, Birgand G, Montravers P, Dilly MP, Tubach F, Andremont A, Timsit JF, Wolff M, Armand-Lefèvre L
Performance and impact of a rapid method combining mass spectrometry and direct antimicrobial susceptibility testing on treatment adequacy of patients with ventilator-associated pneumonia.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 468.e1-6.

Weiss E, Zahar JR, Lesprit P, Ruppe E, Leone M, Chastre J, Lucet JC, Paugam-Burtz C, Brun-Buisson C, Timsit JF, DeSG
Elaboration of a consensual definition of de-escalation allowing a ranking of β-lactams.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 649.e1-10.

Lemaignen A, Birgand G, Ghodhbane W, Alkhoder S, Lolom I, Belorgey S, Lescure FX, Armand-Lefevre L, Raffoul R, Dilly MP, Nataf P, Lucet JC
Sternal wound infection after cardiac surgery: incidence and risk factors according to clinical presentation.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 674.e11-18.

LeGoff J, Roques P, Jenabian MA, Charpentier C, Brochier C, Bouhlal H, Gresenguet G, Frost E, Pepin J, Mayaud P, Belec L, A1SG
Variability of human immunodeficiency virus-1 in the female genital reservoir during genital reactivation of herpes simplex virus type 2.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 873.e1-9.

Birgand G, Johansson A, Szilagyi E, Lucet JC
Overcoming the obstacles of implementing infection prevention and control guidelines.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2015, 21, 1067-1071.

Maraux B, Hamelin C, Bajos N, Dray-Spira R, Spire B, Lert F, Vsg
Women living with HIV still lack highly effective contraception: results from the ANRS VESPA2 study, France, 2011.
Contraception 2015, 92, 160–169.

Shadoud L, Almahmoud I, Jarraud S, Etienne J, Larrat S, Schwebel C, Timsit JF, Schneider D, Maurin M
Hidden Selection of Bacterial Resistance to Fluoroquinolones In Vivo: The Case of Legionella pneumophila and Humans.
EBioMedicine 2015, 2, 1179-1185.

Gauzit R, Pean Y, Alfandari S, Bru JP, Bedos JP, Rabaud C, Robert J, SdPIdLF(, ONdldlRBaA(, SdlPdA(G
Carbapenem use in French hospitals: A nationwide survey at the patient level.
International Journal of Antimicrobial Agents 2015, 46, 707-712.

Lefebvre A, Saliou P, Mimoz O, Lucet JC, Le Guyader A, Bruyère F, Roche PH, Astruc K, Tiv M, Lepelletier D, Aho-Glélé LS, FSGftPoPoSSI
Is surgical site scrubbing before painting of value? Review and meta-analysis of clinical studies.
The Journal of Hospital Infection 2015, 89, 28-37.

Lepelletier D, Berthelot P, Lucet JC, Fournier S, Jarlier V, Grandbastien B, NWG
French recommendations for the prevention of 'emerging extensively drug-resistant bacteria' (eXDR) cross-transmission.
The Journal of Hospital Infection 2015, 90, 186-195.

Lefebvre A, Saliou P, Lucet JC, Mimoz O, Keita-Perse O, Grandbastien B, Bruyère F, Boisrenoult P, Lepelletier D, Aho-Glélé LS, FSGftPPoSSI
Preoperative hair removal and surgical site infections: network meta-analysis of randomized controlled trials.
The Journal of Hospital Infection 2015, 91, 100-108.

Charlier C, Hourrier S, Leruez-Ville M, Zahar JR, Floret D, Salomon LJ, Toubiana J, Lecuit M, Lapillonne A, Lortholary O, Kermorvant-Duchemin E
Polyvalent immunoglobulins in neonates after perinatal exposure to measles: Benefits and long-term tolerance of immunoglobulins.
The Journal of Infection 2015, 71, 131-134.

Bonnal C, Birgand G, Lolom I, Diamantis S, Dumortier C, L'Heriteau F, Armand-Lefevre L, Lucet JC
Staphylococcus aureus healthcare associated bacteraemia: An indicator of catheter related infections.
Medecine Et Maladies Infectieuses 2015, 45, 84-88.

Lefébure A, Papy E, Rioux C, Diamantis S, Armand-Lefèvre L, Longuet P, Lescure FX, Wolff M, Arnaud P, Lucet JC
Audit of carbapenem prescriptions comparing 2 assessment periods.
Medecine Et Maladies Infectieuses 2015, 45, 273-278.

Alfandari S, Robert J, Péan Y, Rabaud C, Bedos JP, Varon E, Lepape A, Bru JP, Gauzit R, FIDS(aStFNOfEoBRtA(atSg
Antibiotic use and good practice in 314 French hospitals: The 2010 SPA2 prevalence study.
Medecine Et Maladies Infectieuses 2015, 45, 475–480.

Wagner N, Wyler-Lazarevic CA, Yerly S, Samer C, Peytavin G, Posfay-Barbe KM, Calmy A, Ambrosioni J
Dolutegravir-based antiretroviral therapy in a severely overweight child with a multidrug-resistant human immunodeficiency virus infection. A case report and review.
New Microbes and New Infections 2015, 6, 1–4.

Caseris M, Burdet C, Lepeule R, Houhou N, Yeni P, Yazdanpanah Y, Joly V
[An update on measles].
La Revue De Medecine Interne 2015, 36, 339-345.

Ribadeau Dumas F, N’Diaye DS, Paireau J, Gautret P, Bourhy H, Le Pen C, Yazdanpanah Y
Cost-effectiveness of rabies post-exposure prophylaxis in the context of very low rabies risk: A decision-tree model based on the experience of France.
Vaccine 2015, 33, 2367-2378.

Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O
Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency.
Vaccine 2015, 33, 3703-3708.

Mullaert J, Abgrall S, Lele N, Batteux F, Slama LB, Meritet JF, Lebon P, Bouchaud O, Grabar S, Launay O
Diphtheria, tetanus, poliomyelitis, yellow fever and hepatitis B seroprevalence among HIV1-infected migrants. Results from the ANRS VIHVO vaccine sub-study.
Vaccine 2015, 33, 4938-4944.

Guerrier G, Sjögren L, Guerrier M, Bretonnière S, Letier T, Dancoisne A, Wirtz M, D'Ortenzio E
Scientific journalism in Africa to help fight global health emergencies.
Lancet (London, England) 2015, 386, 851.

Mimoz O, Lucet JC, Kerforne T, Pascal J, Souweine B, Goudet V, Mercat A, Bouadma L, Lasocki S, Alfandari S, Friggeri A, Wallet F, Allou N, Ruckly S, Balayn D, Lepape A, Timsit JF, Cti
Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Lancet (London, England) 2015, 386, 2069-2077.

Guerrier G, D'Ortenzio E
Teaching anthropology to medical students.
Lancet (London, England) 2015, 385, 603.

Ndawinz JDA, Cissé M, Diallo MSK, Sidibé CT, D'Ortenzio E
Prevention of HIV spread during the Ebola outbreak in Guinea.
Lancet (London, England) 2015, 385, 1393.

Arribas JR, Girard PM, Landman R, Pich J, Mallolas J, Martínez-Rebollar M, Zamora FX, Estrada V, Crespo M, Podzamczer D, Portilla J, Dronda F, Iribarren JA, Domingo P, Pulido F, Montero M, Knobel H, Cabié A, Weiss L, Gatell JM, OESG
Dual treatment with lopinavir-ritonavir plus lamivudine versus triple treatment with lopinavir-ritonavir plus lamivudine or emtricitabine and a second nucleos(t)ide reverse transcriptase inhibitor for maintenance of HIV-1 viral suppression (OLE): a randomised, open-label, non-inferiority trial.
The Lancet. Infectious Diseases 2015, 15, 785-792.

Rey D, Piroth L, Wendling MJ, Miailhes P, Michel ML, Dufour C, Haour G, Sogni P, Rohel A, Ajana F, Billaud E, Molina JM, Launay O, Carrat F, AHBBsg
Safety and immunogenicity of double-dose versus standard-dose hepatitis B revaccination in non-responding adults with HIV-1 (ANRS HB04 B-BOOST): a multicentre, open-label, randomised controlled trial.
The Lancet. Infectious Diseases 2015, 15, 1283–1291.

Yazdanpanah Y, Horby P, van Griensven J, Mentre F, Nguyen VK, Malvy JMD, Dunning J, Sissoko D, Delfraissy JF, Levy Y
Drug assessment in the Ebola virus disease epidemic in west Africa.
The Lancet. Infectious Diseases 2015, 15, 1258.

Horby PW, Endzt H, Muyembe-Tamfum JJ, van Griensven J, Gevao S, Goossens H, Malvy JMD, Haba NY, Yazdanpanah Y, Olliaro P, Semple C, de Jong M, Delamou A, Lang T, Carson G, Kennedy S
Ebola: Europe-Africa research collaborations.
The Lancet. Infectious Diseases 2015, 15, 1258-1259.

Chéret A, Nembot G, Mélard A, Lascoux C, Slama L, Miailhes P, Yeni P, Abel S, Avettand-Fenoel V, Venet A, Chaix ML, Molina JM, Katlama C, Goujard C, Tamalet C, Raffi F, Lafeuillade A, Reynes J, Ravaux I, Hoën B, Delfraissy JF, Meyer L, Rouzioux C, OASG
Intensive five-drug antiretroviral therapy regimen versus standard triple-drug therapy during primary HIV-1 infection (OPTIPRIM-ANRS 147): a randomised, open-label, phase 3 trial.
Lancet Infect Dis 2015, 15, 387–396.

Lodi S, Phillips A, Logan R, Olson A, Costagliola D, Abgrall S, van Sighem A, Reiss P, Miró JM, Ferrer E, Justice A, Gandhi N, Bucher HC, Furrer H, Moreno S, Monge S, Touloumi G, Pantazis N, Sterne J, Young JG, Meyer L, Seng R, Dabis F, Vandehende MA, Pérez-Hoyos S, Jarrín I, Jose S, Sabin C, Hernán MA, HCC
Comparative effectiveness of immediate antiretroviral therapy versus CD4-based initiation in HIV-positive individuals in high-income countries: observational cohort study.
The lancet. HIV 2015, 2, e335–343.

Birgand G, Saliou P, Lucet JC
Influence of staff behavior on infectious risk in operating rooms: what is the evidence?.
Infection Control and Hospital Epidemiology 2015, 36, 93-106.

Lucet JC, Abiteboul D, Estellat C, Roy C, Chollet-Martin S, Tubach F, Carcelain G, QSG
Interferon-γ release assay vs. tuberculin skin test for tuberculosis screening in exposed healthcare workers: a longitudinal multicenter comparative study.
Infection Control and Hospital Epidemiology 2015, 36, 569-574.

Molina JM, Capitant C, Spire B, Pialoux G, Cotte L, Charreau I, Tremblay C, Le Gall JM, Cua E, Pasquet A, Raffi F, Pintado C, Chidiac C, Chas J, Charbonneau P, Delaugerre C, Suzan-Monti M, Loze B, Fonsart J, Peytavin G, Cheret A, Timsit J, Girard G, Lorente N, Préau M, Rooney JF, Wainberg MA, Thompson D, Rozenbaum W, Doré V, Marchand L, Simon MC, Etien N, Aboulker JP, Meyer L, Delfraissy JF, AISG
On-Demand Preexposure Prophylaxis in Men at High Risk for HIV-1 Infection.
The New England Journal of Medicine 2015, 373, 2237–2246.

TA1SG, Danel C, Moh R, Gabillard D, Badje A, Le Carrou J, Ouassa T, Ouattara E, Anzian A, Ntakpé JB, Minga A, Kouame GM, Bouhoussou F, Emieme A, Kouamé A, Inwoley A, Toni Td, Ahiboh H, Kabran M, Rabe C, Sidibé B, Nzunetu G, Konan R, Gnokoro J, Gouesse P, Messou E, Dohoun L, Kamagate S, Yao A, Amon S, Kouame AB, Koua A, Kouamé E, Ndri Y, Ba-Gomis O, Daligou M, Ackoundzé S, Hawerlander D, Ani A, Dembélé F, Koné F, Guéhi C, Kanga C, Koule S, Séri J, Oyebi M, Mbakop N, Makaila O, Babatunde C, Babatounde N, Bleoué G, Tchoutedjem M, Kouadio AC, Sena G, Yededji SY, Assi R, Bakayoko A, Mahassadi A, Attia A, Oussou A, Mobio M, Bamba D, Koman M, Horo A, Deschamps N, Chenal H, Sassan-Morokro M, Konate S, Aka K, Aoussi E, Journot V, Nchot C, Karcher S, Chaix ML, Rouzioux C, Sow PS, Perronne C, Girard PM, Menan H, Bissagnene E, Kadio A, Ettiegne-Traore V, Moh-Semdé C, Kouame A, Massumbuko JM, Chêne G, Dosso M, Domoua SK, N'Dri-Yoman T, Salamon R, Eholié SP, Anglaret X
A Trial of Early Antiretrovirals and Isoniazid Preventive Therapy in Africa.
The New England Journal of Medicine 2015, 373, 808–822.

Soulie C, Peytavin G, Charpentier C, Lambert-Niclot S, Sayon S, Visseaux B, Simon A, Katlama C, Yazdanpanah Y, Descamps D, Calvez V, Marcelin AG
Antiretroviral-Experienced HIV-1-Infected Patients Treated with Maraviroc: Factors Associated with Virological Response.
AIDS research and human retroviruses 2015, 31, 475-478.

Grabar S, Tattevin P, Selinger-Leneman H, de La Blanchardiere A, de Truchis P, Rabaud C, Rey D, Daneluzzi V, Ferret S, Lascaux AS, Hanslik T, Costagliola D, Launay O, FHDoH(ACC
Incidence of herpes zoster in HIV-infected adults in the combined antiretroviral therapy era: results from the FHDH-ANRS CO4 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1269–1277.

HCC, Cain LE, Phillips A, Olson A, Sabin C, Jose S, Justice A, Tate J, Logan R, Robins JM, Sterne JAC, van Sighem A, Reiss P, Young J, Fehr J, Touloumi G, Paparizos V, Esteve A, Casabona J, Monge S, Moreno S, Seng R, Meyer L, Pérez-Hoyos S, Muga R, Dabis F, Vandenhende MA, Abgrall S, Costagliola D, Hernán MA
Boosted lopinavir- versus boosted atazanavir-containing regimens and immunologic, virologic, and clinical outcomes: a prospective study of HIV-infected individuals in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 1262–1268.

Delaugerre C, Ghosn J, Lacombe JM, Pialoux G, Cuzin L, Launay O, Menard A, de Truchis P, Costagliola D, FAC
Significant reduction in HIV virologic failure during a 15-year period in a setting with free healthcare access.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 60, 463–472.

Descamps D, Peytavin G, Visseaux B, Tubiana R, Damond F, Campa P, Charpentier C, Khuong-Josses MA, Duvivier C, Karmochkine M, Lukiana T, Matheron S
Dolutegravir in HIV-2 infected patients with resistant virus to first-line integrase inhibitors from the French Named Patient Program.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Carrieri MP, Serfaty L, Vilotitch A, Winnock M, Poizot-Martin I, Loko MA, Lions C, Lascoux-Combe C, Roux P, Salmon-Ceron D, Spire B, Dabis F, ACHSG
Cannabis use and reduced risk of insulin-resistance in HIV-HCV infected patients: a longitudinal analysis (ANRS HEPAVIH CO-13).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015

Sibiude J, Le Chenadec J, Bonnet D, Tubiana R, Faye A, Dollfus C, Mandelbrot L, Delmas S, Lelong N, Khoshnood B, Warszawski J, Blanche S, FNAfRoAaVHFPCIMET
In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 270-280.

Abgrall S, Rachas A, Tourret J, Isnard-Bagnis C, Billaud E, Tattevin P, Costagliola D, Guiguet M, Durieux P, FHDoH
A multifaceted intervention designed to improve medical management of moderate to advanced chronic kidney disease in HIV-infected patients: a cluster randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 375–384.

Ruppé E, Armand-Lefèvre L, Estellat C, Consigny PH, El Mniai A, Boussadia Y, Goujon C, Ralaimazava P, Campa P, Girard PM, Wyplosz B, Vittecoq D, Bouchaud O, Le Loup G, Pialoux G, Perrier M, Wieder I, Moussa N, Esposito-Farèse M, Hoffmann I, Coignard B, Lucet JC, Andremont A, Matheron S
High Rate of Acquisition but Short Duration of Carriage of Multidrug-Resistant Enterobacteriaceae After Travel to the Tropics.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 593-600.

Charpentier C, Camacho R, Ruelle J, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Kaiser R, Descamps D, Obermeier M
HIV-2EU-Supporting Standardized HIV-2 Drug-Resistance Interpretation in Europe: An Update.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1346–1347.

Mandelbrot L, Tubiana R, Le Chenadec J, Dollfus C, Faye A, Pannier E, Matheron S, Khuong MA, Garrait V, Reliquet V, Devidas A, Berrebi A, Allisy C, Elleau C, Arvieux C, Rouzioux C, Warszawski J, Blanche S, AESG
No perinatal HIV-1 transmission from women with effective antiretroviral therapy starting before conception.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2015, 61, 1715-1725.

Fofana DB, Charpentier C, Maïga AI, Lambert-Niclot S, Sayon S, Désiré N, Simon A, Yazdanpanah Y, Katlama C, Descamps D, Calvez V, Marcelin AG, Soulié C
Genetic barrier for attachment inhibitor BMS-626529 resistance in HIV-1 B and non-B subtypes.
The Journal of Antimicrobial Chemotherapy 2015, 70, 130-135.

Lê MP, Landman R, Koulla-Shiro S, Charpentier C, Sow PS, Diallo MB, Ngom Gueye NF, Ngolle M, Le Moing V, Eymard-Duvernay S, Benalycherif A, Delaporte E, Girard PM, Peytavin G, DSG
Tenofovir plasma concentrations related to estimated glomerular filtration rate changes in first-line regimens in African HIV-infected patients: ANRS 12115 DAYANA substudy.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1517–1521.

Fourati S, Charpentier C, Amiel C, Morand-Joubert L, Reigadas S, Trabaud MA, Delaugerre C, Nicot F, Rodallec A, Maillard A, Mirand A, Jeulin H, Montès B, Barin F, Bettinger D, Le Guillou-Guillemette H, Vallet S, Signori-Schmuck A, Descamps D, Calvez V, Flandre P, Marcelin AG, AARSG
Cross-resistance to elvitegravir and dolutegravir in 502 patients failing on raltegravir: a French national study of raltegravir-experienced HIV-1-infected patients.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1507–1512.

Danion F, Belissa E, Peytavin G, Thierry E, Lanternier F, Scemla A, Lortholary O, Delelis O, Avettand-Fenoel V, Duvivier C
Non-virological response to a dolutegravir-containing regimen in a patient harbouring a E157Q-mutated virus in the integrase region.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1921–1923.

Raymond S, Maillard A, Amiel C, Peytavin G, Trabaud MA, Desbois D, Bellecave P, Delaugerre C, Soulie C, Marcelin AG, Descamps D, Izopet J, obtAARSG
Virological failure of patients on maraviroc-based antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2015

Loubet P, Charpentier C, Visseaux B, Borbor A, Nuta C, Adu E, Chapplain JM, Baysah M, Tattevin P, Yazdanpanah Y, Descamps D
Prevalence of HIV-1 drug resistance among patients failing first-line ART in Monrovia, Liberia: a cross-sectional study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1881-1884.

Bastard JP, Fellahi S, Couffignal C, Raffi F, Gras G, Hardel L, Sobel A, Leport C, Fardet L, Capeau J, ACACCSG
Increased systemic immune activation and inflammatory profile of long-term HIV-infected ART-controlled patients is related to personal factors, but not to markers of HIV infection severity.
The Journal of Antimicrobial Chemotherapy 2015, 70, 1816-1824.

Charpentier C, Lee GQ, Rodriguez C, Visseaux B, Storto A, Fagard C, Molina JM, Katlama C, Yazdanpanah Y, Harrigan PR, Descamps D
Highly frequent HIV-1 minority resistant variants at baseline of the ANRS 139 TRIO trial had a limited impact on virological response.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2090-2096.

Frange P, Assoumou L, Descamps D, Chéret A, Goujard C, Tran L, Gousset M, Avettand-Fenoël V, Bocket L, Fafi-Kremer S, Guinard J, Morand-Joubert L, Nicot F, Plantier JC, Rogez S, Wirden M, Rouzioux C, Meyer L, Chaix ML, FAC6PCtA1OCTatARSG, FAC6PCtA1OCTatARSG
HIV-1 subtype B-infected MSM may have driven the spread of transmitted resistant strains in France in 2007-12: impact on susceptibility to first-line strategies.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2084–2089.

Raffi F, Yazdanpanah Y, Fagnani F, Laurendeau C, Lafuma A, Gourmelen J
Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2121-2128.

Chéret A, Bacchus-Souffan C, Avettand-Fenoël V, Mélard A, Nembot G, Blanc C, Samri A, Sáez-Cirión A, Hocqueloux L, Lascoux-Combe C, Allavena C, Goujard C, Valantin MA, Leplatois A, Meyer L, Rouzioux C, Autran B, OA1SG
Combined ART started during acute HIV infection protects central memory CD4+ T cells and can induce remission.
J. Antimicrob. Chemother. 2015, 70, 2108–2120.

Wirden M, Todesco E, Valantin MA, Lambert-Niclot S, Simon A, Calin R, Tubiana R, Peytavin G, Katlama C, Calvez V, Marcelin AG
Low-level HIV-1 viraemia in patients on HAART: risk factors and management in clinical practice.
The Journal of Antimicrobial Chemotherapy 2015

Lê MP, Soulié C, Assoumou L, Valantin MA, Duvivier C, Chas J, Ponscarme D, Marcelin AG, Calvez V, Katlama C, Peytavin G, RA1SG
Plasma concentrations of maraviroc and raltegravir after dual therapy in patients with long-term suppressed viraemia: ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2418–2420.

Tabah A, De Waele J, Lipman J, Zahar JR, Cotta MO, Barton G, Timsit JF, Roberts JA, WGfAUitIwtISotESoICM(
The ADMIN-ICU survey: a survey on antimicrobial dosing and monitoring in ICUs.
The Journal of Antimicrobial Chemotherapy 2015, 70, 2671-2677.

Ferrand H, Blanc-Gruyelle AL, Amsilli M, Lemaire X, Papot E, Papy E, Bervar J, Senneville E, Bouvet E, Yazdanpanah Y
Use of fluoroquinolones for the treatment of TB: 8 years of experience.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3166-3167.

Lanternier F, Poiree S, Elie C, Garcia-Hermoso D, Bakouboula P, Sitbon K, Herbrecht R, Wolff M, Ribaud P, Lortholary O, FMSG
Prospective pilot study of high-dose (10 mg/kg/day) liposomal amphotericin B (L-AMB) for the initial treatment of mucormycosis.
The Journal of Antimicrobial Chemotherapy 2015, 70, 3116–3123.

Soulié C, Assoumou L, Darty M, Rodriguez C, Donati F, Sayon S, Peytavin G, Valantin MA, Caby F, Schneider L, Canestri A, Costagliola D, Katlama C, Calvez V, Marcelin AG, RA1SG
Virological factors associated with outcome of dual maraviroc/raltegravir therapy (ANRS-157 trial).
The Journal of Antimicrobial Chemotherapy 2015, 70, 3339–3344.

Cazanave C, Reigadas S, Mazubert C, Bellecave P, Hessamfar M, Le Marec F, Lazaro E, Peytavin G, Bruyand M, Fleury H, Dabis F, Neau D
Switch to Rilpivirine/Emtricitabine/Tenofovir Single-Tablet Regimen of Human Immunodeficiency Virus-1 RNA-Suppressed Patients, Agence Nationale de Recherches sur le SIDA et les Hépatites Virales CO3 Aquitaine Cohort, 2012-2014.
Open Forum Infectious Diseases 2015, 2, ofv018.

Belkacem A, Caseris M, Yazdanpanah Y
A Case of Aggregatibacter aphrophilus Multiple Abscess.
Open Forum Infectious Diseases 2015, 2, ofv031.

Bouadma L, Sonneville R, Garrouste-Orgeas M, Darmon M, Souweine B, Voiriot G, Kallel H, Schwebel C, Goldgran-Toledano D, Dumenil AS, Argaud L, Ruckly S, Jamali S, Planquette B, Adrie C, Lucet JC, Azoulay E, Timsit JF, OSG
Ventilator-Associated Events: Prevalence, Outcome, and Relationship With Ventilator-Associated Pneumonia.
Critical Care Medicine 2015, 43, 1798-1806.

Feeney ER, Chung RT, Yazdanpanah Y
Current guidelines and prioritizing treatment of hepatitis C virus in HIV-infected patients.
Current opinion in HIV and AIDS 2015, 10, 323-329.

Bertine M, Charpentier C, Visseaux B, Storto A, Collin G, Larrouy L, Damond F, Matheron S, Brun-Vézinet F, Descamps D, ACH2C
High level of APOBEC3F/3G editing in HIV-2 DNA vif and pol sequences from antiretroviral-naive patients.
AIDS (London, England) 2015, 29, 779–784.

Alessandri-Gradt E, Morgand M, Delaugerre C, Peytavin G, Sellier P, Simon F, Plantier JC
HIV-1 group O resistance pathway with raltegravir is similar to HIV-1 group M.
AIDS (London, England) 2015, 29, 1271–1273.

Péré H, Roques P, Talla F, Meillo H, Charpentier C, Bélec L
Sustained virological failure in Cameroonese patient infected by HIV-1 group N evidenced by sequence-based genotyping assay.
AIDS (London, England) 2015, 29, 1267–1269.

Annequin M, Lert F, Spire B, Dray-Spira R, VSG
Has the employment status of people living with HIV changed since the early 2000s?.
AIDS 2015, 29, 1537–1547.

Cuzin L, Pugliese P, Sauné K, Allavena C, Ghosn J, Cottalorda J, Rodallec A, Chaix ML, Fafi-Kremer S, Soulié C, Ouka M, Charpentier C, Bocket L, Mirand A, Guiguet M, Dsg
Levels of intracellular HIV-DNA in patients with suppressive antiretroviral therapy.
AIDS (London, England) 2015, 29, 1665–1671.

Loubet P, Mabileau G, Baysah M, Nuta C, Taylor M, Jusu H, Weeks H, Ingels A, Perennec-Olivier M, Chapplain JM, Cartier N, Mendiharat P, Raguin G, Tattevin P, Yazdanpanah Y
Likely effect of the 2014 Ebola epidemic on HIV care in Liberia.
AIDS (London, England) 2015, 29, 2347-2351.

Visseaux B, Charpentier C, Ozanne A, Nizard A, Drumard S, Fagard C, Glohi D, Damond F, Brun-Vézinet F, Matheron S, Descamps D, ACH2C
Tropism distribution among antiretroviral-naive HIV-2-infected patients.
AIDS (London, England) 2015, 29, 2209–2212.

Zucman D, Sené T, Hillaire S, Kahn JE, Farfour E, Peytavin G
Antihepatitis C virus treatments for HIV-hepatitis C virus coinfected cirrhotic patients: a need to look beyond the sustained viral response.
AIDS (London, England) 2015, 29, 1903–1904.

Boullé C, Kouanfack C, Laborde-Balen G, Boyer S, Aghokeng AF, Carrieri MP, Kazé S, Dontsop M, Mben JM, Koulla-Shiro S, Peytavin G, Spire B, Delaporte E, Laurent C, SA1SG
Gender Differences in Adherence and Response to Antiretroviral Treatment in the Stratall Trial in Rural District Hospitals in Cameroon.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 69, 355–364.

Harrison L, Melvin A, Fiscus S, Saidi Y, Nastouli E, Harper L, Compagnucci A, Babiker A, McKinney R, Gibb D, Tudor-Williams G, P1(93ST
HIV-1 Drug Resistance and Second-Line Treatment in Children Randomized to Switch at Low Versus Higher RNA Thresholds.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 42–53.

Moulignier A, Gueguen A, Lescure FX, Ziegler M, Girard PM, Cardon B, Pialoux G, Molina JM, Brandel JP, Lamirel C
Does HIV Infection Alter Parkinson Disease?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2015, 70, 129-136.

Marcellin F, Demoulin B, Suzan-Monti M, Maradan G, Carrieri MP, Dray-Spira R, Spire B, AVSG
Risk Factors for HCV Reinfection or Transmission in HIV-HCV Coinfected MSM (ANRS-VESPA2 French National Survey).
J. Acquir. Immune Defic. Syndr. 2015, 70, e179–182.

Sonneville R, Gault N, de Montmollin E, Klein IF, Mariotte E, Chemam S, Tubach F, Mourvillier B, Timsit JF, Wolff M, Bouadma L
Clinical spectrum and outcomes of patients with encephalitis requiring intensive care.
European Journal of Neurology: The Official Journal of the European Federation of Neurological Societies 2015, 22, 6-16, e1.

Deconinck L, Yazdanpanah Y, Gilson RJ, Melliez H, Viget N, Joly V, Sabin CA
Time to initiation of antiretroviral therapy in HIV-infected patients diagnosed with an opportunistic disease: a cohort study.
HIV medicine 2015, 16, 219-229.

Winston A, Stöhr W, Antinori A, Arenas-Pinto A, Llibre JM, Amieva H, Cabié A, Williams I, Di Perri G, Tellez MJ, Rockstroh J, Babiker A, Pozniak A, Raffi F, Richert L, N0NdRslS(1SG, N0NdRslSA1SG
Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy.
HIV medicine 2015

Polivka L, Peytavin G, Franck N, Mouthon L, Dupin N
Testing for levamisole and cocaine in hair samples for the diagnosis of levamisole-related panniculitis.
Journal of the European Academy of Dermatology and Venereology: JEADV 2015, 29, 2487–2489.

Cousien A, Tran VC, Deuffic-Burban S, Jauffret-Roustide M, Dhersin JS, Yazdanpanah Y
Dynamic modelling of hepatitis C virus transmission among people who inject drugs: a methodological review.
Journal of Viral Hepatitis 2015, 22, 213-229.

Sellier P, Maylin S, Amarsy R, Mazeron MC, Larrouy L, Haïm-Boukobza S, Lopes A, Moreno MD, Ricbourg A, Simoneau G, Magnier JD, Mercier-Delarue S, Delcey V, Evans J, Cambau E, Barranger E, Simon F, Bergmann JF
Untreated highly viraemic pregnant women from Asia or sub-Saharan Africa often transmit hepatitis B virus despite serovaccination to newborns.
Liver Int. 2015, 35, 409–416.

Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of rilpivirine in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2015, 59, 2901-2903.

Pain JB, Lê MP, Caseris M, Amiel C, Lassel L, Charpentier C, Desnoyer A, Farnoux C, Pialoux G, Descamps D, Peytavin G
Pharmacokinetics of dolutegravir in a premature neonate after HIV treatment intensification during pregnancy.
Antimicrobial Agents and Chemotherapy 2015, 59, 3660–3662.

Solis M, Meddeb M, Sueur C, Domingo-Calap P, Soulier E, Chabaud A, Perrin P, Moulin B, Bahram S, Stoll-Keller F, Caillard S, Barth H, Fafi-Kremer S, FBSG
Sequence Variation in Amplification Target Genes and Standards Influences Interlaboratory Comparison of BK Virus DNA Load Measurement.
Journal of Clinical Microbiology 2015, 53, 3842–3852.

Deuzing IP, Charpentier C, Wright DW, Matheron S, Paton J, Frentz D, van de Vijver DA, Coveney PV, Descamps D, ACH2C, Boucher CAB, Beerens N
Mutation V111I in HIV-2 reverse transcriptase increases the fitness of the nucleoside analogue-resistant K65R and Q151M viruses.
J. Virol. 2015, 89, 833–843.

Desnos-Ollivier M, Patel S, Raoux-Barbot D, Heitman J, Dromer F, FCSG
Cryptococcosis Serotypes Impact Outcome and Provide Evidence of Cryptococcus neoformans Speciation.
mBio 2015, 6, e00311.

Deuffic-Burban S, Yazdanpanah Y
Fair prices for new direct-acting antiviral agents (DAAs) to make treatment for all affordable.
Gut 2015, 64, 1190-1191.

Zoulim F, Liang TJ, Gerbes AL, Aghemo A, Deuffic-Burban S, Dusheiko G, Fried MW, Pol S, Rockstroh JK, Terrault NA, Wiktor S
Hepatitis C virus treatment in the real world: optimising treatment and access to therapies.
Gut 2015, 64, 1824-1833.

Mansiaux Y, Salez N, Lapidus N, Setbon M, Andreoletti L, Leruez-Ville M, Cauchemez S, Gougeon ML, Vely F, Schwarzinger M, Abel L, Delabre RM, Flahault A, de Lamballerie X, Carrat F
Causal analysis of H1N1pdm09 influenza infection risk in a household cohort.
Journal of Epidemiology and Community Health 2015, 69, 272-277.

Borel JC, Pelletier J, Taleux N, Briault A, Arnol N, Pison C, Tamisier R, Timsit JF, Pepin JL
Parameters recorded by software of non-invasive ventilators predict COPD exacerbation: a proof-of-concept study.
Thorax 2015, 70, 284-285.

El Maaroufi H, Goubard A, Redjoul R, Legrand P, Pautas C, Mikdame M, Doghmi K, Toma A, Maury S, Schwarzinger M, Cordonnier C
Risk factors and scoring system for predicting bacterial resistance to cefepime as used empirically in haematology wards.
BioMed Research International 2015, 2015, 945769.

Souweine B, Lautrette A, Gruson D, Canet E, Klouche K, Argaud L, Bohe J, Garrouste-Orgeas M, Mariat C, Vincent F, Cayot S, Cointault O, Lepape A, Guelon D, Darmon M, Vesin A, Caillot N, Schwebel C, Boyer A, Azoulay E, Bouadma L, Timsit JF
Ethanol lock and risk of hemodialysis catheter infection in critically ill patients. A randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1024-1032.

Bailly S, Bouadma L, Azoulay E, Orgeas MG, Adrie C, Souweine B, Schwebel C, Maubon D, Hamidfar-Roy R, Darmon M, Wolff M, Cornet M, Timsit JF
Failure of empirical systemic antifungal therapy in mechanically ventilated critically ill patients.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 1139-1146.

van Mourik MSM, Bouadma L, Bonten MJM
An old world's view on a new world's solution.
American Journal of Respiratory and Critical Care Medicine 2015, 191, 243-245.

Pahlavan G, Burdet C, Laouénan C, Guiroy F, Bouscarat F, Tosini W, Yazdanpanah Y, Bouvet E
Predictors of return rate for an HIV-positive result in a French Voluntary Counseling and Testing centre.
International journal of STD & AIDS 2015, 26, 33-36.

Dallaudière B, Larbi A, Lefere M, Perozziello A, Hauger O, Pommerie F, Fraboulet B, Jacob D
Musculoskeletal injuries in a resource-constrained environment: comparing diagnostic accuracy of on-the-spot ultrasonography and conventional radiography for bone fracture screening during the Paris-Dakar rally raid.
Acta Radiologica Open 2015, 4, 2058460115577566.

Toffart AC, Pizarro CA, Schwebel C, Sakhri L, Minet C, Duruisseaux M, Azoulay E, Moro-Sibilot D, Timsit JF
Selection criteria for intensive care unit referral of lung cancer patients: a pilot study.
European Respiratory Journal 2015, 45, 491-500.

Chauveau L, Puigdomenech I, Ayinde D, Roesch F, Porrot F, Bruni D, Visseaux B, Descamps D, Schwartz O
HIV-2 infects resting CD4+ T cells but not monocyte-derived dendritic cells.
Retrovirology 2015, 12, 2.

Orne-Gliemann J, Larmarange J, Boyer S, Iwuji C, McGrath N, Bärnighausen T, Zuma T, Dray-Spira R, Spire B, Rochat T, Lert F, Imrie J, A1TG
Addressing social issues in a universal HIV test and treat intervention trial (ANRS 12249 TasP) in South Africa: methods for appraisal.
BMC public health 2015, 15, 209.

Gaillard T, Wurtz N, Houzé S, Sriprawat K, Wangsing C, Hubert V, Lebras J, Nosten F, Briolant S, Pradines B, FNRCfIMSG
Absence of association between Plasmodium falciparum small sub-unit ribosomal RNA gene mutations and in vitro decreased susceptibility to doxycycline.
Malar. J. 2015, 14, 348.

Sartelli M, Malangoni MA, Abu-Zidan FM, Griffiths EA, Di Bella S, McFarland LV, Eltringham I, Shelat VG, Velmahos GC, Kelly CP, Khanna S, Abdelsattar ZM, Alrahmani L, Ansaloni L, Augustin G, Bala M, Barbut F, Ben-Ishay O, Bhangu A, Biffl WL, Brecher SM, Camacho-Ortiz A, Caínzos MA, Canterbury LA, Catena F, Chan S, Cherry-Bukowiec JR, Clanton J, Coccolini F, Cocuz ME, Coimbra R, Cook CH, Cui Y, Czepiel J, Das K, Demetrashvili Z, Di Carlo I, Di Saverio S, Dumitru IM, Eckert C, Eckmann C, Eiland EH, Enani MA, Faro M, Ferrada P, Forrester JD, Fraga GP, Frossard JL, Galeiras R, Ghnnam W, Gomes CA, Gorrepati V, Ahmed MH, Herzog T, Humphrey F, Kim JI, Isik A, Ivatury R, Lee YY, Juang P, Furuya-Kanamori L, Karamarkovic A, Kim PK, Kluger Y, Ko WC, LaBarbera FD, Lee JG, Leppaniemi A, Lohsiriwat V, Marwah S, Mazuski JE, Metan G, Moore EE, Moore FA, Nord CE, Ordoñez CA, Júnior GAP, Petrosillo N, Portela F, Puri BK, Ray A, Raza M, Rems M, Sakakushev BE, Sganga G, Spigaglia P, Stewart DB, Tattevin P, Timsit JF, To KB, Tranà C, Uhl W, Urbánek L, van Goor H, Vassallo A, Zahar JR, Caproli E, Viale P
WSES guidelines for management of Clostridium difficile infection in surgical patients.
World journal of emergency surgery: WJES 2015, 10,

Kutz A, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Schuetz P
Prognostic value of procalcitonin in respiratory tract infections across clinical settings.
Critical Care (London, England) 2015, 19,

Allou N, Allyn J, Snauwaert A, Welsch C, Lucet JC, Kortbaoui R, Desmard M, Augustin P, Montravers P
Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: is there any difference?.
Critical Care (London, England) 2015, 19, 845.

Minet C, Potton L, Bonadona A, Hamidfar-Roy R, Somohano CA, Lugosi M, Cartier JC, Ferretti G, Schwebel C, Timsit JF
Venous thromboembolism in the ICU: main characteristics, diagnosis and thromboprophylaxis.
Critical Care (London, England) 2015, 19,

El Khoury P, Ghislain M, Villard EF, Le Goff W, Lascoux-Combe C, Yeni P, Meyer L, Vigouroux C, Goujard C, Guerin M
Plasma cholesterol efflux capacity from human THP-1 macrophages is reduced in HIV-infected patients: impact of HAART.
Journal of Lipid Research 2015, 56, 692–702.

Timsit JF, Chemam S, Bailly S
Empiric/pre-emptive anti-Candida therapy in non-neutropenic ICU patients.
F1000prime Reports 2015, 7, 21.

Mocroft A, Lundgren JD, Ross M, Law M, Reiss P, Kirk O, Smith C, Wentworth D, Neuhaus J, Fux CA, Moranne O, Morlat P, Johnson MA, Ryom L, Dsg, RFHCC, Isg, Ssg, Esg
Development and validation of a risk score for chronic kidney disease in HIV infection using prospective cohort data from the D:A:D study.
PLoS medicine 2015, 12,

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Ng KP, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12,

Rhee SY, Blanco JL, Jordan MR, Taylor J, Lemey P, Varghese V, Hamers RL, Bertagnolio S, de Wit TFR, Aghokeng AF, Albert J, Avi R, Avila-Rios S, Bessong PO, Brooks JI, Boucher CAB, Brumme ZL, Busch MP, Bussmann H, Chaix ML, Chin BS, D'Aquin TT, De Gascun CF, Derache A, Descamps D, Deshpande AK, Djoko CF, Eshleman SH, Fleury H, Frange P, Fujisaki S, Harrigan PR, Hattori J, Holguin A, Hunt GM, Ichimura H, Kaleebu P, Katzenstein D, Kiertiburanakul S, Kim JH, Kim SS, Li Y, Lutsar I, Morris L, Ndembi N, Kee PN, Paranjape RS, Peeters M, Poljak M, Price MA, Ragonnet-Cronin ML, Reyes-Terán G, Rolland M, Sirivichayakul S, Smith DM, Soares MA, Soriano VV, Ssemwanga D, Stanojevic M, Stefani MA, Sugiura W, Sungkanuparph S, Tanuri A, Tee KK, Truong HHM, van de Vijver DAMC, Vidal N, Yang C, Yang R, Yebra G, Ioannidis JPA, Vandamme AM, Shafer RW
Correction: Geographic and Temporal Trends in the Molecular Epidemiology and Genetic Mechanisms of Transmitted HIV-1 Drug Resistance: An Individual-Patient- and Sequence-Level Meta-Analysis.
PLoS medicine 2015, 12, e1001845.

de Monteynard LA, Dray-Spira R, de Truchis P, Grabar S, Launay O, Meynard JL, Khuong-Josses MA, Gilquin J, Rey D, Simon A, Pavie J, Mahamat A, Matheron S, Costagliola D, Abgrall S, FHDoH
Later cART Initiation in Migrant Men from Sub-Saharan Africa without Advanced HIV Disease in France.
PloS One 2015, 10, e0118492.

Pereira L, Choquet C, Perozziello A, Wargon M, Juillien G, Colosi L, Hellmann R, Ranaivoson M, Casalino E
Unscheduled-return-visits after an emergency department (ED) attendance and clinical link between both visits in patients aged 75 years and over: a prospective observational study.
PloS One 2015, 10, e0123803.

Chas J, Hema A, Slama L, Kabore NF, Lescure FX, Fontaine C, Pialoux G, Sawadogo A
The Day-Hospital of the University Hospital, Bobo Dioulasso: An Example of Optimized HIV Management in Southern Burkina Faso.
PloS One 2015, 10, e0125588.

Venot M, Weis L, Clec'h C, Darmon M, Allaouchiche B, Goldgran-Tolédano D, Garrouste-Orgeas M, Adrie C, Timsit JF, Azoulay E
Acute Kidney Injury in Severe Sepsis and Septic Shock in Patients with and without Diabetes Mellitus: A Multicenter Study.
PloS One 2015, 10, e0127411.

Rodriguez C, Soulié C, Marcelin AG, Calvez V, Descamps D, Charpentier C, Flandre P, Recordon-Pinson P, Bellecave P, Pawlotsky JM, Masquelier B, AASG
HIV-1 Coreceptor Usage Assessment by Ultra-Deep Pyrosequencing and Response to Maraviroc.
PloS One 2015, 10, e0127816.

Ekouévi DK, Avettand-Fènoël V, Tchounga BK, Coffie PA, Sawadogo A, Minta D, Minga A, Eholie SP, Plantier JC, Damond F, Dabis F, Rouzioux C, IWAc
Plasma HIV-2 RNA According to CD4 Count Strata among HIV-2-Infected Adults in the IeDEA West Africa Collaboration.
PloS One 2015, 10, e0129886.

Maunoury F, Motrunich A, Palka-Santini M, Bernatchez SF, Ruckly S, Timsit JF
Cost-Effectiveness Analysis of a Transparent Antimicrobial Dressing for Managing Central Venous and Arterial Catheters in Intensive Care Units.
PloS One 2015, 10, e0130439.

Béraud G, Kazmercziak S, Beutels P, Levy-Bruhl D, Lenne X, Mielcarek N, Yazdanpanah Y, Boëlle PY, Hens N, Dervaux B
The French Connection: The First Large Population-Based Contact Survey in France Relevant for the Spread of Infectious Diseases.
PloS One 2015, 10, e0133203.

Charpentier C, Lê MP, Joly V, Visseaux B, Lariven S, Phung B, Yéni P, Yazdanpanah Y, Descamps D, Peytavin G, Landman R
Use of PCR Signal and Therapeutic Drug Monitoring in a Switch Cohort Study to Tenofovir/Emtricitabine/Rilpivirine: A W96 Follow-Up.
PloS One 2015, 10, e0134430.

Visseaux B, Charpentier C, Collin G, Bertine M, Peytavin G, Damond F, Matheron S, Lefebvre E, Brun-Vézinet F, Descamps D, ACH2C
Cenicriviroc, a Novel CCR5 (R5) and CCR2 Antagonist, Shows In Vitro Activity against R5 Tropic HIV-2 Clinical Isolates.
PloS One 2015, 10, e0134904.

Philippart F, Bouroche G, Timsit JF, Garrouste-Orgeas M, Azoulay E, Darmon M, Adrie C, Allaouchiche B, Ara-Somohano C, Ruckly S, Dumenil AS, Souweine B, Goldgran-Toledano D, Bouadma L, Misset B, Osg
Decreased Risk of Ventilator-Associated Pneumonia in Sepsis Due to Intra-Abdominal Infection.
PloS One 2015, 10, e0137262.

Dubert M, Pourbaix A, Alkhoder S, Mabileau G, Lescure FX, Ghodhbane W, Belorgey S, Rioux C, Armand-Lefèvre L, Wolff M, Raffoul R, Nataf P, Yazdanpanah Y, Lucet JC
Sternal Wound Infection after Cardiac Surgery: Management and Outcome.
PloS One 2015, 10, e0139122.

Lefebvre A, Bertrand X, Vanhems P, Lucet JC, Chavanet P, Astruc K, Thouverez M, Quantin C, Aho-Glélé LS
Detection of Temporal Clusters of Healthcare-Associated Infections or Colonizations with Pseudomonas aeruginosa in Two Hospitals: Comparison of SaTScan and WHONET Software Packages.
PloS One 2015, 10, e0139920.

Raben D, Mocroft A, Rayment M, Mitsura VM, Hadziosmanovic V, Sthoeger ZM, Palfreeman A, Morris S, Kutsyna G, Vassilenko A, Minton J, Necsoi C, Estrada VP, Grzeszczuk A, Johansson VS, Begovac J, Ong ELC, Cabié A, Ajana F, Celesia BM, Maltez F, Kitchen M, Comi L, Dragsted UB, Clumeck N, Gatell J, Gazzard B, d'Arminio Monforte A, Rockstroh J, Yazdanpanah Y, Champenois K, Jakobsen ML, Sullivan A, Lundgren JD, HASG
Auditing HIV Testing Rates across Europe: Results from the HIDES 2 Study.
PloS One 2015, 10, e0140845.

Fung M, Kim J, Marty FM, Schwarzinger M, Koo S
Meta-Analysis and Cost Comparison of Empirical versus Pre-Emptive Antifungal Strategies in Hematologic Malignancy Patients with High-Risk Febrile Neutropenia.
PloS One 2015, 10, e0140930.

Bonnal C, Leleu C, Brugière O, Chochillon C, Porcher R, Boelle PY, Menotti J, Houze S, Lucet JC, Derouin F
Relationship between Fungal Colonisation of the Respiratory Tract in Lung Transplant Recipients and Fungal Contamination of the Hospital Environment.
PloS One 2015, 10, e0144044.

Potard V, Reynes J, Ferry T, Aubin C, Finkielsztejn L, Yazdanpanah Y, Costagliola D, FAC
Durability and Effectiveness of Maraviroc-Containing Regimens in HIV-1-Infected Individuals with Virological Failure in Routine Clinical Practice.
PloS One 2015, 10, e0144746.

Leoz M, Feyertag F, Kfutwah A, Mauclère P, Lachenal G, Damond F, De Oliveira F, Lemée V, Simon F, Robertson DL, Plantier JC
The Two-Phase Emergence of Non Pandemic HIV-1 Group O in Cameroon.
PLoS pathogens 2015, 11, e1005029.

Schuetz P, Balk R, Briel M, Kutz A, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Luyt CE, Chastre J, Tubach F, Mueller B, Lacey MJ, Ohsfeldt RL, Scheibling CM, Schneider JE
Economic evaluation of procalcitonin-guided antibiotic therapy in acute respiratory infections: a US health system perspective.
Clinical Chemistry and Laboratory Medicine 2015, 53, 583-592.

Marcellin F, Demoulin B, Spire B, Suzan-Monti M, Roux P, Protopopescu C, Sagaon-Teyssier L, Duracinsky M, Dray-Spira R, Carrieri MP, AVSG
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study).
Expert Rev Gastroenterol Hepatol 2015, 9, 701–713.

Basmaci R, Bonacorsi S, Ilharreborde B, Doit C, Lorrot M, Kahil M, Visseaux B, Houhou N, Bidet P
High respiratory virus oropharyngeal carriage rate during Kingella kingae osteoarticular infections in children.
Future Microbiology 2015, 10, 9-14.

Desgrées-du-Loû A, Pannetier J, Ravalihasy A, Gosselin A, Supervie V, Panjo H, Bajos N, Lert F, Lydié N, Dray-Spira R, PSG
Sub-Saharan African migrants living with HIV acquired after migration, France, ANRS PARCOURS study, 2012 to 2013.
Euro Surveill. 2015, 20,

LpwgiCiE, Mocroft A, Lundgren J, Antinori A, Monforte Ad, Brännström J, Bonnet F, Brockmeyer N, Casabona J, Castagna A, Costagliola D, De Wit S, Fätkenheuer G, Furrer H, Jadand C, Johnson A, Lazanas M, Leport C, Moreno S, Mussini C, Obel N, Post F, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Loano I, Torti C, Warszawski J, Wittkop L, Zangerle R, Chene G, Raben D, Kirk O
Late presentation for HIV care across Europe: update from the Collaboration of Observational HIV Epidemiological Research Europe (COHERE) study, 2010 to 2013.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2015, 20,

Maignan M, Richard A, Debaty G, Pommier P, Viglino D, Loizzo F, Timsit JF, Hanna J, Carpentier F, Danel V
Intentional Drug Poisoning Care in a Physician-manned Emergency Medical Service.
Prehospital emergency care: official journal of the National Association of EMS Physicians and the National Association of State EMS Directors 2015, 19, 224-231.

Pommier JD, Ben Lasfar N, Van Grunderbeeck N, Burdet C, Laouénan C, Rioux C, Pierre-Audigier C, Meybeck A, Choudat L, Benchikh A, Nguyen S, Bouvet E, Yeni P, Yazdanpanah Y, Joly V
Complications following intravesical bacillus Calmette-Guerin treatment for bladder cancer: a case series of 22 patients.
Infectious Diseases (London, England) 2015, 47, 725-731.

Jauréguiberry S, Thellier M, Ndour PA, Ader F, Roussel C, Sonneville R, Mayaux J, Matheron S, Angoulvant A, Wyplosz B, Rapp C, Pistone T, Lebrun-Vignes B, Kendjo E, Danis M, Houzé S, Bricaire F, Mazier D, Buffet P, Caumes E, FAWG
Delayed-Onset Hemolytic Anemia in Patients with Travel-Associated Severe Malaria Treated with Artesunate, France, 2011-2013.
Emerging Infectious Diseases 2015, 21, 804–812.

Lê MP, Mandelbrot L, Descamps D, Soulié C, Ichou H, Bourgeois-Moine A, Damond F, Lariven S, Valantin MA, Landman R, Faucher P, Tubiana R, Duro D, Meier F, Legac S, Bourse P, Mortier E, Dommergues M, Calvez V, Matheron S, Peytavin G
Pharmacokinetics, safety and efficacy of ritonavir-boosted atazanavir (300/100 mg once daily) in HIV-1-infected pregnant women.
Antiviral Therapy 2015, 20, 507-513.

Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP, ACACSG
Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.
Antiviral Therapy 2015, 20, 763-772.

Jenabian MA, Talla F, Talla P, Mbopi-Kéou FX, Charpentier C, Kane CT, Bélec L
Pitfalls of antiretroviral drug resistance genotyping of HIV-1 Group M and Group N from Cameroon by sequenced-based assays.
Nigerian Medical Journal: Journal of the Nigeria Medical Association 2015, 56, 420–424.

Dimopoulos G, Koulenti D, Tabah A, Poulakou G, Vesin A, Arvaniti K, Lathyris D, Matthaiou DK, Armaganidis A, Timsit JF
Bloodstream infections in ICU with increased resistance: epidemiology and outcomes.
Minerva Anestesiologica 2015, 81, 405-418.

Loubet P, Lescure FX, Lepage L, Kirsch M, Armand-Lefevre L, Bouadma L, Lariven S, Duval X, Yazdanpanah Y, Joly V
Endocarditis due to gram-negative bacilli at a French teaching hospital over a 6-year period: clinical characteristics and outcome.
Infectious Diseases (London, England) 2015, 47, 889-895.

Freedberg KA, Possas C, Deeks S, Ross AL, Rosettie KL, Di Mascio M, Collins C, Walensky RP, Yazdanpanah Y
The HIV Cure Research Agenda: The Role of Mathematical Modelling and Cost-Effectiveness Analysis.
Journal of Virus Eradication 2015, 1, 245-249.

 2014                                                                            

van Zanten ARH, Sztark F, Kaisers UX, Zielmann S, Felbinger TW, Sablotzki AR, De Waele JJ, Timsit JF, Honing MLH, Keh D, Vincent JL, Zazzo JF, Fijn HBM, Petit L, Preiser JC, van Horssen PJ, Hofman Z
High-protein enteral nutrition enriched with immune-modulating nutrients vs standard high-protein enteral nutrition and nosocomial infections in the ICU: a randomized clinical trial.
JAMA: the journal of the American Medical Association 2014, 312, 514-524.

Mourad A, Deuffic-Burban S, Ganne-Carrié N, Renaut-Vantroys T, Rosa I, Bouvier AM, Launoy G, Cattan S, Louvet A, Dharancy S, Trinchet JC, Yazdanpanah Y, Mathurin P
Hepatocellular carcinoma screening in patients with compensated hepatitis C virus (HCV)-related cirrhosis aware of their HCV status improves survival: A modeling approach.
Hepatology (Baltimore, Md.) 2014, 59, 1471-1481.

Boyd A, Gozlan J, Maylin S, Delaugerre C, Peytavin G, Girard PM, Zoulim F, Lacombe K
Persistent viremia in human immunodeficiency virus/hepatitis B coinfected patients undergoing long-term tenofovir: virological and clinical implications.
Hepatology (Baltimore, Md.) 2014, 60, 497–507.

Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF, Azoulay E
Year in review in Intensive Care Medicine 2013: I. Acute kidney injury, ultrasound, hemodynamics, cardiac arrest, transfusion, neurocritical care, and nutrition.
Intensive Care Medicine 2014, 40, 147-159.

Azoulay E, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Timsit JF
Year in review in Intensive Care Medicine 2013: II. Sedation, invasive and noninvasive ventilation, airways, ARDS, ECMO, family satisfaction, end-of-life care, organ donation, informed consent, safety, hematological issues in critically ill patients.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 305-319.

Schnell D, Timsit JF, Darmon M, Vesin A, Goldgran-Toledano D, Dumenil AS, Garrouste-Orgeas M, Adrie C, Bouadma L, Planquette B, Cohen Y, Schwebel C, Soufir L, Jamali S, Souweine B, Azoulay E
Noninvasive mechanical ventilation in acute respiratory failure: trends in use and outcomes.
Intensive Care Medicine 2014, 40, 582-591.

Timsit JF, Citerio G, Bakker J, Bassetti M, Benoit D, Cecconi M, Curtis JR, Hernandez G, Herridge M, Jaber S, Joannidis M, Papazian L, Peters M, Singer P, Smith M, Soares M, Torres A, Vieillard-Baron A, Azoulay E
Year in review in Intensive Care Medicine 2013: III. Sepsis, infections, respiratory diseases, pediatrics.
Intensive care medicine [YEAR IN REVIEW 2013] 2014, 40, 471-483.

Lucet JC, Koulenti D, Zahar JR
Persistence of colonisation with MDRO following discharge from the ICU.
Intensive Care Medicine 2014, 40, 603-605.

Giannini A, Garrouste-Orgeas M, Latour JM
What's new in ICU visiting policies: can we continue to keep the doors closed?.
Intensive Care Medicine 2014, 40, 730-733.

de Montmollin E, Bouadma L, Gault N, Mourvillier B, Mariotte E, Chemam S, Massias L, Papy E, Tubach F, Wolff M, Sonneville R
Predictors of insufficient amikacin peak concentration in critically ill patients receiving a 25 mg/kg total body weight regimen.
Intensive Care Medicine 2014, 40, 998-1005.

Timsit JF, Harbarth S, Carlet J
De-escalation as a potential way of reducing antibiotic use and antimicrobial resistance in ICU.
Intensive Care Medicine 2014, 40, 1580-1582.

Wolff M, Mourvillier B, Sonneville R, Timsit JF
My paper 10 years later: infective endocarditis in the intensive care unit.
Intensive Care Medicine [MY PAPER 20 YEARS LATER] 2014, 40, 1843-1852.

Debaty G, Maignan M, Savary D, Koch FX, Ruckly S, Durand M, Picard J, Escallier C, Chouquer R, Santre C, Minet C, Guergour D, Hammer L, Bouvaist H, Belle L, Adrie C, Payen JF, Carpentier F, Gueugniaud PY, Danel V, Timsit JF
Impact of intra-arrest therapeutic hypothermia in outcomes of prehospital cardiac arrest: a randomized controlled trial.
Intensive Care Medicine 2014, 40, 1832-1842.

Benenson JF, Kuhn MN, Ryan PJ, Ferranti AJ, Blondin R, Shea M, Charpentier C, Thompson ME, Wrangham RW
Human males appear more prepared than females to resolve conflicts with same-sex peers.
Human Nature (Hawthorne, N.Y.) 2014, 25, 251–268.

Camara S, Zucman D, Vasse M, Goudjo A, Guillard E, Peytavin G
[Lack of bioavailability of generic lopinavir/ritonavir not prequalified by WHO marketed in Africa (Congo Brazzaville).].
Bulletin De La Societe De Pathologie Exotique (1990) 2014

Caby F, Schneider L, Blanc C, Soulié C, Tindel M, Peytavin G, Agher R, Valantin MA, Tubiana R, Wirden M, Calvez V, Marcelin AG, Katlama C
Efficacy of raltegravir switching strategies in HIV-infected patients with suppressed viraemia according to the genotypic sensitivity score.
Infection 2014, 42, 295–301.

Elsen S, Huber P, Bouillot S, Couté Y, Fournier P, Dubois Y, Timsit JF, Maurin M, Attrée I
A type III secretion negative clinical strain of Pseudomonas aeruginosa employs a two-partner secreted exolysin to induce hemorrhagic pneumonia.
Cell Host & Microbe 2014, 15, 164-176.

Rahier J, Magro F, Abreu C, Armuzzi A, Ben-Horin S, Chowers Y, Cottone M, de Ridder L, Doherty G, Ehehalt R, Esteve M, Katsanos K, Lees C, MacMahon E, Moreels T, Reinisch W, Tilg H, Tremblay L, Veereman-Wauters G, Viget N, Yazdanpanah Y, Eliakim R, Colombel J
Second European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease.
Journal of Crohn's and Colitis 2014, 8, 443-468.

Deuffic-Burban S, Mathurin P, Rosa I, Bouvier AM, Cannesson A, Mourad A, Canva V, Louvet A, Deltenre P, Boleslawski E, Truant S, Pruvot FR, Dharancy S
Impact of emerging hepatitis C virus treatments on future needs for liver transplantation in France: a modelling approach.
Digestive and Liver Disease: Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2014, 46, 157-163.

Dallaudière B, Dautry R, Preux PM, Perozziello A, Lincot J, Schouman-Claeys E, Serfaty JM
Comparison of apparent diffusion coefficient in spondylarthritis axial active inflammatory lesions and type 1 Modic changes.
European Journal of Radiology 2014, 83, 366-370.

Mandelbrot L, Berrebi A, Rouzioux C, Partisani M, Faucher P, Tubiana R, Matheron S, Bujan L, Morlat P, cPecmdpvaVcDdeg
[Reproductive options for people living with HIV: 2013 guidelines from the French expert working group].
Gynecologie, Obstetrique & Fertilite 2014, 42, 543-550.

Leporrier J, Etienne M, Chapuzet C, Peytavin G, Bord S, Borsa-Lebas F, Caron F, Plantier JC, Mourez T
Association of dolutegravir and rilpivirine, enhanced by foscarnet induction, in effective salvage antiretroviral therapy.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2014, 60, 428–430.

Mandelbrot L, Berrébi A, Matheron S, Blanche S, Tubiana R, Rouzioux C, Faucher P, Partisani M, Boyer V, Taeron C, Faye A, Bujan L, Dabis F, Warszawski J, Morlat P
[HIV and pregnancy: 2013 guidelines from the French expert working group].
Journal De Gynecologie, Obstetrique Et Biologie De La Reproduction 2014, 43, 534-548.

Carrieri MP, Lions C, Sogni P, Winnock M, Roux P, Mora M, Bonnard P, Salmon D, Dabis F, Spire B, ACHSG
Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Journal of Hepatology 2014, 60, 46–53.

Deuffic-Burban S, Schwarzinger M, Obach D, Mallet V, Pol S, Pageaux GP, Canva V, Deltenre P, Roudot-Thoraval F, Larrey D, Dhumeaux D, Mathurin P, Yazdanpanah Y
Should we await IFN-free regimens to treat HCV genotype 1 treatment-naive patients? A cost-effectiveness analysis (ANRS 95141).
Journal of Hepatology 2014, 61, 7-14.

Elliott T, Timsit JF
epic3: guidelines for preventing infections associated with the use of intravascular access devices.
The Journal of Hospital Infection 2014, 87, 182.

Krastinova E, Bani-Sadr F, Fromentin D, Goujard C, Hessamfar M, Yazdanpanah Y, Pol S, Cacoub P, Perronne C, Carrat F
Re-treatment of chronic HCV infection in HIV co-infected patients and predictors of sustained viral response.
The Journal of Infection 2014, 68, 462-466.

Lugosi M, Alberti C, Zahar JR, Garrouste M, Lemiale V, Descorps-Desclère A, Ricard JD, Goldgran-Tolédano D, Cohen Y, Schwebel C, Vésin A, Timsit JF, Azoulay E
Aspergillus in the lower respiratory tract of immunocompetent critically ill patients.
The Journal of Infection 2014, 69, 284-292.

Marc F, Esquirol C, Papy E, Longuet P, Armand-Lefevre L, Rioux C, Diamantis S, Dumortier C, Bourgeois-Nicolaos N, Lucet JC, Wolff M, Arnaud P
A retrospective study of daptomycin use in a Paris teaching-hospital.
Médecine et maladies infectieuses 2014, 44, 25-31.

Neulier C, Birgand G, Ruppé E, Armand-Lefèvre L, Lolom I, Yazdanpanah Y, Lucet JC, Andremont A
Enterobacteriaceae bacteremia: Risk factors for ESBLPE.
Médecine et maladies infectieuses 2014, 44, 32-38.

Alioua MA, Labid A, Amoura K, Bertine M, Gacemi-Kirane D, Dekhil M
Emergence of the European ST80 clone of community-associated methicillin-resistant Staphylococcus aureus as a cause of healthcare-associated infections in Eastern Algeria.
Médecine Et Maladies Infectieuses 2014, 44, 180–183.

Lepelletier D, Saliou P, Lefebvre A, Lucet JC, Grandbastien B, Bruyère F, Stahl JP, Keita-Perse O, Berthelot P, Aho S, wS
"Preoperative risk management: strategy for Staphylococcus aureus preoperative decolonization" (2013 update). French society of Hospital Hygiene.
Medecine Et Maladies Infectieuses 2014, 44, 261-267.

Flicoteaux R, Pulcini C, Carrieri P, Schwarzinger M, Leport C, Verger P
Correlates of general practitioners' recommendations to patients regarding vaccination for the 2009-2010 pandemic influenza (A/H1N1) in France: implications for future vaccination campaigns.
Vaccine 2014, 32, 2281-2287.

Clotet B, Feinberg J, van Lunzen J, Khuong-Josses MA, Antinori A, Dumitru I, Pokrovskiy V, Fehr J, Ortiz R, Saag M, Harris J, Brennan C, Fujiwara T, Min S, IST
Once-daily dolutegravir versus darunavir plus ritonavir in antiretroviral-naive adults with HIV-1 infection (FLAMINGO): 48 week results from the randomised open-label phase 3b study.
Lancet 2014, 383, 2222–2231.

Raffi F, Babiker AG, Richert L, Molina JM, George EC, Antinori A, Arribas JR, Grarup J, Hudson F, Schwimmer C, Saillard J, Wallet C, Jansson PO, Allavena C, Van Leeuwen R, Delfraissy JF, Vella S, Chêne G, Pozniak A, NSG
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet 2014, 384, 1942–1951.

Matheron S, Baize S, Lerat I, Houhou N, Yazdanpanah Y
Ebola: should we consider influenza vaccination?.
Lancet (London, England) 2014, 384, 2023-2024.

Zahar JR, Lucet JC, Timsit JF
Antimicrobial resistance in intensive care units.
The Lancet. Infectious Diseases 2014, 14, 3-5.

Guerrier G, D'Ortenzio E
Africa: Ebola virus control needs local buy-in.
Nature 2014, 513, 315.

Landman R, Sharma J, Sur M, Desimone R
Effect of distracting faces on visual selective attention in the monkey.
Proceedings of the National Academy of Sciences of the United States of America 2014

Rosenthal E, Piroth L, Cua E, Joulié A, Ravaux I, Chauveau M, Lacombe K, Cotte L, Bonnard P, Weiss L, Longuet M, Pradier C, Cacoub P, GSG
Preexposure prophylaxis (PrEP) of HIV infection in France: a nationwide cross-sectional study (PREVIC study).
AIDS care 2014, 26, 176–185.

Birgand G, Schwarzinger M, Perozziello A, Lolom I, Pelat C, Armand-Lefevre L, Buzzi JC, Andremont A, Yazdanpanah Y, Lucet JC
Prolonged hospital stay, an adverse effect of strict national policy for controlling the spread of highly resistant microorganisms.
Infection Control and Hospital Epidemiology 2014, 35, 1427-1429.

Loubet P, Charpentier C, Visseaux B, Nuta C, Adu E, Chapplain JM, Baysah M, Walters-Doe S, Tattevin P, Peytavin G, Yazdanpanah Y, Descamps D
Short communication: Prevalence of HIV-1 transmitted drug resistance in Liberia.
AIDS research and human retroviruses 2014, 30, 863-866.

Soares M, Toffart AC, Timsit JF, Burghi G, Irrazábal C, Pattison N, Tobar E, Almeida BFC, Silva UVA, Azevedo LCP, Rabbat A, Lamer C, Parrot A, Souza-Dantas VC, Wallet F, Blot F, Bourdin G, Piras C, Delemazure J, Durand M, Tejera D, Salluh JIF, Azoulay E, LCiCC(SI
Intensive care in patients with lung cancer: a multinational study.
Annals of Oncology: Official Journal of the European Society for Medical Oncology 2014, 25, 1829-1835.

Aghokeng AF, Monleau M, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Toni TD, Touré-Kane C, Truong LXT, Delaporte E, Chaix ML, Peeters M, Ayouba A, A1SG
Extraordinary heterogeneity of virological outcomes in patients receiving highly antiretroviral therapy and monitored with the World Health Organization public health approach in sub-saharan Africa and southeast Asia.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 99–109.

Engsig FN, Zangerle R, Katsarou O, Dabis F, Reiss P, Gill J, Porter K, Sabin C, Riordan A, Fätkenheuer G, Gutiérrez F, Raffi F, Kirk O, Mary-Krause M, Stephan C, de Olalla PG, Guest J, Samji H, Castagna A, d'Arminio Monforte A, Skaletz-Rorowski A, Ramos J, Lapadula G, Mussini C, Force L, Meyer L, Lampe F, Boufassa F, Bucher HC, De Wit S, Burkholder GA, Teira R, Justice AC, Sterling TR, M Crane H, Gerstoft J, Grarup J, May M, Chêne G, Ingle SM, Sterne J, Obel N, ATCC(CatCoOHERE(iE
Long-term mortality in HIV-positive individuals virally suppressed for \textgreater3 years with incomplete CD4 recovery.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1312–1321.

Obach D, Deuffic-Burban S, Esmat G, Anwar WA, Dewedar S, Canva V, Cousien A, Doss W, Mostafa A, Pol S, Buti M, Siebert U, Fontanet A, Mohamed MK, Yazdanpanah Y
Effectiveness and cost-effectiveness of immediate versus delayed treatment of hepatitis C virus-infected patients in a country with limited resources: the case of Egypt.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1064-1071.

Ghosn J, Leruez-Ville M, Blanche J, Delobelle A, Beaudoux C, Mascard L, Lecuyer H, Canestri A, Landman R, Zucman D, Ponscarme D, Rami A, Viard JP, Spire B, Rouzioux C, Costagliola D, Suzan-Monti M, EE4SG
HIV-1 DNA levels in peripheral blood mononuclear cells and cannabis use are associated with intermittent HIV shedding in semen of men who have sex with men on successful antiretroviral regimens.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 58, 1763–1770.

Marcellin F, Roux P, Loko MA, Lions C, Caumont-Prim A, Dabis F, Salmon-Ceron D, Spire B, Carrieri MP, H(CSG
High levels of alcohol consumption increase the risk of advanced hepatic fibrosis in HIV/hepatitis C virus-coinfected patients: a sex-based analysis using transient elastography at enrollment in the HEPAVIH ANRS CO13 cohort.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2014, 59, 1190–1192.

Izzedine H, Lescure FX, Bonnet F
HIV medication-based urolithiasis.
Clinical Kidney Journal 2014, 7, 121-126.

Mirabel M, Sonneville R, Hajage D, Novy E, Tubach F, Vignon P, Perez P, Lavoue S, Kouatchet A, Pajot O, Mekontso-Dessap A, Tonnelier JM, Bollaert PE, Frat JP, Navellou JC, Hyvernat H, Hssain AA, Timsit JF, Megarbane B, Wolff M, Trouillet JL, ftESG
Long-term outcomes and cardiac surgery in critically ill patients with infective endocarditis.
European Heart Journal 2014, 35, 1195-1204.

Mary-Krause M, Grabar S, Lièvre L, Abgrall S, Billaud E, Boué F, Boyer L, Cabié A, Cotte L, De Truchis P, Duval X, Duvivier C, Enel P, Gasnault J, Gaud C, Gilquin J, Guiguet M, Katlama C, Khuong-Josses MA, Lacombe JM, Lang S, Lascaux AS, Launay O, Mahamat A, Matheron S, Meynard JL, Pavie J, Pilorgé F, Piroth L, Poizot-Martin I, Potard V, Pradier C, Reynes J, Rouveix E, Selinger-Leneman H, Simon A, Tattevin P, Tissot-Dupont H, Viard JP, Viget N, Costagliola D
Cohort Profile: French hospital database on HIV (FHDH-ANRS CO4).
International Journal of Epidemiology 2014, 43, 1425-1436.

Lambert-Niclot S, Charpentier C, Storto A, Fofana D, Soulie C, Fourati S, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Rilpivirine, emtricitabine and tenofovir resistance in HIV-1-infected rilpivirine-naive patients failing antiretroviral therapy.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1086–1089.

Katlama C, Assoumou L, Valantin MA, Soulié C, Duvivier C, Chablais L, Kolta S, Pialoux G, Mercié P, Simon A, Costagliola D, Peytavin G, Marcelin AG, RA1SG
Maraviroc plus raltegravir failed to maintain virological suppression in HIV-infected patients with lipohypertrophy: results from the ROCnRAL ANRS 157 study.
The Journal of Antimicrobial Chemotherapy 2014, 69, 1648–1652.

Charpentier C, Joly V, Ghosn J, Yeni P, Raffi F, Descamps D, Morand-Joubert L
Change in HIV-1 DNA tropism despite virological success in patients receiving an enfuvirtide-based regimen.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2588–2590.

Burdet C, Lepeule R, Duval X, Caseris M, Rioux C, Lucet JC, Yazdanpanah Y
Quinolones versus macrolides in the treatment of legionellosis: a systematic review and meta-analysis.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2354-2360.

Charpentier C, Choquet M, Joly V, Yeni P, Visseaux B, Caseris M, Brun-Vézinet F, Yazdanpanah Y, Peytavin G, Descamps D, Landman R
Virological outcome at week 48 of three recommended first-line regimens using ultrasensitive viral load and plasma drug assay.
The Journal of Antimicrobial Chemotherapy 2014, 69, 2819-2825.

Soulie C, Descamps D, Grudé M, Schneider V, Trabaud MA, Morand-Joubert L, Delaugerre C, Montes B, Barin F, Ferre V, Raymond S, Jeulin H, Alloui C, Yerly S, Pallier C, Reigadas S, Signori-Schmuck A, Guigon A, Fafi-Kremer S, Haïm-Boukobza S, Mirand A, Maillard A, Vallet S, Roussel C, Assoumou L, Calvez V, Flandre P, Marcelin AG, obotARAG
Antiretroviral-naive and -treated HIV-1 patients can harbour more resistant viruses in CSF than in plasma.
The Journal of Antimicrobial Chemotherapy 2014

Chumpitazi BFF, Lebeau B, Faure-Cognet O, Hamidfar-Roy R, Timsit JF, Pavese P, Thiebaut-Bertrand A, Quesada JL, Pelloux H, Pinel C
Characteristic and clinical relevance of Candida mannan test in the diagnosis of probable invasive candidiasis.
Medical Mycology 2014, 52, 462-471.

Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, Laouénan C, Montravers P
Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*.
Critical Care Medicine 2014, 42, 1150-1156.

Garrouste-Orgeas M, Ben-Rehouma M, Darmon M, Ruckly S, Clec'h C, Adrie C, Tabah A, Vesin A, Schwebel C, Misset B, Timsit JF
ICU physician-based determinants of life-sustaining therapy during nights and weekends: French multicenter study from the Outcomerea Research Group.
Critical Care Medicine 2014, 42, 2393-2400.

Aupiais C, Faye A, Le Chenadec J, Rouzioux C, Bouallag N, Laurent C, Blanche S, Dollfus C, Warszawski J, AECFPC
Interruption of cART in clinical practice is associated with an increase in the long-term risk of subsequent immunosuppression in HIV-1-infected children.
The Pediatric Infectious Disease Journal 2014, 33, 1237–1245.

Zucman D, Camara S, Gravisse J, Dimi S, Vasse M, Goudjo A, Choquet M, Peytavin G
Generic antiretroviral drugs in developing countries: friends or foes?.
AIDS (London, England) 2014, 28, 607–609.

NHPWGftCoOHERE(iE
Factors associated with short-term changes in HIV viral load and CD4(+) cell count in antiretroviral-naive individuals.
AIDS (London, England) 2014, 28, 1351–1356.

Charpentier C, Eholié S, Anglaret X, Bertine M, Rouzioux C, Avettand-Fenoël V, Messou E, Minga A, Damond F, Plantier JC, Dabis F, Peytavin G, Brun-Vézinet F, Ekouevi DK, IWAC
Genotypic resistance profiles of HIV-2-treated patients in West Africa.
AIDS (London, England) 2014, 28, 1161–1169.

Yazdanpanah Y, Champenois K
Assessing characteristics of hidden epidemics to design the most efficient HIV testing strategies.
AIDS (London, England) 2014, 28, 1831-1833.

Visseaux B, Charpentier C, Rouard C, Fagard C, Glohi D, Tubiana R, Damond F, Brun-Vézinet F, Matheron S, Descamps D, FH2ACC
HIV-2 X4 tropism is associated with lower CD4+ cell count in treatment-experienced patients.
AIDS (London, England) 2014, 28, 2160–2162.

Nguyen LBL, Harent S, Peytavin G, Visseaux B, Bastard JP, Dubourg O, Lariven S, Patrick Yeni n, Yazdanpanah Y, Lescure FX
Skeletal muscle toxicity associated with emtricitabine/rilpivirine/tenofovir fixed-dose combination: a case report.
AIDS (London, England) 2014, 28, 1995-1997.

Ouattara EN, Ross EL, Yazdanpanah Y, Wong AY, Robine M, Losina E, Moh R, Walensky RP, Danel C, Paltiel AD, Eholié SP, Freedberg KA, Anglaret X
Clinical impact and cost-effectiveness of making third-line antiretroviral therapy available in sub-Saharan Africa: a model-based analysis in Côte d'Ivoire.
Journal of Acquired Immune Deficiency Syndromes (1999) 2014, 66, 294-302.

Darmon M, Pichon M, Schwebel C, Ruckly S, Adrie C, Haouache H, Azoulay E, Bouadma L, Clec'h C, Garrouste-Orgeas M, Souweine B, Goldgran-Toledano D, Khallel H, Argaud L, Dumenil AS, Jamali S, Allaouchiche B, Zeni F, Timsit JF
Influence of early dysnatremia correction on survival of critically ill patients.
Shock (Augusta, Ga.) 2014, 41, 394-399.

Barbut F, Surgers L, Eckert C, Visseaux B, Cuingnet M, Mesquita C, Pradier N, Thiriez A, Ait-Ammar N, Aifaoui A, Grandsire E, Lalande V
Does a rapid diagnosis of Clostridium difficile infection impact on quality of patient management?.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, 136–144.

Caseris M, Houhou N, Longuet P, Rioux C, Lepeule R, Choquet C, Yazdanpanah Y, Yeni P, Joly V
French 2010-2011 measles outbreak in adults: report from a Parisian teaching hospital.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O242-244.

Vironneau P, Kania R, Morizot G, Elie C, Garcia-Hermoso D, Herman P, Lortholary O, Lanternier F, FMSG
Local control of rhino-orbito-cerebral mucormycosis dramatically impacts survival.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O336–339.

Birgand G, Armand-Lefevre L, Lepainteur M, Lolom I, Neulier C, Reibel F, Yazdanpanah Y, Andremont A, Lucet JC
Introduction of highly resistant bacteria into a hospital via patients repatriated or recently hospitalized in a foreign country.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases [RESEARCH NOTE] 2014, 20, O887-890.

Gagneux-Brunon A, Timsit JF, Lepape A, Berthelot P
Vascular catheter-related infection claims to health insurance company: often preventable.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2014, 20, O1084-1087.

Almudimeegh A, Rioux C, Ferrand H, Crickx B, Yazdanpanah Y, Descamps V
Drug reaction with eosinophilia and systemic symptoms, or virus reactivation with eosinophilia and systemic symptoms as a manifestation of immune reconstitution inflammatory syndrome in a patient with HIV?.
The British Journal of Dermatology [CASE REPORT] 2014, 171, 895-898.

Borel JC, Pepin JL, Pison C, Vesin A, Gonzalez-Bermejo J, Court-Fortune I, Timsit JF
Long-term adherence with non-invasive ventilation improves prognosis in obese COPD patients.
Respirology (Carlton, Vic.) 2014, 19, 857-865.

Cottrell G, Musset L, Hubert V, Le Bras J, Clain J, APTFSG
Emergence of resistance to atovaquone-proguanil in malaria parasites: insights from computational modeling and clinical case reports.
Antimicrobial Agents and Chemotherapy 2014, 58, 4504–4514.

Laouénan C, Marcellin P, Lapalus M, Khelifa-Mouri F, Boyer N, Zoulim F, Serfaty L, Bronowicki JP, Martinot-Peignoux M, Lada O, Asselah T, Dorival C, Hézode C, Carrat F, Nicot F, Peytavin G, Mentré F, Guedj J
Using pharmacokinetic and viral kinetic modeling to estimate the antiviral effectiveness of telaprevir, boceprevir, and pegylated interferon during triple therapy in treatment-experienced hepatitis C virus-infected cirrhotic patients.
Antimicrobial Agents and Chemotherapy 2014, 58, 5332-5341.

Mandelbrot L, Duro D, Belissa E, Peytavin G
Placental transfer of darunavir in an ex vivo human cotyledon perfusion model.
Antimicrobial Agents and Chemotherapy 2014, 58, 5617-5620.

Avettand-Fenoel V, Damond F, Gueudin M, Matheron S, Mélard A, Collin G, Descamps D, Chaix ML, Rouzioux C, Plantier JC, ACH2atAAQWG
New sensitive one-step real-time duplex PCR method for group A and B HIV-2 RNA load.
Journal of Clinical Microbiology 2014, 52, 3017–3022.

Rouet F, Kania D, Tuaillon E, Maiga A, Nouhin J, Rouzioux C, Descamps D, Plantier JC
Use of reverse transcription-PCR-based assays for quantification of HIV-1 in dried blood spots requires specific HIV-1 RNA isolation for monitoring of antiretroviral treatment efficiency.
Journal of Clinical Microbiology 2014, 52, 2740–2741.

Monleau M, Aghokeng AF, Eymard-Duvernay S, Dagnra A, Kania D, Ngo-Giang-Huong N, Touré-Kane C, Truong LXT, Chaix ML, Delaporte E, Ayouba A, Peeters M, A1SG
Field evaluation of dried blood spots for routine HIV-1 viral load and drug resistance monitoring in patients receiving antiretroviral therapy in Africa and Asia.
Journal of Clinical Microbiology 2014, 52, 578–586.

Moulignier A, Lescure FX, Savatovsky J, Campa P
CD8 transverse myelitis in a patient with HIV-1 infection.
BMJ case reports 2014, 2014,

Birgand G, Azevedo C, Toupet G, Pissard-Gibollet R, Grandbastien B, Fleury E, Lucet JC
Attitudes, risk of infection and behaviours in the operating room (the ARIBO Project): a prospective, cross-sectional study.
BMJ open 2014, 4, e004274.

Pépin JL, Timsit JF, Tamisier R, Lévy P
Is CPAP effective in reducing blood pressure in minimally symptomatic obstructive sleep apnoea?.
Thorax [Editorial] 2014, 69, 1068-1070.

Borel JC, Pison C, Timsit JF, Pepin JL
Domiciliary long-term non-invasive ventilation in COPD: should we select subgroups with a better likelihood to respond to NIV in subsequent randomised controlled trials?.
Thorax 2014, 69, 1143.

Fassa AA, Mazighi M, Himbert D, Deschamps L, Ducrocq G, Cheong AP, Depoix JP, Dilly MP, Alkhoder S, Mourvillier B, Vahanian A
Successful endovascular stroke rescue with retrieval of an embolized calcium fragment after transcatheter aortic valve replacement.
Circulation. Cardiovascular Interventions 2014, 7, 125-126.

Nordell AD, McKenna M, Borges ÁH, Duprez D, Neuhaus J, Neaton JD, INSIGHT SMART ESG, SSC
Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
Journal of the American Heart Association 2014

Puntillo KA, Max A, Timsit JF, Vignoud L, Chanques G, Robleda G, Roche-Campo F, Mancebo J, Divatia JV, Soares M, Ionescu DC, Grintescu I, Vasiliu IL, Maggiore SM, Rusinova K, Owczuk R, Egerod I, Papathanassoglou EDE, Kyranou M, Joynt GM, Burghi G, Freebairn RC, Ho KM, Kaarlola A, Gerritsen RT, Kesecioglu J, Sulaj MMS, Norrenberg M, Benoit DD, Seha MSG, Hennein A, Periera FJ, Benbenishty JS, Abroug F, Aquilina A, Monte JRC, An Y, Azoulay E
Determinants of Procedural Pain Intensity in the Intensive Care Unit The Europain (R) Study.
American Journal of Respiratory and Critical Care Medicine 2014, 189, 39-47.

Abgrall S, Fugon L, Lélé N, Carde E, Bentata M, Patey O, Khuong MA, Spire B, Bouchaud O, Carrieri P, AVsg
Risk factors for adherence failure in HIV-infected sub-Saharan migrants living in France and travelling back to their native country.
Int J STD AIDS 2014, 25, 389–390.

Weiss E, Timsit JF
Management of invasive candidiasis in nonneutropenic ICU patients.
Therapeutic Advances in Infectious Disease 2014, 2, 105-115.

Cousien A, Obach D, Deuffic-Burban S, Mostafa A, Esmat G, Canva V, El Kassas M, El-Sayed M, Anwar WA, Fontanet A, Mohamed MK, Yazdanpanah Y
Is expert opinion reliable when estimating transition probabilities? The case of HCV-related cirrhosis in Egypt.
BMC medical research methodology 2014, 14, 39.

Timsit JF, Soubirou JF, Voiriot G, Chemam S, Neuville M, Mourvillier B, Sonneville R, Mariotte E, Bouadma L, Wolff M
Treatment of bloodstream infections in ICUs.
BMC infectious diseases 2014, 14, 489.

Toffart AC, Moro-Sibilot D, Couraud S, Merle P, Perol M, Girard N, Souquet PJ, Mastroianni B, Ferretti GR, Romand P, Chatellain P, Vesin A, Brambilla E, Brambilla C, Timsit JF
Evaluation of RECIST in chemotherapy-treated lung cancer: the Pharmacogenoscan Study.
Bmc Cancer 2014, 14, 989.

N'Diaye DS, Schwarzinger M, Obach D, Poissy J, Matheron S, Casalino E, Yazdanpanah Y
Effectiveness and cost of quick diagnostic tests to determine tetanus immunity in patients with a wound in French emergency departments.
BMC infectious diseases 2014, 14, 603.

Ferraretto X, Estellat C, Damond F, Longuet P, Epelboin S, Demailly P, Yazbeck C, Llabador MA, Pasquet B, Yazdanpanah Y, Matheron S, Patrat C
Timing of intermittent seminal HIV-1 RNA shedding in patients with undetectable plasma viral load under combination antiretroviral therapy.
PloS One 2014, 9, e88922.

N'Diaye DS, Yazdanpanah Y, Krivine A, Andrieu T, Rozenberg F, Picone O, Tsatsaris V, Goffinet F, Launay O
Predictive factors of cytomegalovirus seropositivity among pregnant women in Paris, France.
PloS One 2014, 9, e89857.

Borges AH, O'Connor JL, Phillips AN, Baker JV, Vjecha MJ, Losso MH, Klinker H, Lopardo G, Williams I, Lundgren JD, ISSG, ESG, SSC
Factors associated with D-dimer levels in HIV-infected individuals.
PloS One 2014, 9, e90978.

Casalino E, Choquet C, Leleu A, Hellmann R, Wargon M, Juillien G, Yazdanpanah Y, Bouvet E
Trends in Condom Use and Risk Behaviours after Sexual Exposure to HIV: A Seven-Year Observational Study.
PloS One 2014, 9, e104350.

Garrouste-Orgeas M, Périer A, Mouricou P, Grégoire C, Bruel C, Brochon S, Philippart F, Max A, Misset B
Writing in and reading ICU diaries: qualitative study of families' experience in the ICU.
PloS One 2014, 9, e110146.

Tolsma V, Schwebel C, Azoulay E, Darmon M, Souweine B, Vesin A, Goldgran-Toledano D, Lugosi M, Jamali S, Cheval C, Adrie C, Kallel H, Descorps-Declere A, Garrouste-Orgeas M, Bouadma L, Timsit JF
Sepsis severe or septic shock: outcome according to immune status and immunodeficiency profile.
Chest 2014, 146, 1205-1213.

Yin DE, Warshaw MG, Miller WC, Castro H, Fiscus SA, Harper LM, Harrison LJ, Klein NJ, Lewis J, Melvin AJ, Tudor-Williams G, McKinney RE, P1(93ST
Using CD4 percentage and age to optimize pediatric antiretroviral therapy initiation.
Pediatrics 2014, 134, e1104–1116.

Darmon M, Clec'h C, Adrie C, Argaud L, Allaouchiche B, Azoulay E, Bouadma L, Garrouste-Orgeas M, Haouache H, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Souweine B, Zeni F, Cohen Y, Timsit JF
Acute respiratory distress syndrome and risk of AKI among critically ill patients.
Clinical journal of the American Society of Nephrology: CJASN 2014, 9, 1347-1353.

Soubirou JF, Gault N, Alfaiate T, Lolom I, Tubach F, Andremont A, Lucet JC, Wolff M, Barbier F
Ventilator-associated pneumonia due to carbapenem-resistant Gram-negative bacilli in an intensive care unit without carbapenemase-producing Enterobacteriaceae or epidemic Acinetobacter baumannii.
Scandinavian Journal of Infectious Diseases 2014, 46, 215-220.

Landman R, Koulla-Shiro S, Sow PS, Ngolle M, Diallo MB, Guèye NFN, Le Moing V, Eymard-Duvernay S, Benalycherif A, Charpentier C, Peytavin G, Delaporte E, Girard PM, DSG
Evaluation of four tenofovir-containing regimens as first-line treatments in Cameroon and Senegal: the ANRS 12115 DAYANA Trial.
Antiviral Therapy 2014, 19, 51–59.

Reliquet V, Chirouze C, Allavena C, Muret P, Peytavin G, André-Garnier E, Bettinger D, Ferré V, Hoen B, Raffi F
Nevirapine-raltegravir combination, an NRTI and PI/r sparing regimen, as maintenance antiretroviral therapy in virologically suppressed HIV-1-infected patients.
Antiviral Therapy 2014, 19, 117–123.

Wohl DA, Orkin C, Doroana M, Pilotto JH, Sungkanuparph S, Yeni P, Vanveggel S, Deckx H, Boven K
Change in vitamin D levels and risk of severe vitamin D deficiency over 48 weeks among HIV-1-infected, treatment-naive adults receiving rilpivirine or efavirenz in a Phase III trial (ECHO).
Antiviral Therapy 2014, 19, 191–200.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Yeni P, Strohmaier KM, Rodgers A, Barnard RJ, Nguyen BYT, Teppler H, tBST
Association between first-year virological response to raltegravir and long-term outcomes in treatment-experienced patients with HIV-1 infection.
Antiviral Therapy 2014

Borel AL, Schwebel C, Planquette B, Vésin A, Garrouste-Orgeas M, Adrie C, Clec'h C, Azoulay E, Souweine B, Allaouchiche B, Goldgran-Toledano D, Jamali S, Darmon M, Timsit JF
Initiation of nutritional support is delayed in critically ill obese patients: a multicenter cohort study.
The American Journal of Clinical Nutrition 2014, 100, 859-866.

Ruppe E, Armand-Lefevre L, Estellat C, El-Mniai A, Boussadia Y, Consigny P, Girard P, Vittecoq D, Bouchaud O, Pialoux G, Esposito-Farese M, Coignard B, Lucet J, Andremont A, Matheron S
Acquisition of carbapenemase-producing Enterobacteriaceae by healthy travellers to India, France, February 2012 to March 2013.
Euro surveillance: bulletin Européen sur les maladies transmissibles = European communicable disease bulletin 2014, 19,

Poletto C, Pelat C, Levy-Bruhl D, Yazdanpanah Y, Boelle P, Colizza V
Assessment of the Middle East respiratory syndrome coronavirus (MERS-CoV) epidemic in the Middle East and risk of international spread using a novel maximum likelihood analysis approach.
Euro Surveillance: Bulletin Européen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2014, 19,

Sellier P, Schnepf N, Amarsy R, Maylin S, Coutellier M, Lopes A, Mazeron MC, Flateau C, Morgand M, Ciraru-Vigneron N, Berthe A, Ricbourg A, Dolores-Moreno AM, Simoneau G, Evans J, Souak S, Matheron S, Mouly S, Benifla JL, Simon F, Bergmann JF
Hepatitis B virus (HBV) status of children born to HIV/HBV co-infected women in a French hospital: a cross-sectional study.
Journal of the International AIDS Society 2014, 17, 19632.

Marcelin AG, Charpentier C, Wirden M, Descamps D, Calvez V
Less frequent follow-up in routine care than in trials does not impact resistance selection in patients failing DRV/r or ATV/r first line treatment.
Journal of the International AIDS Society 2014, 17, 19744.

Yeni P
[HIV infection. Screening, broadcast treatment and prevention of infection are now linked ].
La Revue Du Praticien 2014, 64, 1057–1059.

 2013                                                                            

Mourvillier B, Tubach F, van de Beek D, Garot D, Pichon N, Georges H, Lefevre LM, Bollaert PE, Boulain T, Luis D, Cariou A, Girardie P, Chelha R, Megarbane B, Delahaye A, Chalumeau-Lemoine L, Legriel S, Beuret P, Brivet F, Bruel C, Camou F, Chatellier D, Chillet P, Clair B, Constantin JM, Duguet A, Galliot R, Bayle F, Hyvernat H, Ouchenir K, Plantefeve G, Quenot JP, Richecoeur J, Schwebel C, Sirodot M, Esposito-Farèse M, Le Tulzo Y, Wolff M
Induced hypothermia in severe bacterial meningitis: a randomized clinical trial.
JAMA 2013, 310, 2174-2183.

Steff M, Joly V, Di Lucca J, Feldman J, Burg S, Sarda-Mantel L, Peytavin G, Marinho E, Crickx B, Raymond E, Lariven S, Maubec E
Clinical activity of lenalidomide in visceral human immunodeficiency virus-related Kaposi sarcoma.
JAMA dermatology 2013, 149, 1319-1322.

Demaret J, Walencik A, Jacob MC, Timsit JF, Venet F, Lepape A, Monneret G
Inter-laboratory assessment of flow cytometric monocyte HLA-DR expression in clinical samples.
Cytometry. Part B, Clinical Cytometry 2013, 84, 59-62.

Schuetz P, Müller B, Christ-Crain M, Stolz D, Tamm M, Bouadma L, Luyt CE, Wolff M, Chastre J, Tubach F, Kristoffersen KB, Burkhardt O, Welte T, Schroeder S, Nobre V, Wei L, Bhatnagar N, Bucher HC, Briel M
Procalcitonin to initiate or discontinue antibiotics in acute respiratory tract infections.
Evidence-Based Child Health: A Cochrane Review Journal 2013, 8, 1297-1371.

Ghosn J, Slama L, Chermak A, Houssaini A, Lambert-Niclot S, Schneider L, Fourn E, Duvivier C, Simon A, Courbon E, Murphy R, Flandre P, Peytavin G, Katlama C, RSG
Switching to darunavir/ritonavir 800/100 mg once-daily containing regimen maintains virological control in fully suppressed pre-treated patients infected with HIV-1.
Journal of Medical Virology 2013, 85, 8-15.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.
Intensive Care Medicine 2013, 39, 232-246.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012. II: Pneumonia and infection, sepsis, coagulation, hemodynamics, cardiovascular and microcirculation, critical care organization, imaging, ethics and legal issues.
Intensive Care Medicine 2013, 39, 345-364.

Antonelli M, Bonten M, Cecconi M, Chastre J, Citerio G, Conti G, Curtis JR, Hedenstierna G, Joannidis M, Macrae D, Maggiore SM, Mancebo J, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2012: III. Noninvasive ventilation, monitoring and patient-ventilator interactions, acute respiratory distress syndrome, sedation, paediatrics and miscellanea.
Intensive Care Medicine 2013, 39, 543-557.

Potton L, Bonadona A, Minet C, Timsit JF
Pink urine.
Intensive Care Medicine 2013, 39, 389-390.

Vesin A, Azoulay E, Ruckly S, Vignoud L, Rusinovà K, Benoit D, Soares M, Azeivedo-Maia P, Abroug F, Benbenishty J, Timsit JF
Reporting and handling missing values in clinical studies in intensive care units.
Intensive Care Medicine 2013, 39, 1396-1404.

Thiolliere F, Serre-Sapin AF, Reignier J, Benedit M, Constantin JM, Lebert C, Guélon D, Timsit JF, Souweine B
Epidemiology and outcome of thrombocytopenic patients in the intensive care unit: results of a prospective multicenter study.
Intensive Care Medicine 2013, 39, 1460-1468.

Philippart F, Vesin A, Bruel C, Kpodji A, Durand-Gasselin B, Garçon P, Levy-Soussan M, Jagot JL, Calvo-Verjat N, Timsit JF, Misset B, Garrouste-Orgeas M
The ETHICA study (part I): elderly's thoughts about intensive care unit admission for life-sustaining treatments.
Intensive Care Medicine 2013, 39, 1565-1573.

Garrouste-Orgeas M, Tabah A, Vesin A, Philippart F, Kpodji A, Bruel C, Grégoire C, Max A, Timsit JF, Misset B
The ETHICA study (part II): simulation study of determinants and variability of ICU physician decisions in patients aged 80 or over.
Intensive Care Medicine 2013, 39, 1574-1583.

Garrouste-Orgeas M, Valentin A
What's new for patient safety in the ICU?.
Intensive Care Medicine 2013, 39, 1829-1831.

Zahar JR, Garrouste-Orgeas M, Vesin A, Schwebel C, Bonadona A, Philippart F, Ara-Somohano C, Misset B, Timsit JF
Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.
Intensive Care Medicine 2013, 39, 2153-2160.

Fagedet D, Thony F, Timsit JF, Rodiere M, Monnin-Bares V, Ferretti GR, Vesin A, Moro-Sibilot D
Endovascular treatment of malignant superior vena cava syndrome: results and predictive factors of clinical efficacy.
Cardiovascular and Interventional Radiology 2013, 36, 140-149.

Harrison L, Ananworanich J, Hamadache D, Compagnucci A, Penazzato M, Bunupuradah T, Mazza A, Ramos JT, Flynn J, Rampon O, Mellado Pena MJ, Floret D, Marczynska M, Puga A, Forcat S, Riault Y, Lallemant M, Castro H, Gibb DM, Giaquinto C, PENfToA(1TT
Adherence to antiretroviral therapy and acceptability of planned treatment interruptions in HIV-infected children.
AIDS and behavior 2013, 17, 193-202.

Moulignier A, Savatovsky J, Polivka M, Boutboul D, Depaz R, Lescure FX
CD8 T lymphocytes encephalitis mimicking brain tumor in HIV-1 infection.
Journal of Neurovirology 2013, 19, 606-609.

Prinapori R, Guinaud J, Khalil A, Lecuyer H, Gendrel D, Lortholary O, Nassif X, Viscoli C, Zahar JR
Risk associated with a systematic search of extended-spectrum β-lactamase-producing Enterobacteriaceae.
American Journal of Infection Control 2013, 41, 259-260.

Birgand G, Armand-Lefevre L, Lolom I, Ruppe E, Andremont A, Lucet JC
Duration of colonization by extended-spectrum β-lactamase-producing Enterobacteriaceae after hospital discharge.
American Journal of Infection Control 2013, 41, 443-447.

Rivard-Yazigi L, Zahar JR, Le Guillou S, Chalouhi C, Lecuyer H, Bureau C, Nassif X, Gendrel D, Abadie V
Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae carriage at admission in an infant cohort at a tertiary teaching hospital in France.
American Journal of Infection Control 2013, 41, 844-845.

Dallaudière B, Meyer P, Hummel V, Perozziello A, Peuchant A, Moreau-Durieux MH, Silvestre A, Pelé E, Wakim N, Loriaut P, Boyer P, Schouman-Claeys E, Serfaty JM, Pesquer L
Efficacy of second intra-tendinous platelet-rich-plasma injection in case of incomplete response of the first injection: three-year follow up experience.
Diagnostic and Interventional Imaging 2013, 94, 871-877.

Dallaudière B, Lempicki M, Pesquer L, Louedec L, Preux PM, Meyer P, Hess A, Durieux MHM, Hummel V, Larbi A, Deschamps L, Benayoun Y, Journe C, Perozziello A, Schouman-Claeys E, Michel JB, Serfaty JM
Acceleration of tendon healing using US guided intratendinous injection of bevacizumab: first pre-clinical study on a murine model.
European Journal of Radiology 2013, 82, e823-828.

Marcelin AG, Delaugerre C, Beaudoux C, Descamps D, Morand-Joubert L, Amiel C, Schneider V, Ferre V, Izopet J, Si-Mohamed A, Maillard A, Henquell C, Desbois D, Lazrek M, Signori-Schmuck A, Rogez S, Yerly S, Trabaud MA, Plantier JC, Fourati S, Houssaini A, Masquelier B, Calvez V, Flandre P, AARG
A cohort study of treatment-experienced HIV-1-infected patients treated with raltegravir: factors associated with virological response and mutations selected at failure.
International Journal of Antimicrobial Agents 2013, 42, 42-47.

Chousterman BG, Bouadma L, Moutereau S, Loric S, Alvarez-Gonzalez A, Mekontso-Dessap A, Laissy JP, Rahmouni A, Katsahian S, Brochard L, Schortgen F
Prevention of contrast-induced nephropathy by N-acetylcysteine in critically ill patients: different definitions, different results.
Journal of Critical Care 2013, 28, 701-709.

Visseaux B, Larrouy L, Calin R, Katlama C, Poynard T, Ratziu V, Thibault V
Anti-hepatitis C virus antibody detection in oral fluid: influence of human immunodeficiency virus co-infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 385-390.

Delarue S, Didier E, Damond F, Ponscarme D, Brengle-Pesce K, Resche-Rigon M, Vray M, Gueudin M, Simon F
Highly sensitive plasma RNA quantification by real-time PCR in HIV-2 group A and group B infection.
Journal of Clinical Virology: The Official Publication of the Pan American Society for Clinical Virology 2013, 58, 461-467.

Deuffic-Burban S, Yazdanpanah Y
Mathematical modeling: a tool for selecting agents with complementary modes of action?.
Journal of Hepatology 2013, 59, 1346-1348.

Lepelletier D, Lucet JC
Controlling meticillin-susceptible Staphylococcus aureus: not simply meticillin-resistant S. aureus revisited.
The Journal of Hospital Infection 2013, 84, 13-21.

Goulenok T, Ferroni A, Bille E, Lécuyer H, Join-Lambert O, Descamps P, Nassif X, Zahar JR
Risk factors for developing ESBL E. coli: can clinicians predict infection in patients with prior colonization?.
The Journal of Hospital Infection 2013, 84, 294-299.

Denneman L, Vial-Dupuy A, Gault N, Wolff M, van de Beek D, Mourvillier B
Repeated lumbar puncture in adults with pneumococcal meningitis: an observational study.
The Journal of Infection 2013, 67, 350-353.

Chakvetadze C, Bani-Sadr F, Lescure FX, Fontaine C, Le Pendeven C, Bonnard P, Mariot P, Soussan P, Pialoux G
Liver stiffness values in HIV-infected patients with isolated anti-hepatitis B core antibodies.
Medecine Et Maladies Infectieuses 2013, 43, 222-225.

FSfHH(, Lucet JC, Parneix P, Grandbastien B, Berthelot P
Should public reporting be made for performance indicators on healthcare-associated infections?.
Medecine Et Maladies Infectieuses 2013, 43, 108-113.

Stahl JP, Salmon D, Bruneel F, Caumes E, Freymuth F, Bru JP, Morand P, Roblot F, Schmit JL, Strady C, Timsit JF, Rabaud C, I
Adult patients hospitalized for measles in France, in the 21st century.
Medecine Et Maladies Infectieuses 2013, 43, 410-416.

Novy E, Sonneville R, Mazighi M, Klein IF, Mariotte E, Mourvillier B, Bouadma L, Wolff M
Neurological complications of infective endocarditis: new breakthroughs in diagnosis and management.
Medecine Et Maladies Infectieuses 2013, 43, 443-450.

Vaznaisiene D, Beltrand E, Laiskonis AP, Yazdanpanah Y, Migaud H, Senneville E
Major amputation of lower extremity: prognostic value of positive bone biopsy cultures.
Orthopaedics & traumatology, surgery & research: OTSR 2013, 99, 88-93.

Frank T, Gody JC, Nguyen LBL, Berthet N, Le Fleche-Mateos A, Bata P, Rafaï C, Kazanji M, Breurec S
First case of Elizabethkingia anophelis meningitis in the Central African Republic.
Lancet (London, England) 2013, 381, 1876.

Eron JJ, Cooper DA, Steigbigel RT, Clotet B, Gatell JM, Kumar PN, Rockstroh JK, Schechter M, Markowitz M, Yeni P, Loutfy MR, Lazzarin A, Lennox JL, Strohmaier KM, Wan H, Barnard RJO, Nguyen BYT, Teppler H, BST
Efficacy and safety of raltegravir for treatment of HIV for 5 years in the BENCHMRK studies: final results of two randomised, placebo-controlled trials.
The Lancet. Infectious Diseases 2013, 13, 587-596.

Andremont A, Lucet JC
Extensively resistant VIM-2-positive Pseudomonas aeruginosa.
The Lancet. Infectious Diseases 2013, 13, 828-829.

Kebe K, Thiam M, Diagne Gueye NR, Diop H, Dia A, Signate Sy H, Charpentier C, Belec L, Mboup S, Toure Kane C
High rate of antiretroviral drug resistance mutations in HIV type 1-infected Senegalese children in virological failure on first-line treatment according to the World Health Organization guidelines.
AIDS research and human retroviruses 2013, 29, 242-249.

Jin J, Limburg S, Joshi SK, Landman R, Park M, Zhang Q, Kim HT, Kuo AC
Peripheral nerve repair in rats using composite hydrogel-filled aligned nanofiber conduits with incorporated nerve growth factor.
Tissue Engineering. Part A 2013, 19, 2138-2146.

Chaix ML, Seng R, Frange P, Tran L, Avettand-Fenoël V, Ghosn J, Reynes J, Yazdanpanah Y, Raffi F, Goujard C, Rouzioux C, Meyer L, APCSG
Increasing HIV-1 non-B subtype primary infections in patients in France and effect of HIV subtypes on virological and immunological responses to combined antiretroviral therapy.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 880-887.

Charpentier C, Camacho R, Ruelle J, Kaiser R, Eberle J, Gürtler L, Pironti A, Stürmer M, Brun-Vézinet F, Descamps D, Obermeier M
HIV-2EU: supporting standardized HIV-2 drug resistance interpretation in Europe.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 56, 1654-1658.

Lescure FX, Moulignier A, Savatovsky J, Amiel C, Carcelain G, Molina JM, Gallien S, Pacanovski J, Pialoux G, Adle-Biassette H, Gray F
CD8 encephalitis in HIV-infected patients receiving cART: a treatable entity.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 101-108.

Briand N, Warszawski J, Mandelbrot L, Dollfus C, Pannier E, Cravello L, Nguyen R, Matheron I, Winer N, Tubiana R, Rouzioux C, Faye A, Blanche S, AECCSG
Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era?.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 903-914.

Tubiana R, Mandelbrot L, Le Chenadec J, Delmas S, Rouzioux C, Hirt D, Treluyer JM, Ekoukou D, Bui E, Chaix ML, Blanche S, Warszawski J, A1P(IMESG
Lopinavir/ritonavir monotherapy as a nucleoside analogue-sparing strategy to prevent HIV-1 mother-to-child transmission: the ANRS 135 PRIMEVA phase 2/3 randomized trial.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 891-902.

Mocroft A, Furrer HJ, Miro JM, Reiss P, Mussini C, Kirk O, Abgrall S, Ayayi S, Bartmeyer B, Braun D, Castagna A, d'Arminio Monforte A, Gazzard B, Gutierrez F, Hurtado I, Jansen K, Meyer L, Muñoz P, Obel N, Soler-Palacin P, Papadopoulos A, Raffi F, Ramos JT, Rockstroh JK, Salmon D, Torti C, Warszawski J, de Wit S, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Lundgren JD, OIWGobotCoOHERE(siE
The incidence of AIDS-defining illnesses at a current CD4 count ≥ 200 cells/μL in the post-combination antiretroviral therapy era.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2013, 57, 1038-1047.

Birgand G, Radu C, Alkhoder S, Al Attar N, Raffoul R, Dilly MP, Nataf P, Lucet JC
Does a gentamicin-impregnated collagen sponge reduce sternal wound infections in high-risk cardiac surgery patients?.
Interactive Cardiovascular and Thoracic Surgery 2013, 16, 134-141.

PLTOI(IPTotCoOHERE(, Costagliola D, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Perez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chêne G, Grarup J, Phillips A, Lodwick R, Torti C, Dorrucci M, Günthard HF, Michalik C, Chrysos G, Castagna A
Predictors of CD4(+) T-cell counts of HIV type 1-infected persons after virologic failure of all 3 original antiretroviral drug classes.
The Journal of Infectious Diseases 2013, 207, 759-767.

Tang MW, Rhee SY, Bertagnolio S, Ford N, Holmes S, Sigaloff KC, Hamers RL, de Wit TFR, Fleury HJ, Kanki PJ, Ruxrungtham K, Hawkins CA, Wallis CL, Stevens W, van Zyl GU, Manosuthi W, Hosseinipour MC, Ngo-Giang-Huong N, Belec L, Peeters M, Aghokeng A, Bunupuradah T, Burda S, Cane P, Cappelli G, Charpentier C, Dagnra AY, Deshpande AK, El-Katib Z, Eshleman SH, Fokam J, Gody JC, Katzenstein D, Koyalta DD, Kumwenda JJ, Lallemant M, Lynen L, Marconi VC, Margot NA, Moussa S, Ndung'u T, Nyambi PN, Orrell C, Schapiro JM, Schuurman R, Sirivichayakul S, Smith D, Zolfo M, Jordan MR, Shafer RW
Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine.
The Journal of Infectious Diseases 2013, 207 Suppl 2, S70-77.

Lê MP, Stitou H, Soulie C, Katlama C, Peytavin G
Sialolithiasis in an HIV-1-infected patient treated with atazanavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2013, 68, 727-729.

Charpentier C, Joly V, Larrouy L, Fagard C, Visseaux B, de Verdière NC, Raffi F, Yeni P, Descamps D, A1ATSG
Role and evolution of viral tropism in patients with advanced HIV disease receiving intensified initial regimen in the ANRS 130 APOLLO trial.
The Journal of Antimicrobial Chemotherapy 2013, 68, 690-696.

Reigadas S, Marcelin AG, Houssaïni A, Yerly S, Descamps D, Plantier JC, Ruffault A, Amiel C, Trabaud MA, Flandre P, Fleury H, Masquelier B, AARSG
HIV-1 integrase variability and relationship with drug resistance in antiretroviral-naive and -experienced patients with different HIV-1 subtypes.
The Journal of Antimicrobial Chemotherapy 2013, 68, 969-972.

Lê MP, Gervais A, Le Beller C, Long K, Larrouy L, Papy E, Mal H, Descamps D, Peytavin G
Serious neuropsychiatric adverse effects in a hepatitis C virus/hepatitis B virus/HIV-coinfected patient receiving bosentan and telaprevir.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1208-1209.

Lambert-Niclot S, Charpentier C, Storto A, Fofana DB, Soulié C, Fourati S, Visseaux B, Wirden M, Morand-Joubert L, Masquelier B, Flandre P, Calvez V, Descamps D, Marcelin AG
Prevalence of pre-existing resistance-associated mutations to rilpivirine, emtricitabine and tenofovir in antiretroviral-naive patients infected with B and non-B subtype HIV-1 viruses.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1237-1242.

Assoumou L, Descamps D, Yerly S, Dos Santos G, Marcelin AG, Delaugerre C, Morand-Joubert L, Ruffault A, Izopet J, Plantier JC, Pakianather S, Montes B, Chaix ML, Wirden M, Costagliola D, Masquelier B, AARG
Prevalence of HIV-1 drug resistance in treated patients with viral load >50 copies/mL in 2009: a French nationwide study.
The Journal of Antimicrobial Chemotherapy 2013, 68, 1400-1405.

Charpentier C, Lambert-Niclot S, Visseaux B, Morand-Joubert L, Storto A, Larrouy L, Landman R, Calvez V, Marcelin AG, Descamps D
Evolution of the K65R, K103N and M184V/I reverse transcriptase mutations in HIV-1-infected patients experiencing virological failure between 2005 and 2010.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2197-2198.

Fourati S, Visseaux B, Armenia D, Morand-Joubert L, Artese A, Charpentier C, Van Den Eede P, Costa G, Alcaro S, Wirden M, Perno CF, Ceccherini Silberstein F, Descamps D, Calvez V, Marcelin AG
Identification of a rare mutation at reverse transcriptase Lys65 (K65E) in HIV-1-infected patients failing on nucleos(t)ide reverse transcriptase inhibitors.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2199-2204.

Descamps D, Assoumou L, Chaix ML, Chaillon A, Pakianather S, de Rougemont A, Storto A, Dos Santos G, Krivine A, Delaugerre C, Montes B, Izopet J, Charpentier C, Wirden M, Maillard A, Morand-Joubert L, Pallier C, Plantier JC, Guinard J, Tamalet C, Cottalorda J, Marcelin AG, Desbois D, Henquell C, Calvez V, Brun-Vézinet F, Masquelier B, Costagliola D, AARSG
National sentinel surveillance of transmitted drug resistance in antiretroviral-naive chronically HIV-infected patients in France over a decade: 2001-2011.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2626-2631.

Todesco E, Sayon S, Fourati S, Tubiana R, Simon A, Ktorza N, Schneider L, Peytavin G, Malet I, Van den Eede P, Katlama C, Calvez V, Marcelin AG, Wirden M
Highly multidrug-resistant HIV: clonal analysis and therapeutic strategies.
The Journal of Antimicrobial Chemotherapy 2013, 68, 2882-2889.

Antonini TM, Furlan V, Teicher E, Haim-Boukobza S, Sebagh M, Coilly A, Bonhomme-Faivre L, Peytavin G, Roque-Afonso AM, Vittecoq D, Samuel D, Taburet AM, Duclos-Vallée JC
Successful anti-hepatitis C virus therapy with telaprevir in an HIV/hepatitis C virus co-infected patient with a severe recurrence of hepatitis C virus infection on the liver graft.
AIDS (London, England) 2013, 27, 2655-2657.

Timsit JF, Laupland KB
Is the burden of severe sepsis and septic shock changing?.
Critical Care Medicine 2013, 41, 1361-1363.

Schwebel C, Clec'h C, Magne S, Minet C, Garrouste-Orgeas M, Bonadona A, Dumenil AS, Jamali S, Kallel H, Goldgran-Toledano D, Marcotte G, Azoulay E, Darmon M, Ruckly S, Souweine B, Timsit JF
Safety of Intrahospital Transport in Ventilated Critically Ill Patients: A Multicenter Cohort Study.
Critical Care Medicine 2013, 41, 1919-1928.

Barbier F, Andremont A, Wolff M, Bouadma L
Hospital-acquired pneumonia and ventilator-associated pneumonia: recent advances in epidemiology and management.
Current Opinion in Pulmonary Medicine 2013, 19, 216-228.

Charpentier C, Bertine M, Visseaux B, Leleu J, Larrouy L, Peytavin G, Mourez T, Collin G, Brun-Vézinet F, Plantier JC, Descamps D
In-vitro phenotypic susceptibility of HIV-1 'non-B' integrase inhibitors naive clinical isolates to dolutegravir and raltegravir.
AIDS (London, England) 2013, 27, 2959-2961.

Zetterberg E, Neuhaus J, Baker JV, Somboonwit C, Llibre JM, Palfreeman A, Chini M, Lundgren JD, ISSG
Platelet count kinetics following interruption of antiretroviral treatment.
AIDS (London, England) 2013, 27, 59-68.

Larrouy L, Vivot A, Charpentier C, Bénard A, Visseaux B, Damond F, Matheron S, Chene G, Brun-Vezinet F, Descamps D, ACH2C
Impact of gag genetic determinants on virological outcome to boosted lopinavir-containing regimen in HIV-2-infected patients.
AIDS (London, England) 2013, 27, 69-80.

Visseaux B, Charpentier C, Taieb A, Damond F, Bénard A, Larrouy L, Chêne G, Brun-Vézinet F, Matheron S, Descamps D, ACH2C
Concordance between HIV-2 genotypic coreceptor tropism predictions based on plasma RNA and proviral DNA.
AIDS (London, England) 2013, 27, 292-295.

Bunupuradah T, Duong T, Compagnucci A, McMaster P, Bernardi S, Kanjanavanit S, Rampon O, Faye A, Saïdi Y, Riault Y, De Rossi A, Klein N, Ananworanich J, Gibb D, P1ESG
Outcomes after reinitiating antiretroviral therapy in children randomized to planned treatment interruptions.
AIDS (London, England) 2013, 27, 579-589.

Lacombe JM, Boue F, Grabar S, Viget N, Gazaignes S, Lascaux-Cametz AS, Pacanowski J, Partisani M, Launay O, Matheron S, Rosenthal E, Rouveix E, Tattevin P, de Truchis P, Costagliola D, Goedert JJ
Risk of Kaposi sarcoma during the first months on combination antiretroviral therapy.
AIDS (London, England) 2013, 27, 635-643.

Stellbrink HJ, Reynes J, Lazzarin A, Voronin E, Pulido F, Felizarta F, Almond S, St Clair M, Flack N, Min S, S1T
Dolutegravir in antiretroviral-naive adults with HIV-1: 96-week results from a randomized dose-ranging study.
AIDS (London, England) 2013, 27, 1771-1778.

Charpentier C, Visseaux B, Bénard A, Peytavin G, Damond F, Roy C, Taieb A, Chêne G, Matheron S, Brun-Vézinet F, Descamps D, ACH2C
Transmitted drug resistance in French HIV-2-infected patients.
AIDS 2013, 27, 1671–1674.

Leoz M, Feyertag F, Charpentier C, Delaugerre C, Wirden M, Lemee V, Plantier JC
Characterization of CRF56_cpx, a new circulating B/CRF02/G recombinant form identified in MSM in France.
AIDS (London, England) 2013, 27, 2309-2312.

Cuzin L, Allavena C, Pugliese P, Rey D, Hoen B, Poizot-Martin I, Cabie A, Yazdanpanah Y, DSG
Can the "seek, test, treat, and retain" strategy be effective in France?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, e119-121.

Descours B, Lambert-Niclot S, Mory B, Samri A, Charlotte F, Peytavin G, Tubiana R, Papagno L, Bacchus C, Lecardonnel F, Katlama C, Autran B, Marcelin AG, Valantin MA, Carcelain G, DaOSG
Direct quantification of cell-associated HIV DNA in isolated rectal and blood memory CD4 T cells revealed their similar and low infection levels in long-term treated HIV-infected patients.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 62, 255-259.

Rockstroh JK, DeJesus E, Lennox JL, Yazdanpanah Y, Saag MS, Wan H, Rodgers AJ, Walker ML, Miller M, DiNubile MJ, Nguyen BY, Teppler H, Leavitt R, Sklar P, SI
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK.
Journal of acquired immune deficiency syndromes (1999) 2013, 63, 77-85.

Semaille C, Barin F, Bouyssou A, Peytavin G, Guinard J, Le Vu S, Pillonel J, Spire B, Velter A
High viral loads among HIV-positive MSM attending gay venues: implications for HIV transmission.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, e122-124.

Cotte L, Dellamonica P, Raffi F, Yazdanpanah Y, Molina JM, Boué F, Urata Y, Chan HP, Zhu L, Chang I, Bertz R, Hanna GJ, Grasela DM, Hwang C
Randomized placebo-controlled study of the safety, tolerability, antiviral activity, and pharmacokinetics of 10-day monotherapy with BMS-986001, a novel HIV NRTI, in treatment-experienced HIV-1-infected subjects.
Journal of Acquired Immune Deficiency Syndromes (1999) 2013, 63, 346-354.

de Montmollin E, Tandjaoui-Lambiotte Y, Legrand M, Lambert J, Mokart D, Kouatchet A, Lemiale V, Pène F, Bruneel F, Vincent F, Mayaux J, Chevret S, Azoulay E
Outcomes in critically ill cancer patients with septic shock of pulmonary origin.
Shock (Augusta, Ga.) 2013, 39, 250-254.

Gray F, Lescure FX, Adle-Biassette H, Polivka M, Gallien S, Pialoux G, Moulignier A
Encephalitis with infiltration by CD8+ lymphocytes in HIV patients receiving combination antiretroviral treatment.
Brain Pathology (Zurich, Switzerland) 2013, 23, 525-533.

Murat JB, Lebeau B, Chumpitazi B, Cornet M, Maubon D, Faure O, Quesada JL, Thiebaut-Bertrand A, Timsit JF, Pelloux H
Minimum inhibitory concentrations of amphotericin B against Candida krusei isolates from a French teaching hospital laboratory: a retrospective study over 8 years.
Mycoses 2013, 56, 56-60.

Nguyen HL, Charpentier C, Nguyen N, de Truchis P, Molina JM, Ruxrungtham K, Delaugerre C
Longitudinal analysis of integrase N155H variants in heavily treated patients failing raltegravir-based regimens.
HIV medicine 2013, 14, 85-91.

Baroux N, Rouchon B, Huon B, Germain A, Meunier JM, D'Ortenzio E
High prevalence of rheumatic heart disease in schoolchildren detected by echocardiography screening in New Caledonia.
Journal of Paediatrics and Child Health 2013, 49, 109-114.

Hatzakis A, Van Damme P, Alcorn K, Gore C, Benazzouz M, Berkane S, Buti M, Carballo M, Cortes Martins H, Deuffic-Burban S, Dominguez A, Donoghoe M, Elzouki AN, Ben-Alaya Bouafif N, Esmat G, Esteban R, Fabri M, Fenton K, Goldberg D, Goulis I, Hadjichristodoulou C, Hadjichristodoulou T, Hatzigeorgiou T, Hamouda O, Hasurdjiev S, Hughes S, Kautz A, Malik M, Manolakopoulos S, Matičič M, Papatheodoridis G, Peck R, Peterle A, Potamitis G, Prati D, Roudot-Thoraval F, Reic T, Sharara A, Shennak M, Shiha G, Shouval D, Sočan M, Thomas H, Thursz M, Tosti M, Trépo C, Vince A, Vounou E, Wiessing L, Manns M
The state of hepatitis B and C in the Mediterranean and Balkan countries: report from a summit conference.
Journal of Viral Hepatitis 2013, 20 Suppl 2, 1-20.

Bertrand D, Pallet N, Sartorius A, Zahar JR, Soussan RS, Lortholary O, Legendre C, Mamzer MF
Clinical and microbial impact of screening kidney allograft preservative solution for bacterial contamination with high-sensitivity methods.
Transplant International: Official Journal of the European Society for Organ Transplantation 2013, 26, 795-799.

Rousseaux S, Debernardi A, Jacquiau B, Vitte AL, Vesin A, Nagy-Mignotte H, Moro-Sibilot D, Brichon PY, Lantuejoul S, Hainaut P, Laffaire J, de Reyniès A, Beer DG, Timsit JF, Brambilla C, Brambilla E, Khochbin S
Ectopic activation of germline and placental genes identifies aggressive metastasis-prone lung cancers.
Science Translational Medicine 2013, 5, 186ra66.

Barau C, Furlan V, Yazdanpanah Y, Fagard C, Molina JM, Taburet AM, Barrail-Tran A
Characterization of binding of raltegravir to plasma proteins.
Antimicrobial Agents and Chemotherapy 2013, 57, 5147-5150.

Kardas-Sloma L, Boëlle PY, Opatowski L, Guillemot D, Temime L
Antibiotic reduction campaigns do not necessarily decrease bacterial resistance: the example of methicillin-resistant Staphylococcus aureus.
Antimicrobial Agents and Chemotherapy 2013, 57, 4410-4416.

Clavel-Osorio C, Cazassus F, Stegmann S, Huc-Anaïs P, Lecam D, Peytavin G
One-month transplacental pharmacokinetics of raltegravir in a premature newborn after short-course treatment of the HIV-1-infected mother.
Antimicrobial Agents and Chemotherapy 2013, 57, 6393-6394.

Joly V, Fagard C, Grondin C, Descamps D, Yazdanpanah Y, Charpentier C, Colin de Verdiere N, Tabuteau S, Raffi F, Cabie A, Chene G, Yeni P, S1ATG
Intensification of antiretroviral therapy through addition of enfuvirtide in naive HIV-1-infected patients with severe immunosuppression does not improve immunological response: results of a randomized multicenter trial (ANRS 130 Apollo).
Antimicrobial Agents and Chemotherapy 2013, 57, 758-765.

Vinot C, Gavard L, Tréluyer JM, Manceau S, Courbon E, Scherrmann JM, Declèves X, Duro D, Peytavin G, Mandelbrot L, Giraud C
Placental transfer of maraviroc in an ex vivo human cotyledon perfusion model and influence of ABC transporter expression.
Antimicrobial Agents and Chemotherapy 2013, 57, 1415-1420.

Armand-Lefevre L, Angebault C, Barbier F, Hamelet E, Defrance G, Ruppe E, Bronchard R, Lepeule R, Lucet JC, El Mniai A, Wolff M, Montravers P, Plesiat P, Andremont A
Emergence of Imipenem-Resistant Gram-Negative Bacilli in Intestinal Flora of Intensive Care Patients.
Antimicrobial Agents and Chemotherapy 2013, 57, 1488-1495.

Recordon-Pinson P, Raymond S, Bellecave P, Marcelin AG, Soulie C, Descamps D, Calvez V, Harrigan PR, Fleury H, Izopet J, Masquelier B, SARSG
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replication.
Antimicrobial Agents and Chemotherapy 2013, 57, 930-935.

Parienti JJ, Barrail-Tran A, Duval X, Nembot G, Descamps D, Vigan M, Vrijens B, Panhard X, Taburet AM, Mentré F, Goujard C
Adherence profiles and therapeutic responses of treatment-naive HIV-infected patients starting boosted atazanavir-based therapy in the ANRS 134-COPHAR 3 trial.
Antimicrobial Agents and Chemotherapy 2013, 57, 2265-2271.

Champenois K, Cousien A, Ndiaye B, Soukouna Y, Baclet V, Alcaraz I, Choisy P, Chaud P, Velter A, Gallay A, Yazdanpanah Y
Risk factors for syphilis infection in men who have sex with men: results of a case-control study in Lille, France.
Sexually Transmitted Infections 2013, 89, 128-132.

Lorente N, Champenois K, Blanche J, Préau M, Suzan-Monti M, Mora M, Fugon L, Carrieri MP, Sagaon-Teyssier L, Le Gall JM, Spire B, Yazdanpanah Y
Investigating Recent Testing among MSM: Results from Community-Based HIV Rapid Testing Attendees in France.
Journal of Sexually Transmitted Diseases 2013, 2013, 648791.

Goulenok T, Klein I, Mazighi M, Messika-Zeitoun D, Alexandra JF, Mourvillier B, Laissy JP, Leport C, Iung B, Duval X, Isg
Infective endocarditis with symptomatic cerebral complications: contribution of cerebral magnetic resonance imaging.
Cerebrovascular Diseases (Basel, Switzerland) 2013, 35, 327-336.

Pham T, Combes A, Rozé H, Chevret S, Mercat A, Roch A, Mourvillier B, Ara-Somohano C, Bastien O, Zogheib E, Clavel M, Constan A, Marie Richard JC, Brun-Buisson C, Brochard L, RRN
Extracorporeal membrane oxygenation for pandemic influenza A(H1N1)-induced acute respiratory distress syndrome: a cohort study and propensity-matched analysis.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 276-285.

Planquette B, Timsit JF, Misset BY, Schwebel C, Azoulay E, Adrie C, Vesin A, Jamali S, Zahar JR, Allaouchiche B, Souweine B, Darmon M, Dumenil AS, Goldgran-Toledano D, Mourvillier BH, Bédos JP, OSG
Pseudomonas aeruginosa ventilator-associated pneumonia. predictive factors of treatment failure.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 69-76.

Annane D, Timsit JF, Megarbane B, Martin C, Misset B, Mourvillier B, Siami S, Chagnon JL, Constantin JM, Petitpas F, Souweine B, Amathieu R, Forceville X, Charpentier C, Tesnière A, Chastre J, Bohe J, Colin G, Cariou A, Renault A, Brun-Buisson C, Bellissant E, ATI
Recombinant human activated protein C for adults with septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2013, 187, 1091-1097.

Timsit JF, Bouadma L, Mimoz O, Parienti JJ, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Herrault MC, Schwebel C, Ruckly S, Souweine B, Lucet JC
Jugular versus femoral short-term catheterization and risk of infection in intensive care unit patients. Causal analysis of two randomized trials.
American Journal of Respiratory and Critical Care Medicine 2013, 188, 1232-1239.

Domenech de Cellès M, Zahar JR, Abadie V, Guillemot D
Limits of patient isolation measures to control extended-spectrum beta-lactamase-producing Enterobacteriaceae: model-based analysis of clinical data in a pediatric ward.
BMC infectious diseases 2013, 13, 187.

Champenois K, Cousien A, Cuzin L, Le Vu S, Deuffic-Burban S, Lanoy E, Lacombe K, Patey O, Béchu P, Calvez M, Semaille C, Yazdanpanah Y
Missed opportunities for HIV testing in newly-HIV-diagnosed patients, a cross sectional study.
BMC infectious diseases 2013, 13, 200.

Yang ZT, Zahar JR, Méchaï F, Postaire M, Blanot S, Balfagon-Viel S, Nassif X, Lortholary O
Current ciprofloxacin usage in children hospitalized in a referral hospital in Paris.
BMC infectious diseases 2013, 13, 245.

Gasse B, Baroux N, Rouchon B, Meunier JM, Frémicourt ID, D'Ortenzio E
Determinants of poor adherence to secondary antibiotic prophylaxis for rheumatic fever recurrence on Lifou, New Caledonia: a retrospective cohort study.
BMC public health 2013, 13, 131.

Gharbi M, Flegg JA, Hubert V, Kendjo E, Metcalf JE, Bertaux L, Guérin PJ, Le Bras J, MotFNRCfIMS, Aboubaca A, Agnamey P, Angoulvant A, Barbut P, Basset D, Belkadi G, Bellanger AP, Bemba D, Benoit-Vica F, Berry A, Bigel ML, Bonhomme J, Botterel F, Bouchaud O, Bougnoux ME, Bourée P, Bourgeois N, Branger C, Bret L, Buret B, Casalino E, Chevrier S, Conquere de Monbrison F, Cuisenier B, Danis M, Darde ML, De Gentile L, Delarbre JM, Delaunay P, Delaval A, Desoubeaux G, Develoux M, Dunand J, Durand R, Eloy O, Fauchet N, Faugere B, Faye A, Fenneteau O, Flori P, Fontrouge M, Garabedian C, Gayandrieu F, Godineau N, Houzé P, Houzé S, Hurst JP, Ichou H, Lachaud L, Lebuisson A, Lefevre M, LeGuern AS, Le Moal G, Lusina D, Machouart MC, Malvy D, Matheron S, Maubon D, Mechali D, Megarbane B, Menard G, Millon L, Aiach MM, Minodier P, Morelle C, Nevez G, Parola P, Parzy D, Patey O, Patoz P, Penn P, Perignon A, Picot S, Pilo JE, Poilane I, Pons D, Poupart M, Pradines B, Raffenot D, Rapp C, Receveur MC, Sarfati C, Senghor Y, Simon F, Siriez JY, Taudon N, Thellier M, Thouvenin M, Toubas D
Longitudinal study assessing the return of chloroquine susceptibility of Plasmodium falciparum in isolates from travellers returning from West and Central Africa, 2000-2011.
Malar. J. 2013, 12, 35.

Cordel H, Cailhol J, Matheron S, Bloch M, Godineau N, Consigny PH, Gros H, Campa P, Bourée P, Fain O, Ralaimazava P, Bouchaud O
Atovaquone-proguanil in the treatment of imported uncomplicated Plasmodium falciparum malaria: a prospective observational study of 553 cases.
Malaria Journal 2013, 12,

Gaillard T, Briolant S, Houzé S, Baragatti M, Wurtz N, Hubert V, Lavina M, Pascual A, Travaillé C, Le Bras J, Pradines B, FNRCfIMSG
PftetQ and pfmdt copy numbers as predictive molecular markers of decreased ex vivo doxycycline susceptibility in imported Plasmodium falciparum malaria.
Malar. J. 2013, 12, 414.

Goudet V, Timsit JF, Lucet JC, Lepape A, Balayn D, Seguin S, Mimoz O
Comparison of four skin preparation strategies to prevent catheter-related infection in intensive care unit (CLEAN trial): a study protocol for a randomized controlled trial.
Trials 2013, 14, 114.

Timsit JF, Azoulay E, Cornet M, Gangneux JP, Jullien V, Vésin A, Schir E, Wolff M
EMPIRICUS micafungin versus placebo during nosocomial sepsis in Candida multi-colonized ICU patients with multiple organ failures: study protocol for a randomized controlled trial.
Trials 2013, 14, 399.

Birgand G, Ruimy R, Schwarzinger M, Lolom I, Bendjelloul G, Houhou N, Armand-Lefevre L, Andremont A, Yazdanpanah Y, Lucet JC
Rapid detection of glycopeptide-resistant enterococci: impact on decision-making and costs.
Antimicrobial Resistance and Infection Control 2013, 2, 30.

Darmon M, Diconne E, Souweine B, Ruckly S, Adrie C, Azoulay E, Clec'h C, Garrouste-Orgeas M, Schwebel C, Goldgran-Toledano D, Khallel H, Dumenil AS, Jamali S, Cheval C, Allaouchiche B, Zeni F, Timsit JF
Prognostic consequences of borderline dysnatremia: pay attention to minimal serum sodium change.
Critical Care (London, England) 2013, 17, R12.

Perier A, Revah-Levy A, Bruel C, Cousin N, Angeli S, Brochon S, Philippart F, Max A, Gregoire C, Misset B, Garrouste-Orgeas M
Phenomenologic analysis of healthcare worker perceptions of intensive care unit diaries.
Critical Care (London, England) 2013, 17, R13.

Toffart AC, Timsit JF
Is prolonged mechanical ventilation of cancer patients futile?.
Critical Care (London, England) 2013, 17, 189.

Adrie C, Schwebel C, Garrouste-Orgeas M, Vignoud L, Planquette B, Azoulay E, Kallel H, Darmon M, Souweine B, Dinh-Xuan AT, Jamali S, Zahar JR, Timsit JF, AWWobotOSG
Initial use of one or two antibiotics for critically ill patients with community-acquired pneumonia: impact on survival and bacterial resistance.
Critical Care (London, England) 2013, 17, R265.

Niven DJ, Laupland KB, Tabah A, Vesin A, Rello J, Koulenti D, Dimopoulos G, de Waele J, Timsit JF, EI
Diagnosis and management of temperature abnormality in ICUs: a EUROBACT investigators' survey.
Critical Care (London, England) 2013, 17, R289.

Abgrall S, Le Bel J, Lele N, Laouénan C, Eychenne N, Mentré F, Peytavin G, Bouchaud O, VSG
Lack of effect of doxycycline on trough concentrations of protease inhibitors or non-nucleoside reverse transcriptase inhibitors in HIV-infected patients.
HIV clinical trials 2013, 14, 313-318.

Auvert B, Taljaard D, Rech D, Lissouba P, Singh B, Bouscaillou J, Peytavin G, Mahiane SG, Sitta R, Puren A, Lewis D
Association of the ANRS-12126 male circumcision project with HIV levels among men in a South African township: evaluation of effectiveness using cross-sectional surveys.
PLoS medicine 2013, 10, e1001509.

Mocroft A, Lundgren JD, Sabin ML, Monforte Ad, Brockmeyer N, Casabona J, Castagna A, Costagliola D, Dabis F, De Wit S, Fätkenheuer G, Furrer H, Johnson AM, Lazanas MK, Leport C, Moreno S, Obel N, Post FA, Reekie J, Reiss P, Sabin C, Skaletz-Rorowski A, Suarez-Lozano I, Torti C, Warszawski J, Zangerle R, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Kirk O, CoOHERE(siE
Risk factors and outcomes for late presentation for HIV-positive persons in Europe: results from the Collaboration of Observational HIV Epidemiological Research Europe Study (COHERE).
PLoS medicine 2013, 10, e1001510.

Tubiana S, Mikulski M, Becam J, Lacassin F, Lefèvre P, Gourinat AC, Goarant C, D'Ortenzio E
Risk factors and predictors of severe leptospirosis in New Caledonia.
PLoS neglected tropical diseases 2013, 7, e1991.

Goarant C, Bourhy P, D'Ortenzio E, Dartevelle S, Mauron C, Soupé-Gilbert ME, Bruyère-Ostells L, Gourinat AC, Picardeau M, Nato F, Chanteau S
Sensitivity and Specificity of a New Vertical Flow Rapid Diagnostic Test for the Serodiagnosis of Human Leptospirosis.
PLoS neglected tropical diseases 2013, 7, e2289.

Cordel H, Prendki V, Madec Y, Houze S, Paris L, Bourée P, Caumes E, Matheron S, Bouchaud O, ASG
Imported amoebic liver abscess in France.
PLoS neglected tropical diseases 2013

Guerrier G, Hie P, Gourinat AC, Huguon E, Polfrit Y, Goarant C, D'Ortenzio E, Missotte I
Association between age and severity to leptospirosis in children.
PLoS neglected tropical diseases 2013, 7, e2436.

Charpentier C, Fagard C, Colin C, Katlama C, Molina JM, Jacomet C, Visseaux B, Taburet AM, Brun-Vézinet F, Chêne G, Yazdanpanah Y, Descamps D, ATTsg
Role of baseline HIV-1 DNA level in highly-experienced patients receiving raltegravir, etravirine and darunavir/ritonavir regimen (ANRS139 TRIO trial).
PloS One 2013, 8, e53621.

Charpentier C, Lambert-Niclot S, Alteri C, Storto A, Flandre P, Svicher V, Perno CF, Brun-Vézinet F, Calvez V, Marcelin AG, Ceccherini-Silberstein F, Descamps D
Description of the L76V resistance protease mutation in HIV-1 B and "non-B" subtypes.
PloS One 2013

Bjerk SM, Baker JV, Emery S, Neuhaus J, Angus B, Gordin FM, Pett SL, Stephan C, Kunisaki KM, ISSG
Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
PloS One 2013

Charpentier C, Champenois K, Gervais A, Landman R, Joly V, Le Gac S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, Yazdanpanah Y
Predictive value of liver enzymes and inflammatory biomarkers for the severity of liver fibrosis stage in HIV/HCV co-infected patients.
PloS One 2013, 8, e59205.

Guerrier G, D'Ortenzio E
The Jarisch-Herxheimer reaction in leptospirosis: a systematic review.
PloS One 2013, 8, e59266.

Lécuroux C, Girault I, Chéret A, Versmisse P, Nembot G, Meyer L, Rouzioux C, Pancino G, Venet A, Sáez-Cirión A, A1Oct
CD8 T-cells from most HIV-infected patients lack ex vivo HIV-suppressive capacity during acute and early infection.
PloS One 2013

Lapidus N, de Lamballerie X, Salez N, Setbon M, Delabre RM, Ferrari P, Moyen N, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Factors associated with post-seasonal serological titer and risk factors for infection with the pandemic A/H1N1 virus in the French general population.
PloS One 2013, 8, e60127.

Bacchus C, Cheret A, Avettand-Fenoël V, Nembot G, Mélard A, Blanc C, Lascoux-Combe C, Slama L, Allegre T, Allavena C, Yazdanpanah Y, Duvivier C, Katlama C, Goujard C, Seksik BCP, Leplatois A, Molina JM, Meyer L, Autran B, Rouzioux C, OA1sg
A single HIV-1 cluster and a skewed immune homeostasis drive the early spread of HIV among resting CD4+ cell subsets within one month post-infection.
PloS One 2013, 8, e64219.

Schwarzinger M, Sagaon-Teyssier L, Cabaret O, Bretagne S, Cordonnier C, PI
Performance of serum biomarkers for the early detection of invasive aspergillosis in febrile, neutropenic patients: a multi-state model.
PloS One 2013, 8, e65776.

Birgand G, Lepelletier D, Baron G, Barrett S, Breier AC, Buke C, Markovic-Denic L, Gastmeier P, Kluytmans J, Lyytikainen O, Sheridan E, Szilagyi E, Tacconelli E, Troillet N, Ravaud P, Lucet JC
Agreement among healthcare professionals in ten European countries in diagnosing case-vignettes of surgical-site infections.
PloS One 2013, 8, e68618.

Frange P, Meyer L, Jung M, Goujard C, Zucman D, Abel S, Hochedez P, Gousset M, Gascuel O, Rouzioux C, Chaix ML, APCSG
Sexually-transmitted/founder HIV-1 cannot be directly predicted from plasma or PBMC-derived viral quasispecies in the transmitting partner.
PloS One 2013

Krastinova E, Seng R, Yeni P, Viard JP, Vittecoq D, Lascoux-Combe C, Fourn E, Pahlavan G, Delfraissy JF, Meyer L, APaCC
Is clinical practice concordant with the changes in guidelines for antiretroviral therapy initiation during primary and chronic HIV-1 infection? The ANRS PRIMO and COPANA cohorts.
PLoS ONE 2013, 8, e71473.

Legeai C, Vigouroux C, Souberbielle JC, Bouchaud O, Boufassa F, Bastard JP, Carlier R, Capeau J, Goujard C, Meyer L, Viard JP, ACCSG
Associations between 25-hydroxyvitamin D and immunologic, metabolic, inflammatory markers in treatment-naive HIV-infected persons: the ANRS CO9 «COPANA» cohort study.
PLoS ONE 2013, 8, e74868.

Houzé S, Boutron I, Marmorat A, Dalichampt M, Choquet C, Poilane I, Godineau N, Le Guern AS, Thellier M, Broutier H, Fenneteau O, Millet P, Dulucq S, Hubert V, Houzé P, Tubach F, Le Bras J, Matheron S
Performance of rapid diagnostic tests for imported malaria in clinical practice: results of a national multicenter study.
PloS One 2013

Klein N, Sefe D, Mosconi I, Zanchetta M, Castro H, Jacobsen M, Jones H, Bernardi S, Pillay D, Giaquinto C, Walker AS, Gibb DM, De Rossi A, PENfToA1TT
The immunological and virological consequences of planned treatment interruptions in children with HIV infection.
PloS One 2013

Yazdanpanah Y, Perelman J, DiLorenzo MA, Alves J, Barros H, Mateus C, Pereira J, Mansinho K, Robine M, Park JE, Ross EL, Losina E, Walensky RP, Noubary F, Freedberg KA, Paltiel AD
Routine HIV screening in Portugal: clinical impact and cost-effectiveness.
PloS One 2013, 8, e84173.

Chougrani I, Luton D, Matheron S, Mandelbrot L, Azria E
Safety of protease inhibitors in HIV-infected pregnant women.
HIV/AIDS (Auckland, N.Z.) 2013, 5, 253-262.

Zaidan M, Lescure FX, Brochériou I, Dettwiler S, Guiard-Schmid JB, Pacanowski J, Rondeau E, Pialoux G, Girard PM, Ronco P, Plaisier E
Tubulointerstitial nephropathies in HIV-infected patients over the past 15 years: a clinico-pathological study.
Clinical journal of the American Society of Nephrology: CJASN 2013, 8, 930-938.

Dervaux B, Baseilhac E, Fagon JY, portNoGWX(, Ameye V, Angot P, Audry A, Becquemont L, Borel T, Cazeneuve B, Courtois J, Detournay B, Favre P, Granger M, Josseran A, Lassale C, Louvet O, Pinson J, de Pouvourville G, Rochaix L, Rumeau-Pichon C, de Saab R, Schwarzinger M, Sun A
Medico-economic evaluation of health products in the context of the Social Security Financing Act for 2012.
Therapie 2013, 68, 253-263.

Zucman D, De Truchis P, Peytavin G, Descamps D, Duvivier C, Tegna L, Weiss L, Delassus JL, Benalycherif A, Landman R
Efficacy, safety, and pharmacokinetics of once-daily boosted darunavir in pretreated HIV-infected patients.
Scandinavian Journal of Infectious Diseases 2013, 45, 407-410.

Schnell D, Lécuyer H, Geeraerts T, Dumenil AS, Bille E, Mercier FJ, Benhamou D, Zahar JR
Preliminary evaluation of a new clinical algorithm to interpret blood cultures growing coagulase-negative staphylococci.
Scandinavian Journal of Infectious Diseases 2013, 45, 562-566.

Nguyen LBL, Epelboin L, Gabarre J, Lecso M, Guillot S, Bricaire F, Caumes E, Guiso N
Recurrent Bordetella holmesii bacteremia and nasal carriage in a patient receiving rituximab.
Emerging Infectious Diseases 2013, 19, 1703-1705.

Zahar JR, Timsit JF
Clostridium difficile outcomes difficult to generalize. Authors' response.
Critical Care (London, England) 2013, 17, 415.

 2012                                                                            

Yazdanpanah Y, Walensky RP, Rozenbaum W, Yeni P, Paltiel AD
What is a modest public health impact?.
Archives of Internal Medicine 2012, 172, 521-522; author reply 522-523.

Coeurjolly JF, Nguile-Makao M, Timsit JF, Liquet B
Attributable risk estimation for adjusted disability multistate models: application to nosocomial infections.
Biometrical Journal. Biometrische Zeitschrift 2012, 54, 600-616.

Soulié C, Charpentier C, Flandre P, Nino C, Carcelain G, Simon A, Katlama C, Landman R, Brun-Vézinet F, Descamps D, Calvez V, Marcelin AG
Natural evolution of CD4+ cell count in patients with CD4 >350 or >500  cells/mm3 at the time of diagnosis according to HIV-1 coreceptor tropism.
Journal of Medical Virology 2012, 84, 1853-1856.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: I. Nephrology, epidemiology, nutrition and therapeutics, neurology, ethical and legal issues, experimentals.
Intensive Care Medicine 2012, 38, 192-209.

Rhodes A, Moreno RP, Azoulay E, Capuzzo M, Chiche JD, Eddleston J, Endacott R, Ferdinande P, Flaatten H, Guidet B, Kuhlen R, León-Gil C, Martin Delgado MC, Metnitz PG, Soares M, Sprung CL, Timsit JF, Valentin A, TFoSaQoESoICM(
Prospectively defined indicators to improve the safety and quality of care for critically ill patients: a report from the Task Force on Safety and Quality of the European Society of Intensive Care Medicine (ESICM).
Intensive Care Medicine 2012, 38, 598-605.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011. II. Cardiovascular, infections, pneumonia and sepsis, critical care organization and outcome, education, ultrasonography, metabolism and coagulation.
Intensive Care Medicine 2012, 38, 345-358.

Antonelli M, Bonten M, Chastre J, Citerio G, Conti G, Curtis JR, De Backer D, Hedenstierna G, Joannidis M, Macrae D, Mancebo J, Maggiore SM, Mebazaa A, Preiser JC, Rocco P, Timsit JF, Wernerman J, Zhang H
Year in review in Intensive Care Medicine 2011: III. ARDS and ECMO, weaning, mechanical ventilation, noninvasive ventilation, pediatrics and miscellanea.
Intensive Care Medicine 2012, 38, 542-556.

Azoulay E, Garrouste M, Goldgran-Toledano D, Adrie C, Max A, Vesin A, Francais A, Zahar JR, Cohen Y, Allaouchiche B, Schlemmer B, Timsit JF
Increased nonbeneficial care in patients spending their birthday in the ICU.
Intensive Care Medicine 2012, 38, 1169-1176.

Timsit JF, L'Hériteau F, Lepape A, Francais A, Ruckly S, Venier AG, Jarno P, Boussat S, Coignard B, Savey A
A multicentre analysis of catheter-related infection based on a hierarchical model.
Intensive Care Medicine 2012, 38, 1662-1672.

Tabah A, Koulenti D, Laupland K, Misset B, Valles J, Bruzzi de Carvalho F, Paiva JA, Cakar N, Ma X, Eggimann P, Antonelli M, Bonten MJM, Csomos A, Krueger WA, Mikstacki A, Lipman J, Depuydt P, Vesin A, Garrouste-Orgeas M, Zahar JR, Blot S, Carlet J, Brun-Buisson C, Martin C, Rello J, Dimopoulos G, Timsit JF
Characteristics and determinants of outcome of hospital-acquired bloodstream infections in intensive care units: the EUROBACT International Cohort Study.
Intensive Care Medicine 2012, 38, 1930-1945.

Charpentier C, Piketty C, Laureillard D, Tisserand P, Si-Mohamed A, Weiss L, Bélec L
Dynamics of HIV-1 DNA level in highly antiretroviral-experienced patients receiving raltegravir-based therapy.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 129-133.

Ruppe E, Pitsch A, Tubach F, de Lastours V, Chau F, Pasquet B, Lucet JC, Andremont A, Fantin B
Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.
European Journal of Clinical Microbiology & Infectious Diseases 2012, 31, 319-325.

Diamantis S, Rioux C, Bonnal C, Farfour É, Papy E, Andremont A, Yeni P, Bouvet É, Lucet JC
Suitability of initial antibiotic therapy for the treatment of bloodstream infections and the potential role of antibiotic management teams in improving it.
European Journal of Clinical Microbiology & Infectious Diseases: Official Publication of the European Society of Clinical Microbiology 2012, 31, 1667-1671.

de Montmollin E, Corcos O, Noussair L, Leflon-Guibout V, Belmatoug N, Joly F, Lefort A
Retroperitoneal abscesses due to Nocardia farcinica: report of two cases in patients with malnutrition.
Infection 2012, 40, 93-96.

Guillet M, Zahar JR, Timsit MO, Grandin L, Carbonnelle E, Join-Lambert O, Quesne G, Nassif X, Mejean A, Carbonne A
Horizontal transmission of Streptococcus pneumoniae in the surgical ward: a rare source of nosocomial wound infection.
American Journal of Infection Control 2012, 40, 71-72.

Guet-Revillet H, Le Monnier A, Breton N, Descamps P, Lecuyer H, Alaabouche I, Bureau C, Nassif X, Zahar JR
Environmental contamination with extended-spectrum β-lactamases: is there any difference between Escherichia coli and Klebsiella spp?.
American Journal of Infection Control 2012, 40, 845-848.

Carlet J, Rambaud C, Pulcini C, lcddbm(
[Alliance against MDRO: safeguarding antibiotics].
Ann Fr Anesth Reanim 2012, 31, 704–708.

Fourati S, Malet I, Guenzel CA, Soulie C, Maidou-Peindara P, Morand-Joubert L, Wirden M, Sayon S, Peytavin G, Simon A, Katlama C, Benichou S, Calvez V, Marcelin AG
E17A mutation in HIV-1 Vpr confers resistance to didanosine in association with thymidine analog mutations.
Antiviral Research 2012, 93, 167-174.

Bourcier V, Winnock M, Ait Ahmed M, Sogni P, Pambrun E, Poizot-Martin I, Chaffaut C, Chevret S, Trinchet JC, Salmon D, ACHsg, ACCsg
Primary liver cancer is more aggressive in HIV-HCV coinfection than in HCV infection. A prospective study (ANRS CO13 Hepavih and CO12 Cirvir).
Clinics and Research in Hepatology and Gastroenterology 2012, 36, 214-221.

Ouanes I, Schwebel C, Français A, Bruel C, Philippart F, Vesin A, Soufir L, Adrie C, Garrouste-Orgeas M, Timsit JF, Misset B, OSG
A model to predict short-term death or readmission after intensive care unit discharge.
Journal of Critical Care 2012, 27, 422.e1-9.

Deuffic-Burban S, Castel H, Wiegand J, Manns MP, Wedemeyer H, Mathurin P, Yazdanpanah Y
Immediate vs. delayed treatment in patients with acute hepatitis C based on IL28B polymorphism: a model-based analysis.
Journal of Hepatology 2012, 57, 260-266.

Zahar JR, Masse V, Watier L, Lanternier F, Degand N, Postaire M, Descamps P, Nassif X, Lortholary O
Is hand-rub consumption correlated with hand hygiene and rate of extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-PE)-acquired infections?.
The Journal of Hospital Infection 2012, 80, 348-350.

Gibert P, Brudieu E, Timsit JF, Foroni L, Thiébaut-Bertrand A, Allenet B, Pelloux H, Brenier Pinchart MP
Invasive aspergillosis: drug-dispensing systems as a source of filamentous fungal contamination in high-risk units?.
The Journal of Hospital Infection 2012, 82, 293-296.

Fihman V, Le Monnier A, Corvec S, Jaureguy F, Tankovic J, Jacquier H, Carbonnelle E, Bille E, Illiaquer M, Cattoir V, Zahar JR
Stenotrophomonas maltophilia--the most worrisome threat among unusual non-fermentative gram-negative bacilli from hospitalized patients: a prospective multicenter study.
The Journal of Infection 2012, 64, 391-398.

Nagy-Mignotte H, Guillem P, Vignoud L, Coudurier M, Vesin A, Bonneterre V, Toffart AC, Sakhri L, Brambilla C, Brambilla E, Timsit JF, Moro-Sibilot D, MTOG
Outcomes in recurrent small-cell lung cancer after one to four chemotherapy lines: a retrospective study of 300 patients.
Lung Cancer (Amsterdam, Netherlands) 2012, 78, 112-120.

Renault P, Balleydier E, D'Ortenzio E, Bâville M, Filleul L
Epidemiology of Chikungunya infection on Reunion Island, Mayotte, and neighboring countries.
Medecine Et Maladies Infectieuses 2012, 42, 93-101.

Ciotti C, Pellissier G, Rabaud C, Lucet JC, Abiteboul D, Bouvet E, G
Effectiveness of respirator masks for healthcare workers, in France.
Medecine Et Maladies Infectieuses 2012, 42, 264-269.

Gros C, Yazdanpanah Y, Vachet A, Roussel-Delvallez M, Senneville E, Lemaire X
Skin and soft tissue infections due to Panton-Valentine leukocidin producing Staphylococcus aureus.
Medecine Et Maladies Infectieuses 2012, 42, 488-494.

Minet C, Vivodtzev I, Tamisier R, Arbib F, Wuyam B, Timsit JF, Monneret D, Borel JC, Baguet JP, Lévy P, Pépin JL
Reduced six-minute walking distance, high fat-free-mass index and hypercapnia are associated with endothelial dysfunction in COPD.
Respiratory Physiology & Neurobiology 2012, 183, 128-134.

Boissier F, Khalil A, Chalumeau-Lemoine L, Lescure FX, Parrot A
Rash diagnosis of blood expectoration.
Lancet (London, England) 2012, 379, 1170.

DeJesus E, Rockstroh JK, Henry K, Molina JM, Gathe J, Ramanathan S, Wei X, Yale K, Szwarcberg J, White K, Cheng AK, Kearney BP, G20ST
Co-formulated elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate versus ritonavir-boosted atazanavir plus co-formulated emtricitabine and tenofovir disoproxil fumarate for initial treatment of HIV-1 infection: a randomised, double-blind, phase 3, non-inferiority trial.
Lancet 2012, 379, 2429-2438.

PLTOI(Ipt, OHERE(G, Costagliola D, Lodwick R, Ledergerber B, Torti C, van Sighem A, Podzamczer D, Mocroft A, Dorrucci M, Masquelier B, de Luca A, Jansen K, De Wit S, Obel N, Fätkenheuer G, Touoloumi G, Mussini C, Castagna A, Stephan C, García F, Zangerle R, Duval X, Pérez-Hoyos S, Meyer L, Ghosn J, Fabre-Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Trends in virological and clinical outcomes in individuals with HIV-1 infection and virological failure of drugs from three antiretroviral drug classes: a cohort study.
The Lancet. Infectious Diseases 2012, 12, 119-127.

Savic RM, Barrail-Tran A, Duval X, Nembot G, Panhard X, Descamps D, Verstuyft C, Vrijens B, Taburet AM, Goujard C, Mentré F, A13SG
Effect of adherence as measured by MEMS, ritonavir boosting, and CYP3A5 genotype on atazanavir pharmacokinetics in treatment-naive HIV-infected patients.
Clinical Pharmacology and Therapeutics 2012, 92, 575-583.

Deuffic-Burban S, Deltenre P, Buti M, Stroffolini T, Parkes J, Mühlberger N, Siebert U, Moreno C, Hatzakis A, Rosenberg W, Zeuzem S, Mathurin P
Predicted effects of treatment for HCV infection vary among European countries.
Gastroenterology 2012, 143, 974-985.e14.

Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B, ACACSG
Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.
AIDS care 2012, 24, 434-443.

Wilkin A, Pozniak AL, Morales-Ramirez J, Lupo SH, Santoscoy M, Grinsztejn B, Ruxrungtham K, Rimsky LT, Vanveggel S, Boven K, TCSG
Long-term efficacy, safety, and tolerability of rilpivirine (RPV, TMC278) in HIV type 1-infected antiretroviral-naive patients: week 192 results from a phase IIb randomized trial.
AIDS research and human retroviruses 2012, 28, 437-446.

Péré H, Charpentier C, Mbelesso P, Dandy M, Matta M, Moussa S, De Dieu Longo J, Grésenguet G, Abraham B, Bélec L
Virological response and resistance profiles after 24 months of first-line antiretroviral treatment in adults living in Bangui, Central African Republic.
AIDS research and human retroviruses 2012, 28, 315-323.

Rozenberg S, Lanoy E, Bentata M, Viard JP, Valantin MA, Missy P, Darasteanu I, Roux C, Kolta S, Costagliola D, A1FSG
Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120).
AIDS research and human retroviruses 2012, 28, 972-980.

Monleau M, Aghokeng AF, Nkano BA, Chaix ML, Peeters M, AAWG
Drug resistance mutations of HIV type 1 non-B viruses to integrase inhibitors in treatment-naive patients from sub-saharan countries and discordant interpretations.
AIDS research and human retroviruses 2012, 28, 1157-1160.

Jacquier H, Le Monnier A, Carbonnelle E, Corvec S, Illiaquer M, Bille E, Zahar JR, Jauréguy F, Fihman V, Tankovic J, Cattoir V, GSG
In vitro antimicrobial activity of "last-resort" antibiotics against unusual nonfermenting Gram-negative bacilli clinical isolates.
Microbial Drug Resistance (Larchmont, N.Y.) 2012, 18, 396-401.

Dupont-Rouzeyrol M, Caro V, Guillaumot L, Vazeille M, D'Ortenzio E, Thiberge JM, Baroux N, Gourinat AC, Grandadam M, Failloux AB
Chikungunya virus and the mosquito vector Aedes aegypti in New Caledonia (South Pacific Region).
Vector Borne and Zoonotic Diseases (Larchmont, N.Y.) 2012, 12, 1036-1041.

Laupland KB, Zahar JR, Adrie C, Minet C, Vésin A, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Schwebel C, Jamali S, Darmon M, Dumenil AS, Kallel H, Souweine B, Timsit JF
Severe hypothermia increases the risk for intensive care unit-acquired infection.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1064-1070.

Mermond S, Zurawski V, D'Ortenzio E, Driscoll AJ, DeLuca AN, Deloria-Knoll M, Moïsi JC, Murdoch DR, Missotte I, Besson-Leaud L, Chevalier C, Debarnot V, Feray F, Noireterre S, Duparc B, Fresnais F, O'Connor O, Dupont-Rouzeyrol M, Levine OS
Lower respiratory infections among hospitalized children in New Caledonia: a pilot study for the Pneumonia Etiology Research for Child Health project.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 2, S180-189.

Rammaert B, Lanternier F, Zahar JR, Dannaoui E, Bougnoux ME, Lecuit M, Lortholary O
Healthcare-associated mucormycosis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S44-54.

Lanternier F, Dannaoui E, Morizot G, Elie C, Garcia-Hermoso D, Huerre M, Bitar D, Dromer F, Lortholary O, FMSG
A global analysis of mucormycosis in France: the RetroZygo Study (2005-2007).
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54 Suppl 1, S35-43.

Deuffic-Burban S, Yazdanpanah Y
It is time to change the paradigm for hepatitis C virus testing.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1272-1274.

HCC
Impact of antiretroviral therapy on tuberculosis incidence among HIV-positive patients in high-income countries.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 54, 1364-1372.

Wolff M, Mourvillier B
Linezolid for the treatment of nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 160-161.

Schuetz P, Briel M, Christ-Crain M, Stolz D, Bouadma L, Wolff M, Luyt CE, Chastre J, Tubach F, Kristoffersen KB, Wei L, Burkhardt O, Welte T, Schroeder S, Nobre V, Tamm M, Bhatnagar N, Bucher HC, Mueller B
Procalcitonin to guide initiation and duration of antibiotic treatment in acute respiratory infections: an individual patient data meta-analysis.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 651-662.

Thiébaut R, Charpentier C, Damond F, Taieb A, Antoine R, Capeau J, Chêne G, Collin G, Matheron S, Descamps D, Brun-Vézinet F, FAH2CC
Association of soluble CD14 and inflammatory biomarkers with HIV-2 disease progression.
Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 2012, 55, 1417-1425.

Iung B, Klein I, Mourvillier B, Olivot JM, Détaint D, Longuet P, Ruimy R, Fourchy D, Laurichesse JJ, Laissy JP, Escoubet B, Duval X, SG
Respective effects of early cerebral and abdominal magnetic resonance imaging on clinical decisions in infective endocarditis.
European Heart Journal Cardiovascular Imaging 2012, 13, 703-710.

CoOHERE(iE, Lewden C, Bouteloup V, De Wit S, Sabin C, Mocroft A, Wasmuth JC, van Sighem A, Kirk O, Obel N, Panos G, Ghosn J, Dabis F, Mary-Krause M, Leport C, Perez-Hoyos S, Sobrino-Vegas P, Stephan C, Castagna A, Antinori A, d'Arminio Monforte A, Torti C, Mussini C, Isern V, Calmy A, Teira R, Egger M, Grarup J, Chêne G
All-cause mortality in treated HIV-infected adults with CD4 ≥500/mm3 compared with the general population: evidence from a large European observational cohort collaboration.
International Journal of Epidemiology 2012, 41, 433-445.

May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JAC, ATCC(C
Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics.
International Journal of Epidemiology 2012, 41, 1807-1820.

Visseaux B, Hurtado-Nedelec M, Charpentier C, Collin G, Storto A, Matheron S, Larrouy L, Damond F, Brun-Vézinet F, Descamps D, AC0H2C
Molecular determinants of HIV-2 R5-X4 tropism in the V3 loop: development of a new genotypic tool.
The Journal of Infectious Diseases 2012, 205, 111-120.

Courbon E, Laylavoix F, Soulié C, Le Beller C, Calvez V, Katlama C, Peytavin G
Unexpected atazanavir-associated biliary lithiasis in an HIV-infected patient.
The Journal of Antimicrobial Chemotherapy 2012, 67, 250-251.

Dominguez S, Ghosn J, Cassard B, Melica G, Poizot-Martin I, Solas C, Lascaux AS, Bouvier-Alias M, Katlama C, Lévy Y, Peytavin G
Erythrocyte and plasma ribavirin concentrations in the assessment of early and sustained virological responses to pegylated interferon-alpha 2a and ribavirin in patients coinfected with hepatitis C virus and HIV.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1449-1452.

Marcelin AG, Charpentier C, Wirden M, Landman R, Valantin MA, Simon A, Katlama C, Yeni P, Descamps D, Aubron-Olivier C, Calvez V
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimens.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1475-1478.

Lambert-Niclot S, Flandre P, Valantin MA, Peytavin G, Sayon S, Morand-Joubert L, Delaugerre C, Algarte-Genin M, Katlama C, Calvez V, Marcelin AG
Resistant minority species are rarely observed in patients on darunavir/ritonavir monotherapy.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1470-1474.

Charpentier C, Larrouy L, Visseaux B, Landman R, Levittas M, Storto A, Damond F, Yazdanpanah Y, Yeni P, Brun-Vézinet F, Descamps D
Prevalence of subtype-related polymorphisms associated with in vitro resistance to attachment inhibitor BMS-626529 in HIV-1 'non-B'-infected patients.
The Journal of Antimicrobial Chemotherapy 2012, 67, 1459-1461.

Nelson M, Amaya G, Clumeck N, Arns da Cunha C, Jayaweera D, Junod P, Li T, Tebas P, Stevens M, Buelens A, Vanveggel S, Boven K, EaTSG
Efficacy and safety of rilpivirine in treatment-naive, HIV-1-infected patients with hepatitis B virus/hepatitis C virus coinfection enrolled in the Phase III randomized, double-blind ECHO and THRIVE trials.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2020-2028.

Charpentier C, Landman R, Laouénan C, Joly V, Hamet G, Damond F, Brun-Vézinet F, Mentré F, Descamps D, Yeni P
Persistent low-level HIV-1 RNA between 20 and 50 copies/mL in antiretroviral-treated patients: associated factors and virological outcome.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2231-2235.

Lambert-Niclot S, Masquelier B, Cohen Codar I, Soulie C, Delaugerre C, Morand-Joubert L, Charpentier C, Ferre V, Plantier JC, Montes B, Carret S, Perrot V, Peytavin G, Costagliola D, Calvez V, Marcelin AG, ESG
Impact of lopinavir/ritonavir use on antiretroviral resistance in recent clinical practice.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2487-2493.

Lê MP, Solas C, Garraffo R, Gagnieu MC, Muret P, Yeni P, Dhiver C, Katlama C, Poizot-Martin I, Durant J, Peytavin G
Pharmacokinetic interaction between maraviroc and etravirine in HIV-infected patients receiving regimens containing both drugs and no ritonavir-boosted protease inhibitor.
The Journal of Antimicrobial Chemotherapy 2012, 67, 2779-2781.

Lescure FX, Flateau C, Pacanowski J, Brocheriou I, Rondeau E, Girard PM, Ronco P, Pialoux G, Plaisier E
HIV-associated kidney glomerular diseases: changes with time and HAART.
Nephrology, Dialysis, Transplantation: Official Publication of the European Dialysis and Transplant Association - European Renal Association 2012, 27, 2349-2355.

Quesnel C, Piednoir P, Gelly J, Nardelli L, Garnier M, Leçon V, Lasocki S, Bouadma L, Philip I, Elbim C, Mentré F, Soler P, Crestani B, Dehoux M
Alveolar fibrocyte percentage is an independent predictor of poor outcome in patients with acute lung injury.
Critical Care Medicine 2012, 40, 21-28.

Froissart A, Buffet M, Veyradier A, Poullin P, Provôt F, Malot S, Schwarzinger M, Galicier L, Vanhille P, Vernant JP, Bordessoule D, Guidet B, Azoulay E, Mariotte E, Rondeau E, Mira JP, Wynckel A, Clabault K, Choukroun G, Presne C, Pourrat J, Hamidou M, Coppo P, FTMRC
Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Critical Care Medicine 2012, 40, 104-111.

Schwebel C, Lucet JC, Vesin A, Arrault X, Calvino-Gunther S, Bouadma L, Timsit JF
Economic evaluation of chlorhexidine-impregnated sponges for preventing catheter-related infections in critically ill adults in the Dressing Study.
Critical Care Medicine 2012, 40, 11-17.

Laupland KB, Zahar JR, Adrie C, Schwebel C, Goldgran-Toledano D, Azoulay E, Garrouste-Orgeas M, Cohen Y, Jamali S, Souweine B, Darmon M, Timsit JF
Determinants of temperature abnormalities and influence on outcome of critical illness.
Critical Care Medicine 2012, 40, 145-151.

Garrouste-Orgeas M, Soufir L, Tabah A, Schwebel C, Vesin A, Adrie C, Thuong M, Timsit JF, OSG
A multifaceted program for improving quality of care in intensive care units: IATROREF study.
Critical Care Medicine 2012, 40, 468-476.

Azoulay E, Dupont H, Tabah A, Lortholary O, Stahl JP, Francais A, Martin C, Guidet B, Timsit JF
Systemic antifungal therapy in critically ill patients without invasive fungal infection*.
Critical Care Medicine 2012, 40, 813-822.

Parienti JJ, du Cheyron D, Timsit JF, Traoré O, Kalfon P, Mimoz O, Mermel LA
Meta-analysis of subclavian insertion and nontunneled central venous catheter-associated infection risk reduction in critically ill adults.
Critical Care Medicine 2012, 40, 1627-1634.

Timsit JF, Bouadma L, Ruckly S, Schwebel C, Garrouste-Orgeas M, Bronchard R, Calvino-Gunther S, Laupland K, Adrie C, Thuong M, Herault MC, Pease S, Arrault X, Lucet JC
Dressing disruption is a major risk factor for catheter-related infections.
Crit Care Med 2012, 40, 1707-14.

Garrouste-Orgeas M, Coquet I, Périer A, Timsit JF, Pochard F, Lancrin F, Philippart F, Vesin A, Bruel C, Blel Y, Angeli S, Cousin N, Carlet J, Misset B
Impact of an intensive care unit diary on psychological distress in patients and relatives*.
Critical Care Medicine 2012, 40, 2033-2040.

Piednoir P, Quesnel C, Nardelli L, Leçon V, Bouadma L, Lasocki S, Philip I, Mailleux A, Soler P, Crestani B, Dehoux M
Alveolar fluid in acute respiratory distress syndrome promotes fibroblast migration: role of platelet-derived growth factor pathway*.
Critical Care Medicine 2012, 40, 2041-2049.

Minet C, Lugosi M, Savoye PY, Menez C, Ruckly S, Bonadona A, Schwebel C, Hamidfar-Roy R, Dumanoir P, Ara-Somohano C, Ferretti GR, Timsit JF
Pulmonary embolism in mechanically ventilated patients requiring computed tomography: Prevalence, risk factors, and outcome.
Critical Care Medicine 2012, 40, 3202-3208.

Timsit JF, Laupland KB
Update on bloodstream infections in ICUs.
Current Opinion in Critical Care 2012, 18, 479-486.

Sloan CE, Champenois K, Choisy P, Losina E, Walensky RP, Schackman BR, Ajana F, Melliez H, Paltiel AD, Freedberg KA, Yazdanpanah Y, CEoPAC(i
Newer drugs and earlier treatment: impact on lifetime cost of care for HIV-infected adults.
AIDS (London, England) 2012, 26, 45-56.

Dray-Spira R, Legeai C, Le Den M, Boué F, Lascoux-Combe C, Simon A, May T, Goujard C, Meyer L, ACCSG
Burden of HIV disease and comorbidities on the chances of maintaining employment in the era of sustained combined antiretoviral therapies use.
AIDS 2012, 26, 207–215.

Capeau J, Bouteloup V, Katlama C, Bastard JP, Guiyedi V, Salmon-Ceron D, Protopopescu C, Leport C, Raffi F, Chêne G, ACACCSG
Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment.
AIDS (London, England) 2012, 26, 303-314.

Lévy Y, Thiébaut R, Gougeon ML, Molina JM, Weiss L, Girard PM, Venet A, Morlat P, Poirier B, Lascaux AS, Boucherie C, Sereni D, Rouzioux C, Viard JP, Lane C, Delfraissy JF, Sereti I, Chêne G, ISG
Effect of intermittent interleukin-2 therapy on CD4+ T-cell counts following antiretroviral cessation in patients with HIV.
AIDS (London, England) 2012, 26, 711-720.

HCC
The effect of efavirenz versus nevirapine-containing regimens on immunologic, virologic and clinical outcomes in a prospective observational study.
AIDS (London, England) 2012, 26, 1691-1705.

Pasquet A, Ajana F, Melliez H, Giurca C, Poissy J, Yazdanpanah Y
Central nervous system HIV replication and HIV-related pachymeningitis in a patient on protease inhibitor monotherapy despite an undetectable plasma viral load.
AIDS (London, England) 2012, 26, 1726-1728.

Solas C, Pambrun E, Winnock M, Salmon D, Poizot-Martin I, Dominguez S, Bani-Sadr F, Izopet J, Garraffo R, Peytavin G, AC1HSG
Ribavirin and abacavir drug interaction in HIV-HCV coinfected patients: fact or fiction?.
AIDS (London, England) 2012, 26, 2193-2199.

PLTOI(Ipt, CoOHERE(G, Nakagawa F, Lodwick R, Costagliola D, van Sighem A, Torti C, Podzamczer D, Mocroft A, Ledergerber B, Dorrucci M, Cozzi-Lepri A, Jansen K, Masquelier B, García F, De Wit S, Stephan C, Obel N, Fätkenhaeuer G, Castagna A, Sambatakou H, Mussini C, Ghosn J, Zangerle R, Duval X, Meyer L, Perez-Hoyos S, Fabre Colin C, Kjaer J, Chene G, Grarup J, Phillips A
Calendar time trends in the incidence and prevalence of triple-class virologic failure in antiretroviral drug-experienced people with HIV in Europe.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 294-299.

Fagard C, Colin C, Charpentier C, Rami A, Jacomet C, Yeni P, Vittecoq D, Katlama C, Molina JM, Descamps D, Chêne G, Yazdanpanah Y, A1TTG
Long-term efficacy and safety of raltegravir, etravirine, and darunavir/ritonavir in treatment-experienced patients: week 96 results from the ANRS 139 TRIO trial.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 59, 489-493.

Henard S, Jeanmaire E, Nguyen Y, Yazdanpanah Y, Cheret A, Hoen B, Rey D, Borel A, Chavanet P, May T, Rabaud C, IG
Is total community viral load a robust predictive marker of the efficacy of the TasP strategy?.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 400-402.

Cuzin L, Trabelsi S, Delobel P, Barbuat C, Reynes J, Allavena C, Peytavin G, Ghosn J, Lascoux-Combe C, Psomas C, Corbeau P, Flandre P, A1MSg
Maraviroc intensification of stable antiviral therapy in HIV-1-infected patients with poor immune restoration: MARIMUNO-ANRS 145 study.
Journal of Acquired Immune Deficiency Syndromes (1999) 2012, 61, 557-564.

Bouadma L, Wolff M, Lucet JC
Ventilator-associated pneumonia and its prevention.
Current Opinion in Infectious Diseases 2012, 25, 395-404.

Zhao W, Cella M, Della Pasqua O, Burger D, Jacqz-Aigrain E, PENfToA(1sg
Population pharmacokinetics and maximum a posteriori probability Bayesian estimator of abacavir: application of individualized therapy in HIV-infected infants and toddlers.
British Journal of Clinical Pharmacology 2012, 73, 641-650.

Senneville E, Gaworowska D, Topolinski H, Devemy F, Nguyen S, Singer B, Beltrand E, Legout L, Caillaux M, Descamps D, Canonne JP, Yazdanpanah Y
Outcome of patients with diabetes with negative percutaneous bone biopsy performed for suspicion of osteomyelitis of the foot.
Diabet Med 2012, 29, 56-61.

Pichenot M, Deuffic-Burban S, Cuzin L, Yazdanpanah Y
Efficacy of new antiretroviral drugs in treatment-experienced HIV-infected patients: a systematic review and meta-analysis of recent randomized controlled trials.
HIV Med 2012, 13, 148-55.

Legout L, Sarraz-Bournet B, D'Elia PV, Devos P, Pasquet A, Caillaux M, Wallet F, Yazdanpanah Y, Senneville E, Haulon S, Leroy O
Characteristics and prognosis in patients with prosthetic vascular graft infection: a prospective observational cohort study.
Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 2012, 18, 352-358.

Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Hamet G, Martinot-Peignoux M, Matheron S, Marcellin P
Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: impact of HBV genotype G.
Liver International: Official Journal of the International Association for the Study of the Liver 2012, 32, 93-101.

Fournier S, Lepainteur M, Kassis-Chikhani N, Huang M, Brun-Buisson C, Jarlier V, AHOCG
Link between carbapenemase-producing Enterobacteria carriage and cross-border exchanges: eight-year surveillance in a large French multihospitals institution.
Journal of Travel Medicine 2012, 19, 320-323.

Grégoire C, Brumpt C, Loirat D, Lau N, Bruel C, Philippart F, Couzigou C, Garrouste-Orgeas M, Misset B
A case of daptomycin-induced immune thrombocytopenia.
Antimicrobial Agents and Chemotherapy 2012, 56, 6430-6431.

Visseaux B, Charpentier C, Hurtado-Nedelec M, Storto A, Antoine R, Peytavin G, Damond F, Matheron S, Brun-Vézinet F, Descamps D, FAH2C(C0V2
In vitro phenotypic susceptibility of HIV-2 clinical isolates to CCR5 inhibitors.
Antimicrobial Agents and Chemotherapy 2012, 56, 137-139.

Clavel C, Peytavin G, Tubiana R, Soulié C, Courbon E, Crenn-Hebert C, Ichou H, Blanc C, Schneider L, Katlama C, Marcelin AG, Mandelbrot L
Etravirine concentrations in the cervicovaginal compartment in HIV-1-infected women receiving etravirine-containing antiretroviral therapy: DIVA 02 study.
Antimicrobial Agents and Chemotherapy 2012, 56, 4018-4020.

Lazareth H, Peytavin G, Polivka L, Dupin N
The hairy-print for levamisole-induced vasculitis.
BMJ case reports 2012, 2012,

Champenois K, Le Gall JM, Jacquemin C, Jean S, Martin C, Rios L, Benoit O, Vermoesen S, Lert F, Spire B, Yazdanpanah Y
ANRS-COM'TEST: description of a community-based HIV testing intervention in non-medical settings for men who have sex with men.
BMJ open 2012, 2, e000693.

Deuffic-Burban S, Mathurin P, Pol S, Larsen C, Roudot-Thoraval F, Desenclos JC, Dhumeaux D, Yazdanpanah Y
Impact of hepatitis C triple therapy availability upon the number of patients to be treated and associated costs in France: a model-based analysis.
Gut 2012, 61, 290-296.

Fallot G, Halgand B, Garnier E, Branger M, Gervais A, Roque-Afonso AM, Thiers V, Billaud E, Matheron S, Samuel D, Féray C
Recombination of hepatitis B virus DNA in patients with HIV.
Gut 2012, 61, 1197-1208.

Schortgen F, Clabault K, Katsahian S, Devaquet J, Mercat A, Deye N, Dellamonica J, Bouadma L, Cook F, Beji O, Brun-Buisson C, Lemaire F, Brochard L
Fever control using external cooling in septic shock: a randomized controlled trial.
American Journal of Respiratory and Critical Care Medicine 2012, 185, 1088-1095.

Foucrier A, Woerther PL, Le Dorze M, Ruimy R, Laissy JP, Castier Y, Mourvillier B
Pulmonary sequestration syndrome diagnosed from a Nocardia infection.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 288.

Timsit JF, Mimoz O, Mourvillier B, Souweine B, Garrouste-Orgeas M, Alfandari S, Plantefeve G, Bronchard R, Troche G, Gauzit R, Antona M, Canet E, Bohe J, Lepape A, Vesin A, Arrault X, Schwebel C, Adrie C, Zahar JR, Ruckly S, Tournegros C, Lucet JC
Randomized controlled trial of chlorhexidine dressing and highly adhesive dressing for preventing catheter-related infections in critically ill adults.
American Journal of Respiratory and Critical Care Medicine 2012, 186, 1272-1278.

Shi JG, Chen X, Emm T, Scherle PA, McGee RF, Lo Y, Landman RR, McKeever EG, Punwani NG, Williams WV, Yeleswaram S
The effect of CYP3A4 inhibition or induction on the pharmacokinetics and pharmacodynamics of orally administered ruxolitinib (INCB018424 phosphate) in healthy volunteers.
Journal of Clinical Pharmacology 2012, 52, 809-818.

Scoccianti C, Vesin A, Martel G, Olivier M, Brambilla E, Timsit JF, Tavecchio L, Brambilla C, Field JK, Hainaut P, EELCC
Prognostic value of TP53, KRAS and EGFR mutations in nonsmall cell lung cancer: the EUELC cohort.
The European Respiratory Journal 2012, 40, 177-184.

Liquet B, Timsit JF, Rondeau V
Investigating hospital heterogeneity with a multi-state frailty model: application to nosocomial pneumonia disease in intensive care units.
BMC medical research methodology 2012, 12, 79.

Poissy J, Champenois K, Dewilde A, Melliez H, Georges H, Senneville E, Yazdanpanah Y
Impact of Herpes simplex virus load and red blood cells in cerebrospinal fluid upon herpes simplex meningo-encephalitis outcome.
BMC infectious diseases 2012, 12, 356.

Lapidus N, de Lamballerie X, Salez N, Setbon M, Ferrari P, Delabre RM, Gougeon ML, Vely F, Leruez-Ville M, Andreoletti L, Cauchemez S, Boëlle PY, Vivier E, Abel L, Schwarzinger M, Legeas M, Le Cann P, Flahault A, Carrat F
Integrative study of pandemic A/H1N1 influenza infections: design and methods of the CoPanFlu-France cohort.
BMC public health 2012, 12, 417.

Salmon-Ceron D, Cohen J, Winnock M, Roux P, Sadr FB, Rosenthal E, Martin IP, Loko MA, Mora M, Sogni P, Spire B, Dabis F, Carrieri MP, Hg
Engaging HIV-HCV co-infected patients in HCV treatment: the roles played by the prescribing physician and patients' beliefs (ANRS CO13 HEPAVIH cohort, France).
BMC health services research 2012, 12,

Meybeck A, Lecomte L, Valette M, Van Grunderbeeck N, Boussekey N, Chiche A, Georges H, Yazdanpanah Y, Leroy O
Should highly active antiretroviral therapy be prescribed in critically ill HIV-infected patients during the ICU stay? A retrospective cohort study.
AIDS research and therapy 2012, 9, 27.

Garrouste-Orgeas M, Philippart F, Bruel C, Max A, Lau N, Misset B
Overview of medical errors and adverse events.
Annals of Intensive Care 2012, 2, 2.

Mrozek N, Lautrette A, Timsit JF, Souweine B
How to deal with dialysis catheters in the ICU setting.
Annals of Intensive Care 2012, 2, 48.

Lucet JC
Methicillin-resistant Staphylococcus aureus carriage at ICU admission: to screen (rapidly) or not to screen?.
Critical Care (London, England) 2012, 16, 120.

Richard JCM, Pham T, Brun-Buisson C, Reignier J, Mercat A, Beduneau G, Régnier B, Mourvillier B, Guitton C, Castanier M, Combes A, Le Tulzo Y, Brochard L, Rsg
Interest of a simple on-line screening registry for measuring ICU burden related to an influenza pandemic.
Critical Care (London, England) 2012, 16, R118.

Zahar JR, Schwebel C, Adrie C, Garrouste-Orgeas M, Français A, Vesin A, Nguile-Makao M, Tabah A, Laupland K, Le-Monnier A, Timsit JF, Osg
Outcome of ICU patients with Clostridium difficile infection.
Critical Care (London, England) 2012, 16, R215.

Clec'h C, Darmon M, Lautrette A, Chemouni F, Azoulay E, Schwebel C, Dumenil AS, Garrouste-Orgeas M, Goldgran-Toledano D, Cohen Y, Timsit JF
Efficacy of renal replacement therapy in critically ill patients: a propensity analysis.
Critical Care (London, England) 2012, 16, R236.

Pajares MJ, Agorreta J, Larrayoz M, Vesin A, Ezponda T, Zudaire I, Torre W, Lozano MD, Brambilla E, Brambilla C, Wistuba II, Behrens C, Timsit JF, Pio R, Field JK, Montuenga LM
Expression of tumor-derived vascular endothelial growth factor and its receptors is associated with outcome in early squamous cell carcinoma of the lung.
Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 2012, 30, 1129-1136.

Sonneville R, Schmidt M, Messika J, Ait Hssain A, da Silva D, Klein IF, Bouadma L, Wolff M, Mourvillier B
Neurologic outcomes and adjunctive steroids in HIV patients with severe cerebral toxoplasmosis.
Neurology 2012, 79, 1762-1766.

Colombie V, Pugliese-Wehrlen S, Deuffic-Burban S, Cuzin L, Pugliese P, Katlama C, Poizot-Martin I, Raffi F, Cabie A, Dellamonica P, Yazdanpanah Y, D
Mean cost of a first combination antiretroviral therapy in HIV-infected patients in France, and determinants of expensive drugs prescription.
International journal of STD & AIDS 2012, 23, 865-869.

Schneider L, Ktorza N, Fourati S, Assoumou L, Courbon E, Caby F, Blanc C, Tindel M, Agher R, Marcelin AG, Calvez V, Peytavin G, Katlama C
Switch from etravirine twice daily to once daily in non-nucleoside reverse transcriptase inhibitor (NNRTI)-resistant HIV-infected patients with suppressed viremia: the Monetra study.
HIV clinical trials 2012, 13, 284-288.

OIPTotCoOHERiE(iE, Young J, Psichogiou M, Meyer L, Ayayi S, Grabar S, Raffi F, Reiss P, Gazzard B, Sharland M, Gutierrez F, Obel N, Kirk O, Miro JM, Furrer H, Castagna A, De Wit S, Muñoz J, Kjaer J, Grarup J, Chêne G, Bucher H
CD4 cell count and the risk of AIDS or death in HIV-Infected adults on combination antiretroviral therapy with a suppressed viral load: a longitudinal cohort study from COHERE.
PLoS medicine 2012, 9, e1001194.

Groh M, Faussart A, Villena I, Ajzenberg D, Carme B, Demar M, Joly V, Houze S, Simon S, Aubert D, Charlois-Ou C, Yeni P
Acute lung, heart, liver, and pancreatic involvements with hyponatremia and retinochoroiditis in a 33-year-old French Guianan patient.
PLoS neglected tropical diseases 2012

Boumendil A, Angus DC, Guitonneau AL, Menn AM, Ginsburg C, Takun K, Davido A, Masmoudi R, Doumenc B, Pateron D, Garrouste-Orgeas M, Somme D, Simon T, Aegerter P, Guidet B, ICsg
Variability of intensive care admission decisions for the very elderly.
PloS One 2012, 7, e34387.

Lepelletier D, Ravaud P, Baron G, Lucet JC
Agreement among health care professionals in diagnosing case Vignette-based surgical site infections.
PloS One 2012, 7, e35131.

Lucet JC, Laouenan C, Chelius G, Veziris N, Lepelletier D, Friggeri A, Abiteboul D, Bouvet E, Mentre F, Fleury E
Electronic sensors for assessing interactions between healthcare workers and patients under airborne precautions.
PloS One 2012, 7, e37893.

Bouadma L, Barbier F, Biard L, Esposito-Farèse M, Le Corre B, Macrez A, Salomon L, Bonnal C, Zanker C, Najem C, Mourvillier B, Lucet JC, Régnier B, Wolff M, Tubach F, IASG
Personal decision-making criteria related to seasonal and pandemic A(H1N1) influenza-vaccination acceptance among French healthcare workers.
PloS One 2012, 7, e38646.

Le Vu S, Velter A, Meyer L, Peytavin G, Guinard J, Pillonel J, Barin F, Semaille C
Biomarker-based HIV incidence in a community sample of men who have sex with men in Paris, France.
PloS One 2012

Verger P, Flicoteaux R, Schwarzinger M, Sagaon-Teyssier L, Peretti-Watel P, Launay O, Sebbah R, Moatti JP
Pandemic influenza (A/H1N1) vaccine uptake among French private general practitioners: a cross sectional study in 2010.
PloS One 2012, 7, e41837.

Pellissier G, Yazdanpanah Y, Adehossi E, Tosini W, Madougou B, Ibrahima K, Lolom I, Legac S, Rouveix E, Champenois K, Rabaud C, Bouvet E
Is universal HBV vaccination of healthcare workers a relevant strategy in developing endemic countries? The case of a university hospital in Niger.
PloS one 2012, 7, e44442.

Legriel S, Schraub O, Azoulay E, Hantson P, Magalhaes E, Coquet I, Bretonniere C, Gilhodes O, Anguel N, Megarbane B, Benayoun L, Schnell D, Plantefeve G, Charpentier J, Argaud L, Mourvillier B, Galbois A, Chalumeau-Lemoine L, Rivoal M, Durand F, Geffroy A, Simon M, Stoclin A, Pallot JL, Arbelot C, Nyunga M, Lesieur O, Troché G, Bruneel F, Cordoliani YS, Bedos JP, Pico F, CIPRESSG(
Determinants of recovery from severe posterior reversible encephalopathy syndrome.
PloS One 2012, 7, e44534.

Casalino E, Bernot B, Bouchaud O, Alloui C, Choquet C, Bouvet E, Damond F, Firmin S, Delobelle A, Nkoumazok BE, Der Sahakian G, Viard JP, Zbar OZD, Aslangul E, Krivine A, Zundel J, Ghosn J, Nordmann P, Claessens YE, Tahi T, Riou B, Gautheret-Dejean A, Katlama C, Hausfater P, Brun-Vézinet F, Costagliola D
Twelve months of routine HIV screening in 6 emergency departments in the Paris area: results from the ANRS URDEP study.
PLoS ONE 2012, 7, e46437.

Hocqueloux L, Choisy P, Le Moal G, Borsa-Lebas F, Plainchamp D, Legac E, Prazuck T, de la Tribonnière X, Yazdanpanah Y, Parienti JJ
Pharmacologic boosting of atazanavir in maintenance HIV-1 therapy: the COREYA propensity-score adjusted study.
PloS One 2012, 7, e49289.

Roux D, Huy C, Lolom I, Andremont A, Arlet G, Armand-Lefevre L, Lucet JC
Diversity of extended-spectrum β-lactamase-producing Enterobacteriaceae on hospital admission.
Scandinavian Journal of Infectious Diseases 2012, 44, 231-236.

Lupo J, Bernard S, Wintenberger C, Baccard M, Vabret A, Antona D, Timsit JF, Morand P
Fatal measles without rash in immunocompetent adult, France.
Emerging Infectious Diseases 2012, 18, 521-523.

Cojean S, Houzé S, Haouchine D, Huteau F, Lariven S, Hubert V, Michard F, Bories C, Pratlong F, Le Bras J, Loiseau PM, Matheron S
Leishmania resistance to miltefosine associated with genetic marker.
Emerging Infectious Diseases 2012, 18, 704-706.

Marcelin AG, Descamps D, Tamalet C, Cottalorda J, Izopet J, Delaugerre C, Morand-Joubert L, Trabaud MA, Bettinger D, Rogez S, Ruffault A, Henquell C, Signori-Schmuck A, Bouvier-Alias M, Vallet S, Masquelier B, Flandre P, Calvez V, AARSg
Emerging mutations and associated factors in patients displaying treatment failure on an etravirine-containing regimen.
Antiviral Therapy 2012, 17, 119-123.

Boufassa F, Goujard C, Viard JP, Carlier R, Lefebvre B, Yeni P, Bouchaud O, Capeau J, Meyer L, Vigouroux C, ACCSG
Immune deficiency could be an early risk factor for altered insulin sensitivity in antiretroviral-naive HIV-1-infected patients: the ANRS COPANA cohort.
Antivir. Ther. (Lond.) 2012, 17, 91–100.

Lada O, Gervais A, Branger M, Peytavin G, Roquebert B, Collin G, Fraqueiro G, Moucari R, Leclerc L, Martinot-Peignoux M, Matheron S, Marcellin P
Quasispecies analysis and in vitro susceptibility of HBV strains isolated from HIV-HBV-coinfected patients with delayed response to tenofovir.
Antiviral Therapy 2012, 17, 61-70.

Protopopescu C, Raffi F, Brunet-François C, Salmon D, Verdon R, Reboud P, Carrieri MP, Leport C, Spire B, Michel L, AC(CSG
Incidence, medical and socio-behavioural predictors of psychiatric events in an 11-year follow-up of HIV-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1079-1083.

Calin R, Paris L, Simon A, Peytavin G, Wirden M, Schneider L, Valantin MA, Tubiana R, Agher R, Katlama C
Dual raltegravir/etravirine combination in virologically suppressed HIV-1-infected patients on antiretroviral therapy.
Antiviral Therapy 2012, 17, 1601-1604.

Breton G, Bourgarit A, Pavy S, Bonnet D, Martinez V, Duval X, Longuet P, Abgrall S, Simon A, Leport C, PTSG
Treatment for tuberculosis-associated immune reconstitution inflammatory syndrome in 34 HIV-infected patients.
The International Journal of Tuberculosis and Lung Disease: The Official Journal of the International Union Against Tuberculosis and Lung Disease 2012, 16, 1365-1370.

Fournier S, Brossier F, Fortineau N, Gillaizeau F, Akpabie A, Aubry A, Barbut F, Chedhomme FX, Kassis-Chikhani N, Lucet JC, Robert J, Seytre D, Simon I, Vanjak D, Zahar JR, Brun-Buisson C, Jarlier V
Long-term control of vancomycin-resistant Enterococcus faecium at the scale of a large multihospital institution: a seven-year experience.
Euro Surveillance: Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin 2012, 17,